Neoplasms and Tumor Classification
791 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What are the two basic components of neoplasms?

Clonal cells and reactive stroma.

How do benign tumors differ from malignant tumors?

Benign tumors are localized and do not metastasize, whereas malignant tumors can invade locally and spread to distant sites.

What role does reactive stroma play in neoplasms?

Reactive stroma influences tumor growth and the response to therapies.

What are the histological differences between Squamous Cell Carcinoma and Basal Cell Carcinoma?

<p>SCC has a higher propensity for metastasis compared to BCC, which is typically localized.</p> Signup and view all the answers

Describe the significance of morphology in tumor classification.

<p>Morphology helps classify tumors based on their appearance under a microscope.</p> Signup and view all the answers

What is the relationship between colonic adenomas and colorectal carcinoma?

<p>Colonic adenomas can progress to colorectal carcinoma if they acquire invasive characteristics.</p> Signup and view all the answers

What types of tumors are classified as hematopoietic tumors?

<p>Hematopoietic tumors include conditions like Hodgkin lymphoma.</p> Signup and view all the answers

What is the importance of immunohistochemistry in tumor classification?

<p>Immunohistochemistry is used to classify tumors based on specific markers, distinguishing between types such as epithelial or hematopoietic.</p> Signup and view all the answers

What are the three components evaluated in the Nottingham Grading System for breast cancer?

<p>The components are tubule formation, nuclear grade, and mitotic rate.</p> Signup and view all the answers

How does the Gleason Scoring System determine the aggressiveness of prostate cancer?

<p>The Gleason score is the sum of the two most prevalent grades of tissue architecture, ranging from 2 to 10.</p> Signup and view all the answers

What does a lower grade in tumor grading systems typically suggest about a patient's prognosis?

<p>A lower grade suggests a better prognosis and potentially less aggressive treatment.</p> Signup and view all the answers

What are the four mechanisms by which tumors metastasize?

<p>The mechanisms are local invasion, lymphatic spread, hematogenous spread, and spread within body cavities.</p> Signup and view all the answers

Why is early detection significant in cancer treatment?

<p>Early detection can lead to improved prognosis and more effective treatment outcomes.</p> Signup and view all the answers

What complication can arise from tumor spread in body cavities like the peritoneal space?

<p>It can lead to malignant ascites, which is difficult to treat due to its diffuse nature.</p> Signup and view all the answers

How does the AJCC Staging System classify cancer?

<p>It classifies cancer based on the TNM classification: Tumor size and extent, lymph Node involvement, and presence of Metastasis.</p> Signup and view all the answers

What does the term 'iatrogenic spread' refer to in the context of tumor spread?

<p>Iatrogenic spread refers to the spread of tumors as a result of medical procedures, such as needle biopsies.</p> Signup and view all the answers

What clinical relevance does tumor grading and staging have on treatment decisions?

<p>Tumor grading and staging influence decisions about surgery, chemotherapy, and hormonal therapy.</p> Signup and view all the answers

In the Gleason Scoring System, what does a score of 7 indicate?

<p>A Gleason score of 7 indicates that the tumor tissue is moderately differentiated.</p> Signup and view all the answers

What role does angiogenesis play in the survival of metastasized tumors?

<p>Angiogenesis allows tumors to establish a blood supply necessary for their growth and survival after metastasis.</p> Signup and view all the answers

What is the significance of tumor tattooing during a core biopsy?

<p>Tumor tattooing is crucial to mark the biopsy site, ensuring complete excision of both the tumor and any potential spread along the needle path.</p> Signup and view all the answers

What can bone metastases lead to in patients?

<p>Bone metastases can lead to pain, disability, and unexpected fractures.</p> Signup and view all the answers

How have recent revisions in staging criteria for thyroid cancer altered the focus of assessment?

<p>Revisions emphasize the need for actual invasion into adjacent structures rather than just capsule penetration.</p> Signup and view all the answers

How does chronic inflammation contribute to cancer development?

<p>Chronic inflammation, such as that caused by infections like Helicobacter pylori, can lead to the transformation of normal cells into cancerous ones.</p> Signup and view all the answers

What is the role of driver mutations in cancer?

<p>Driver mutations are critical genetic alterations that confer a selective advantage to tumor cells, allowing for uncontrolled growth and proliferation.</p> Signup and view all the answers

What distinguishes passenger mutations from driver mutations?

<p>Passenger mutations do not contribute to cancer progression and are seen as byproducts, while driver mutations actively promote tumorigenesis.</p> Signup and view all the answers

Why is pancreatic cancer associated with high mortality rates?

<p>Pancreatic cancer typically presents with late-stage diagnosis and is highly aggressive, leading to poor survival outcomes.</p> Signup and view all the answers

How do oncogenes contribute to cancer?

<p>Oncogenes promote cancer development by driving uncontrolled cell proliferation when mutated or overexpressed.</p> Signup and view all the answers

What is meant by tumor heterogeneity?

<p>Tumor heterogeneity refers to the presence of genetically distinct subpopulations of cancer cells within a single tumor, each with unique mutations.</p> Signup and view all the answers

Explain the concept of senescent cells in relation to cancer recurrence.

<p>Senescent cells are non-dividing cells that can contribute to cancer recurrence due to their resistance to conventional therapies.</p> Signup and view all the answers

How does the microenvironment influence cancer development?

<p>The microenvironment can provide signals that promote tumor growth, such as through hypoxia-induced anaerobic respiration.</p> Signup and view all the answers

What is the significance of cell division in the context of mutations?

<p>Mutations occur most frequently during DNA replication and are only passed on during cell division, leading to clonal expansion.</p> Signup and view all the answers

What are the implications of tumor adaptations on therapeutic approaches?

<p>Tumor adaptations through pathway co-option can render therapies ineffective as tumors exploit existing cellular pathways.</p> Signup and view all the answers

Why is understanding the aetiology of carcinogenesis important?

<p>Understanding the aetiology of carcinogenesis is critical for identifying the mutations that initiate cancer and how they contribute to tumor progression.</p> Signup and view all the answers

How do screening programs aim to reduce cancer mortality?

<p>Screening programs focus on early detection of prevalent cancers, which can lead to more effective treatment and improved survival rates.</p> Signup and view all the answers

What is the effect of the immune system on cancer development?

<p>The immune system can exert selective pressure on tumors, influencing their evolution and the emergence of resistant clones.</p> Signup and view all the answers

What are tumor suppressor genes and their role in cancer?

<p>Tumor suppressor genes normally inhibit cell growth, and mutations in these genes can lead to loss of growth control and cancer development.</p> Signup and view all the answers

What makes squamous cell carcinoma (SCC) more concerning in terms of prognosis compared to basal cell carcinoma (BCC)?

<p>SCC has a greater potential for lymphatic and distant spread, making it more aggressive.</p> Signup and view all the answers

Describe the typical management approach for basal cell carcinoma (BCC).

<p>Management typically involves surgical excision, and systemic treatment is rarely required.</p> Signup and view all the answers

What is the significance of tumor mutational burden in targeted therapy?

<p>High tumor mutational burden can guide the use of immunomodulatory therapies due to better responsiveness.</p> Signup and view all the answers

How are tumors classified by biological behavior?

<p>Tumors are classified as benign, malignant, or intermediate/borderline based on their potential for invasion and spread.</p> Signup and view all the answers

Give an example of a benign neoplasm and describe its characteristics.

<p>An example is an adenoma, which is clonal and has no capacity to invade other tissues.</p> Signup and view all the answers

What are the characteristics that define anaplasia in tumor cells?

<p>Anaplasia is characterized by pleomorphism, atypical mitotic figures, lack of polarity, and abnormal nuclear morphology.</p> Signup and view all the answers

What is metaplasia and provide an example?

<p>Metaplasia is the replacement of one differentiated cell type with another, such as the replacement of squamous epithelium with columnar epithelium in Barrett's Esophagus.</p> Signup and view all the answers

How does dysplasia differ from metaplasia?

<p>Dysplasia is characterized by abnormal cell growth within the epithelium and is a pre-cancerous condition, while metaplasia is a change in cell type due to chronic irritation.</p> Signup and view all the answers

What is the role of the WHO Blue Books in tumor classification?

<p>The WHO Blue Books provide a standardized classification system for tumors, incorporating new findings to maintain global consistency.</p> Signup and view all the answers

What defines a malignant neoplasm, such as adenocarcinoma?

<p>Malignant neoplasms, like adenocarcinoma, exhibit properties of invasiveness and can metastasize to distant sites.</p> Signup and view all the answers

Describe the appearance of an anaplastic tumor cell.

<p>Anaplastic tumor cells often show irregular nuclear shapes, high nuclear-cytoplasmic ratios, and abnormal mitotic figures.</p> Signup and view all the answers

What is Familial Adenomatous Polyposis (FAP) and its clinical significance?

<p>FAP is characterized by numerous benign polyps in the colon that have a high risk of progressing to colorectal carcinoma.</p> Signup and view all the answers

What factors potentially influence the reversibility of metaplasia?

<p>Metaplasia can be reversible if the underlying cause, such as chronic irritation, is effectively removed.</p> Signup and view all the answers

Explain the significance of tumor-agnostic biomarkers in cancer treatment.

<p>Tumor-agnostic biomarkers, like high mutational burden, help guide treatment across various tumor types, making them crucial for personalized therapy.</p> Signup and view all the answers

What are typical imaging and diagnostic methods used for neoplasia?

<p>Imaging techniques, morphological assessments, and immunohistochemical profiles are used to diagnose neoplasia.</p> Signup and view all the answers

What role does the immune system play in the presence of pre-cancerous mutations in non-cancerous eyelid skin?

<p>The immune system helps prevent the progression of UV-induced damage into visible cancer by recognizing and dealing with abnormal cells.</p> Signup and view all the answers

Which types of HPV are most commonly associated with cervical cancer, and what percentage of cases do they account for?

<p>HPV types 16 and 18 are linked to approximately 70% of cervical cancer cases.</p> Signup and view all the answers

What is the significance of gene expression in determining the identity of different cell types despite the presence of the same DNA?

<p>Gene expression controls which genes are active in a cell, leading to different functions and identities among cell types.</p> Signup and view all the answers

What are enhancers and how do they influence gene transcription?

<p>Enhancers are DNA sequences that bind transcription factors, helping recruit proteins to initiate transcription by bending DNA to bring them closer to the promoter.</p> Signup and view all the answers

Explain the role of transcription factors in the regulation of gene expression.

<p>Transcription factors bind to specific DNA sequences to promote or inhibit transcription, often requiring additional signals like hormones for activation.</p> Signup and view all the answers

What is the difference between spatial and temporal regulation in gene expression?

<p>Spatial regulation refers to gene expression occurring in specific tissues, while temporal regulation refers to expression at particular developmental stages.</p> Signup and view all the answers

What is post-transcriptional regulation and what are its main components?

<p>Post-transcriptional regulation involves RNA processing, including capping, poly-adenylation, and splicing, impacting mRNA stability and translation.</p> Signup and view all the answers

Describe the process and significance of alternative splicing.

<p>Alternative splicing allows one gene to produce multiple protein variants by including different combinations of exons in the mRNA.</p> Signup and view all the answers

How does mRNA stability affect gene expression?

<p>The lifespan of mRNA in the cytoplasm influences how much protein can be produced, with some proteins stabilizing mRNA to prolong its expression.</p> Signup and view all the answers

What is the role of non-coding RNA in the genome?

<p>Non-coding RNAs, like rRNA and miRNA, play critical roles in regulating gene expression and are involved in various cellular processes.</p> Signup and view all the answers

How do miRNAs regulate gene expression post-transcriptionally?

<p>miRNAs bind to mRNA and form complexes that inhibit translation, thus down-regulating gene expression.</p> Signup and view all the answers

Describe the translation process and its components.

<p>Translation is the process where ribosomes synthesize proteins from mRNA using tRNA to match codons with corresponding amino acids.</p> Signup and view all the answers

What is the significance of having 5' capping and poly-A tail in mRNA?

<p>5' capping and the poly-A tail protect mRNA from degradation and aid in the initiation of translation.</p> Signup and view all the answers

Explain how ribosomes contribute to protein synthesis.

<p>Ribosomes facilitate the matching of tRNA to mRNA codons and catalyze the formation of peptide bonds between amino acids to create polypeptides.</p> Signup and view all the answers

What is MYC addiction and its significance in tumors?

<p>MYC addiction refers to the phenomenon where tumors depend heavily on MYC for survival, making it critical for tumor growth.</p> Signup and view all the answers

What role do Ras proteins play in cancer development?

<p>Ras proteins, particularly K-Ras, act as GTPases that, when mutated, lead to uncontrolled activation of signaling pathways that promote cancer.</p> Signup and view all the answers

How do tumor suppressor genes function in relation to cell proliferation?

<p>Tumor suppressor genes act as regulatory mechanisms that inhibit cell growth and can initiate apoptosis in response to DNA damage.</p> Signup and view all the answers

What is meant by the 'two-hit' effect concerning tumor suppressor genes?

<p>The 'two-hit' effect describes the requirement for both alleles of a tumor suppressor gene to be inactivated for loss of function to occur.</p> Signup and view all the answers

Explain how genomic instability relates to tumor progression.

<p>Genomic instability leads to increased mutations, which create a feedback loop that promotes further tumor progression.</p> Signup and view all the answers

What types of mutations can contribute to cancer, and which are more common?

<p>Both large-scale mutations, like chromosomal translocations, and small-scale mutations, such as point mutations, can contribute to cancer; small-scale mutations are more common.</p> Signup and view all the answers

How does random mutation facilitate carcinogenesis?

<p>Random mutations provide selective advantages to tumor cells, allowing them to proliferate uncontrollably.</p> Signup and view all the answers

What distinguishes oncogenes from tumor suppressor genes?

<p>Oncogenes promote cancer progression when mutated, while tumor suppressor genes inhibit growth and induce apoptosis.</p> Signup and view all the answers

Describe how hereditary mutations can lead to cancer susceptibility.

<p>Hereditary mutations can predispose individuals to cancer by requiring only one additional hit to inactivate the remaining allele of a tumor suppressor gene.</p> Signup and view all the answers

Discuss the impact of UV radiation on skin cancer development.

<p>UV radiation causes direct DNA damage and can lead to mutations that contribute to the development of skin cancer.</p> Signup and view all the answers

What role does the immune system play in managing UV-induced skin damage?

<p>The immune system helps remove pre-cancerous cells that arise from UV-induced DNA damage.</p> Signup and view all the answers

Explain the significance of the 'Philadelphia chromosome' in leukemia.

<p>The 'Philadelphia chromosome' is a specific translocation associated with chronic myeloid leukemia (CML), disrupting normal cell function.</p> Signup and view all the answers

Describe how tumor heterogeneity complicates cancer treatment.

<p>Tumor heterogeneity results from genetic diversity within the tumor, making it difficult for therapies to effectively target all tumor cells.</p> Signup and view all the answers

What are the consequences of mutations in the Ras signaling pathway?

<p>Mutations in the Ras signaling pathway can lead to continuous cell growth and division due to the unregulated activation of downstream signaling cascades.</p> Signup and view all the answers

How does alcohol consumption enhance cancer risk?

<p>Chronic alcohol consumption can damage tissues directly and elevate hormone levels, increasing the risk of certain cancers.</p> Signup and view all the answers

What is the role of microRNAs in translation regulation?

<p>MicroRNAs can bind to mRNA and prevent ribosomes from attaching, thereby inhibiting translation.</p> Signup and view all the answers

How do translation initiation factors influence translation efficiency?

<p>Translation initiation factors help assemble the ribosome complex and their availability can regulate translation efficiency based on the protein needs.</p> Signup and view all the answers

Explain the significance of tRNA heterogeneity and codon usage bias.

<p>The relative abundance of tRNA and the preferential use of specific codons can regulate the rate of translation in different tissues.</p> Signup and view all the answers

What are chaperones and their role in protein folding?

<p>Chaperones are proteins that assist in the proper folding and stabilization of other proteins.</p> Signup and view all the answers

Define phosphorylation and its relevance in cancer research.

<p>Phosphorylation is the addition of phosphate groups to proteins for activation, and phosphorylated kinases can indicate tumor presence or progression.</p> Signup and view all the answers

Describe the concept of epigenetic regulation.

<p>Epigenetic regulation involves changes in gene expression without altering the DNA sequence itself.</p> Signup and view all the answers

What is the effect of DNA methylation on gene expression?

<p>DNA methylation leads to gene silencing by condensing DNA into a less accessible form, inhibiting transcription.</p> Signup and view all the answers

How do histone modifications impact chromatin structure?

<p>Histone acetylation loosens chromatin structure, making it more accessible for transcription, while deacetylation condenses it, reducing accessibility.</p> Signup and view all the answers

What are histone deacetylases (HDACs) and their implications in cancer?

<p>HDACs remove acetyl groups from histones, leading to gene silencing and are associated with reduced transcription in cancer cells.</p> Signup and view all the answers

How does cancer typically originate at the cellular level?

<p>Cancer usually begins from a single abnormal cell due to genetic mutations or epigenetic changes leading to uncontrolled cell growth.</p> Signup and view all the answers

What are the stages of tumor development?

<p>The stages include initiation (initial mutation), promotion (clonal expansion), and progression (invasive behavior).</p> Signup and view all the answers

How do mutations in coding regions differ from those in non-coding regions?

<p>Mutations in coding regions can directly impact cell behavior, while mutations in non-coding regions may not affect function.</p> Signup and view all the answers

What is the relationship between dysregulated gene expression and cancer?

<p>Dysregulated gene expression in cancer involves increased growth-promoting genes and decreased apoptosis-regulating genes.</p> Signup and view all the answers

What are some common post-translational modifications?

<p>Common modifications include phosphorylation, glycosylation, methylation, and acetylation.</p> Signup and view all the answers

How do mutations in proto-oncogenes contribute to cancer?

<p>Mutations in proto-oncogenes can activate them into oncogenes, leading to uncontrolled cell growth due to gain-of-function mutations.</p> Signup and view all the answers

What is the role of tumor suppressor genes in cancer prevention?

<p>Tumor suppressor genes typically inhibit cell division and facilitate DNA repair; their inactivation can remove crucial growth controls.</p> Signup and view all the answers

What is epithelial-mesenchymal transition (EMT) and its significance in cancer?

<p>EMT is a process where epithelial cells lose adhesion and gain migratory traits, facilitating cancer invasion and metastasis.</p> Signup and view all the answers

How can gene expression profiling aid in breast cancer treatment?

<p>Gene expression profiling can categorize breast cancer into subtypes, allowing for targeted therapies based on specific molecular features.</p> Signup and view all the answers

Why is tumor heterogeneity a significant challenge in cancer treatment?

<p>Tumor heterogeneity leads to variations between and within tumors, complicating targeted therapies and contributing to relapse and drug resistance.</p> Signup and view all the answers

Explain the impact of post-transcriptional dysregulation on cancer progression.

<p>Post-transcriptional dysregulation, such as abnormal splicing and mRNA stability, can alter the levels of proteins that drive cancer development.</p> Signup and view all the answers

What are the implications of using platelets for gene expression profiling in myelofibrosis?

<p>Profiling platelets can help classify disease subtypes and predict progression, making monitoring less invasive than bone marrow examinations.</p> Signup and view all the answers

What mechanisms contribute to clonal heterogeneity in tumors?

<p>Clonal heterogeneity arises from genetic and epigenetic alterations, adaptive responses, and fluctuations in signaling pathways.</p> Signup and view all the answers

Describe how oncogenes are related to cancer proliferation.

<p>Oncogenes result from gain-of-function mutations that enhance their activity, promoting excessive cell division and tumor growth.</p> Signup and view all the answers

Discuss the importance of molecular profiling in advancing personalized medicine for cancer.

<p>Molecular profiling can identify deregulated pathways in a patient's cancer, leading to tailored treatment strategies specific to their tumor profile.</p> Signup and view all the answers

How does alternative splicing contribute to cancer progression?

<p>Alternative splicing can produce variant proteins that may promote uncontrolled cell division or inhibit apoptotic processes.</p> Signup and view all the answers

In what way can tumor suppressor genes be lost in cancer cells?

<p>Tumor suppressor genes can be inactivated through mutations or deletions, leading to diminished control over cell growth and division.</p> Signup and view all the answers

What practical role does gene expression profiling play in understanding breast cancer subtypes?

<p>It allows for the classification of breast cancer into specific subtypes, each with distinct prognoses and responses to therapies.</p> Signup and view all the answers

What is the significance of understanding gene expression alterations in cancer therapy?

<p>Understanding these alterations helps identify key pathways involved in cancer progression, informing targeted therapies and improving patient outcomes.</p> Signup and view all the answers

What are BRAF inhibitors used for in cancer treatment?

<p>BRAF inhibitors are used to target specific BRAF mutations in tumors, particularly in melanoma.</p> Signup and view all the answers

How do AKT inhibitors contribute to cancer therapy?

<p>AKT inhibitors induce apoptosis by blocking survival signals in cancer cells.</p> Signup and view all the answers

What role do combination therapies play in overcoming resistance?

<p>Combination therapies target different pathways or components, which can help prevent or overcome resistance to treatments.</p> Signup and view all the answers

Why is hyperactivation of signaling pathways significant in cancer development?

<p>Hyperactivation can lead to aberrant cell proliferation and survival, contributing to carcinogenesis.</p> Signup and view all the answers

What is the significance of the PI3K-AKT pathway in cancer?

<p>The PI3K-AKT pathway is crucial for promoting cell survival and growth, making it a target for cancer therapy.</p> Signup and view all the answers

What is the function of Gleevec in cancer treatment?

<p>Gleevec is designed to inhibit the BCR-ABL fusion protein, which is an oncogenic driver in certain leukemias.</p> Signup and view all the answers

What are the implications of resistance mechanisms in targeted cancer therapies?

<p>Resistance mechanisms, such as mutations in the targeted pathways, can limit the effectiveness of existing therapies.</p> Signup and view all the answers

What is the impact of ongoing research on cancer therapies?

<p>Ongoing research focuses on developing new inhibitors and effective combination therapies to improve treatment outcomes.</p> Signup and view all the answers

What is the purpose of age standardization in cancer epidemiology?

<p>To allow for fair comparisons of cancer incidence rates across different populations or time periods by adjusting for age distribution.</p> Signup and view all the answers

How did the age-standardized incidence rate of all cancers change from 1982 to 2021?

<p>It increased from 383/100,000 to 486/100,000.</p> Signup and view all the answers

What are some common reasons for the increase in breast and prostate cancer rates?

<p>Improved screening practices and technologies, leading to early detection of cancers.</p> Signup and view all the answers

What factor is primarily responsible for the increase in mesothelioma cases?

<p>Asbestos exposure, reflecting past use of the material.</p> Signup and view all the answers

How does smoking impact lung cancer rates, based on historical trends?

<p>The decline in smoking rates has led to a decrease in lung cancer rates, although there is a lag of about 20 years.</p> Signup and view all the answers

At what age does screening for bowel cancer typically begin?

<p>Screening usually starts at age 50.</p> Signup and view all the answers

What is the main difference between screening tests and diagnostic tests?

<p>Screening tests identify individuals who may have a disease, while diagnostic tests confirm the presence or absence of a disease.</p> Signup and view all the answers

What is a key limitation of cancer screening programs?

<p>They can detect indolent cancers that may never progress or cause harm.</p> Signup and view all the answers

What is the survival rate trend for cancers from the mid-1980s to recent years?

<p>The five-year survival rate has increased from around 50% to approximately 75%.</p> Signup and view all the answers

Why is it significant that the PSA test is used unofficially for prostate cancer screening?

<p>It indicates variability in recommendations and reliance on individual risk factors for screening decisions.</p> Signup and view all the answers

What is the primary aim of cancer screening programs?

<p>To detect asymptomatic cancers early to improve treatment outcomes.</p> Signup and view all the answers

How has technological advancement impacted cancer diagnosis and incidence rates?

<p>Advancements have led to improved detection capabilities, thus increasing reported cancer incidence.</p> Signup and view all the answers

What age group is cervical cancer screening generally recommended to start?

<p>Screening typically begins at age 25.</p> Signup and view all the answers

What is a reason for the increased incidence of melanoma linked to sunshine exposure?

<p>Increased sun exposure over time and changes in diagnostic practices may contribute to higher melanoma rates.</p> Signup and view all the answers

What is the primary purpose of analytical epidemiology?

<p>To understand the relationship between risk factors and disease outcomes, aiming to establish causation rather than mere association.</p> Signup and view all the answers

Explain the difference between association and causation in epidemiology.

<p>Association refers to a relationship between two variables, while causation implies that one variable directly affects another.</p> Signup and view all the answers

What key feature distinguishes case-control studies from cohort studies?

<p>Case-control studies compare individuals with a disease (cases) to those without (controls), while cohort studies follow disease-free individuals over time.</p> Signup and view all the answers

What is ecological fallacy, and why is it a limitation in ecological studies?

<p>Ecological fallacy occurs when associations observed at the group level do not reflect individual risk, making these studies less reliable for causal inference.</p> Signup and view all the answers

How do randomized controlled trials ensure a robust assessment of causation?

<p>Participants in randomized controlled trials are randomly assigned to either an intervention group or a control group, which controls for confounding variables.</p> Signup and view all the answers

What is the significance of the odds ratio in case-control studies?

<p>The odds ratio compares the odds of exposure in cases versus controls, providing insight into potential associations between exposures and diseases.</p> Signup and view all the answers

Identify one strength and one limitation of case-control studies.

<p>Strength: Efficient for studying rare diseases. Limitation: Retrospective nature can introduce biases like recall bias.</p> Signup and view all the answers

What role do screening programs play in disease management?

<p>Screening programs aim to detect diseases early to improve survival rates; however, they may have limitations such as false positives.</p> Signup and view all the answers

What is a cohort in the context of cohort studies?

<p>A cohort is a group of individuals who share a common characteristic or event, followed over time to observe disease development.</p> Signup and view all the answers

Why is the consideration of comparison groups essential in analytical epidemiology?

<p>Comparison groups allow researchers to evaluate the impact of risk factors by contrasting outcomes between exposed and unexposed individuals.</p> Signup and view all the answers

What are PFAs, and why are they significant in cancer epidemiology?

<p>PFAs are chemicals identified as Group 1 carcinogens; exposure increases cancer risk but does not guarantee cancer development.</p> Signup and view all the answers

Describe a limitation of ecological studies in establishing causal relationships.

<p>Ecological studies rely on aggregated data, which may not accurately represent individual-level associations and can lead to incorrect conclusions.</p> Signup and view all the answers

What are microRNAs and how do they affect gene expression?

<p>MicroRNAs are small, non-coding RNAs that regulate gene expression post-transcriptionally by binding to target mRNAs and either inhibiting translation or inducing degradation.</p> Signup and view all the answers

Explain the role of long non-coding RNAs (lncRNAs) in gene regulation.

<p>Long non-coding RNAs play roles in gene regulation by affecting chromatin remodeling, transcriptional regulation, and splicing.</p> Signup and view all the answers

How do cohort studies contribute to understanding disease causation?

<p>Cohort studies follow individuals over time to compare disease incidence among those exposed to potential risk factors versus those who are not.</p> Signup and view all the answers

What advantage do case-control studies offer when researching diseases with long latency?

<p>They allow researchers to investigate rare diseases efficiently without waiting for new cases since they can look back at past exposures.</p> Signup and view all the answers

Describe the significance of transcription factor mutations in cancer.

<p>Mutations in transcription factors, such as p53 or MYC, can lead to abnormal gene expression patterns, which are often associated with cancer development.</p> Signup and view all the answers

What is descriptive epidemiology and what does it focus on?

<p>Descriptive epidemiology focuses on the distribution of diseases in a population by observing the basic features of its distribution concerning time, place, and person.</p> Signup and view all the answers

Differentiate between incidence and prevalence.

<p>Incidence refers to the number of new cases of a disease over a specific period, while prevalence refers to the total number of existing cases at a certain time.</p> Signup and view all the answers

How does age affect cancer incidence?

<p>As the population ages, the incidence of cancer cases increases due to older individuals being more likely to develop the disease.</p> Signup and view all the answers

What does cumulative incidence measure?

<p>Cumulative incidence measures the risk of developing a condition by showing how many people will develop the disease within a specified timeframe.</p> Signup and view all the answers

Explain what age-standardized rates are and why they are used.

<p>Age-standardized rates adjust for age differences in populations to allow fair comparisons of disease rates over time or between different populations.</p> Signup and view all the answers

Outline the main purpose of analytical epidemiology.

<p>The main purpose of analytical epidemiology is to understand the determinants of diseases by exploring relationships between exposures and disease outcomes.</p> Signup and view all the answers

What is the significance of microRNA-RISC complex in gene expression?

<p>The microRNA-RISC complex inhibits translation or induces degradation of target mRNAs, thereby reducing protein production.</p> Signup and view all the answers

How do circular RNAs (circRNAs) influence gene expression?

<p>Circular RNAs act as decoys for RNA-binding proteins or miRNAs, preventing their interaction with target RNAs, which indirectly affects gene expression.</p> Signup and view all the answers

Identify the two main principles of epidemiology.

<p>The two main principles of epidemiology are understanding populations (who, where, when) and comparing differences between groups.</p> Signup and view all the answers

What is meant by the term 'population at risk' in epidemiological studies?

<p>Population at risk refers to individuals who have the potential to become a case of the health event being studied.</p> Signup and view all the answers

What is angiogenesis and its role in tumor growth?

<p>Angiogenesis is the formation of new blood vessels that supply the growing tumor with essential nutrients and oxygen.</p> Signup and view all the answers

What are the two primary pathways involved in signal transduction?

<p>The two primary pathways are the JAK-STAT pathway and the Ras-Raf-MEK-ERK pathway.</p> Signup and view all the answers

Why is the distinction between crude incidence rate and age-standardized incidence rate important?

<p>The distinction is important because the crude incidence rate does not consider age distribution, whereas age-standardized rates adjust for age differences, allowing for fairer comparisons.</p> Signup and view all the answers

Define the function of second messengers in signal transduction.

<p>Second messengers amplify the signal received from the receptor and initiate further cellular responses.</p> Signup and view all the answers

What roles do kinases and phosphatases play in cellular signaling?

<p>Kinases add phosphate groups to proteins, activating them, while phosphatases remove phosphate groups, deactivating them.</p> Signup and view all the answers

Explain the importance of the Epidermal Growth Factor (EGF) in cancer biology.

<p>EGF binds to its receptor, activating signaling pathways that promote cell proliferation and survival, often dysregulated in cancer.</p> Signup and view all the answers

What characterizes G-Protein Coupled Receptors (GPCRs) in cellular processes?

<p>GPCRs are involved in numerous physiological processes and influence cell growth and survival through various signaling pathways.</p> Signup and view all the answers

How does the JAK-STAT pathway operate upon cytokine binding?

<p>Cytokine binding activates JAK proteins, which then phosphorylate STAT proteins, prompting their translocation to the nucleus.</p> Signup and view all the answers

Describe the impact of receptor tyrosine kinases in cancer progression.

<p>Receptor tyrosine kinases activate signaling pathways that lead to increased cell division and survival, contributing to cancer growth.</p> Signup and view all the answers

What is the role of transcription factors in signal transduction?

<p>Transcription factors regulate gene expression in response to intracellular signals, modulating cellular functions.</p> Signup and view all the answers

Identify one example of a common ligand involved in cancer signaling.

<p>One example is Platelet-Derived Growth Factor (PDGF), which promotes cell proliferation.</p> Signup and view all the answers

What mechanism does the Ras-Raf-MEK-ERK pathway illustrate in cancer cells?

<p>This pathway illustrates how growth factor binding can lead to a cascade of activations resulting in increased cell proliferation.</p> Signup and view all the answers

How do hormones act as ligands in the context of cell signaling?

<p>Hormones like estrogen and testosterone bind to specific receptors, influencing gene expression and cellular responses.</p> Signup and view all the answers

What is the significance of cross-talk in signaling circuits?

<p>Cross-talk allows integration of multiple signaling pathways, enhancing the cell's ability to respond to complex stimuli.</p> Signup and view all the answers

Explain how intracellular receptors differ from cell surface receptors.

<p>Intracellular receptors bind lipophilic ligands and directly influence transcription, while cell surface receptors interact with hydrophilic ligands and initiate external signaling cascades.</p> Signup and view all the answers

What is a primary strength of cohort studies in epidemiological research?

<p>Cohort studies provide a clear temporal sequence by ensuring that exposure occurs before the disease develops.</p> Signup and view all the answers

How can cohort studies be beneficial for studying rare exposures?

<p>Cohort studies are advantageous because they can follow a group of individuals over time to observe the effects of rare exposures on multiple outcomes.</p> Signup and view all the answers

What is one of the limitations associated with cohort studies?

<p>Cohort studies can be expensive and time-consuming, particularly when tracking diseases with long latency periods.</p> Signup and view all the answers

Identify a common bias that can occur in epidemiological research.

<p>Selection bias occurs when the cases and controls are not representative of the general population.</p> Signup and view all the answers

What role does confounding play in epidemiological studies?

<p>Confounding can distort the association between a potential risk factor and a disease, affecting validity.</p> Signup and view all the answers

How does the IARC classify Group 2B carcinogens?

<p>Group 2B carcinogens are classified as possibly carcinogenic to humans, based on limited evidence.</p> Signup and view all the answers

What is the significance of accurate exposure assessment in epidemiological research?

<p>Accurate exposure assessment is crucial for establishing valid associations between risk factors and disease outcomes.</p> Signup and view all the answers

Explain the term ‘biological gradient’ in establishing causation.

<p>A biological gradient refers to a dose-response relationship where increased levels of exposure correspond to a higher risk of disease.</p> Signup and view all the answers

In the context of cancer development, why is signaling transduction important?

<p>Signal transduction is critical because it governs how cells react to external signals that can influence cancer cell behavior.</p> Signup and view all the answers

What is one of the hallmarks of cancer related to cell proliferation?

<p>Sustained proliferation is a hallmark of cancer where cancer cells continue to divide uncontrollably.</p> Signup and view all the answers

Describe the impact of the Hawthorne effect on epidemiological research.

<p>The Hawthorne effect refers to changes in participant behavior due to awareness of being observed, which can bias study results.</p> Signup and view all the answers

What is the role of statistical models in epidemiological studies?

<p>Statistical models are used to examine how specified factors, such as air pollution, influence disease rates.</p> Signup and view all the answers

How do cohort studies allow for the investigation of multiple outcomes?

<p>Cohort studies can track a single population over time for various health outcomes resulting from a specific exposure.</p> Signup and view all the answers

Name a potential challenge related to long follow-up periods in cohort studies.

<p>Long follow-up periods may lead to loss to follow-up, risking data completeness and affecting study results.</p> Signup and view all the answers

What is the importance of consistency in establishing causation?

<p>Consistency in findings across different studies strengthens the argument for a causal relationship.</p> Signup and view all the answers

What role does AKT play in cell metabolism and survival?

<p>AKT promotes cell survival and metabolism by phosphorylating various substrates such as mTOR, which enhances protein synthesis.</p> Signup and view all the answers

How do AKT inhibitors induce apoptosis in cancer cells?

<p>AKT inhibitors target the AKT pathway, effectively inducing apoptosis by disrupting cell survival signals.</p> Signup and view all the answers

What is the significance of the BRAF V600E mutation in melanoma?

<p>The BRAF V600E mutation is found in around 70% of melanomas and is a critical target for effective targeted therapies like Vemurafenib.</p> Signup and view all the answers

What are the key components of the Ras-Raf-MEK-ERK signaling pathway?

<p>The key components are Ras, Raf, MEK, and ERK, which collectively regulate cell proliferation.</p> Signup and view all the answers

Explain how Gleevec (Imatinib) targets the BCR-ABL fusion protein in CML.

<p>Gleevec targets the BCR-ABL fusion by binding to the ATP-binding site of the active kinase domain, inhibiting its activity.</p> Signup and view all the answers

What are the clinical implications of combining AKT inhibitors with other therapies?

<p>Combining AKT inhibitors with other therapies enhances treatment efficacy and helps overcome resistance in cancer cells.</p> Signup and view all the answers

How does the T315I mutation in BCR-ABL lead to resistance against Imatinib?

<p>The T315I mutation alters the binding pocket of BCR-ABL, preventing Imatinib from fitting properly and thus maintaining kinase activity.</p> Signup and view all the answers

What is the function of mTOR in the AKT signaling pathway?

<p>mTOR regulates protein synthesis and cell growth in response to the activation of AKT.</p> Signup and view all the answers

What strategies are employed to manage resistance to targeted cancer therapies?

<p>Strategies include using combination therapies that target different components of the signaling pathways or additional pathways altogether.</p> Signup and view all the answers

How does the activation of PI3K contribute to cancer cell survival?

<p>PI3K activation leads to the formation of PIP3, which is crucial for activating AKT, thereby promoting cell survival and growth.</p> Signup and view all the answers

Describe the role of Trametinib in cancer treatment.

<p>Trametinib is a MEK inhibitor used to target the Ras-Raf-MEK-ERK pathway, particularly in cancers with BRAF mutations.</p> Signup and view all the answers

What is the importance of targeted therapies based on specific mutations in cancer treatment?

<p>Targeted therapies allow for personalized treatment plans that specifically address the genetic characteristics of a patient's cancer.</p> Signup and view all the answers

In what context is combination therapy particularly significant for treating melanoma?

<p>Combination therapy is significant for melanoma, especially with BRAF inhibitors and MEK inhibitors, to combat resistance and improve response.</p> Signup and view all the answers

Explain the role of the pleckstrin homology (PH) domain in AKT activation.

<p>The PH domain of AKT binds to PIP3, which is crucial for its relocation to the plasma membrane and subsequent activation by PDK1.</p> Signup and view all the answers

What role does the ras-raf-Erk pathway play in cancer proliferation?

<p>The ras-raf-Erk pathway promotes cell proliferation, which is a hallmark of cancer.</p> Signup and view all the answers

How does EGFR contribute to the ras-raf-Erk signaling pathway?

<p>EGFR activates downstream signaling by binding EGF, which triggers a cascade that leads to cell growth.</p> Signup and view all the answers

What are the implications of B-RAF mutations in melanoma treatment?

<p>B-RAF mutations lead to continuous cell proliferation and can be effectively targeted by specific inhibitors like Vemurafenib.</p> Signup and view all the answers

Which cancers are most commonly associated with mutations in the Ras protein?

<p>Ras mutations are commonly associated with pancreatic, thyroid, and colon cancers.</p> Signup and view all the answers

Describe the JAK-STAT pathway's role in cell signaling.

<p>The JAK-STAT pathway involves cytokine binding to receptors, activating JAK proteins and leading to STAT dimerization and gene expression.</p> Signup and view all the answers

What therapeutic strategies can target the ras-raf-Erk pathway?

<p>Therapeutic strategies include inhibitors of receptor tyrosine kinases, small molecule inhibitors, and monoclonal antibodies.</p> Signup and view all the answers

What resistance mechanisms can occur with therapies targeting B-RAF in melanoma?

<p>Resistance can occur through BRAF amplification, downstream mutations in MEK or ERK, and activation of alternate survival pathways.</p> Signup and view all the answers

How does Akt act as a central player in cancer cell viability?

<p>Akt is activated by various upstream signals and regulates multiple downstream pathways that promote cell survival and metabolism.</p> Signup and view all the answers

What is the significance of targeting the EGF/EGFR-ras-raf-Erk pathway in cancer therapy?

<p>Targeting this pathway can inhibit cell proliferation and is applicable to various cancers with EGFR mutations or amplifications.</p> Signup and view all the answers

What are some common small molecule inhibitors targeting the MEK within the ras-raf-Erk pathway?

<p>One common small molecule inhibitor is Trametinib, which specifically targets MEK.</p> Signup and view all the answers

Explain how the activation of the AKT pathway can contribute to cancer.

<p>Activation of the AKT pathway promotes cell survival and growth, which is advantageous for cancer cells.</p> Signup and view all the answers

What role do monoclonal antibodies play in cancer treatment targeting the ras-raf-Erk pathway?

<p>Monoclonal antibodies can bind to specific receptors like EGFR, blocking their activation and function.</p> Signup and view all the answers

Discuss the importance of understanding the mechanisms of resistance in targeted cancer therapies.

<p>Understanding resistance mechanisms can help in developing new strategies or combination therapies to overcome treatment failures.</p> Signup and view all the answers

How does the JAK-STAT pathway affect gene expression related to cell survival?

<p>Activated STAT dimers translocate to the nucleus and activate transcription of genes that promote cell survival.</p> Signup and view all the answers

What happens to normal cells when they reach the limit of their division cycles?

<p>They enter a phase called senescence, where they stop proliferating but do not die.</p> Signup and view all the answers

How does telomerase activity in cancerous cells affect their replication capacity?

<p>High telomerase activity allows cancerous cells to continue dividing without entering senescence.</p> Signup and view all the answers

What is the significance of rapidly replicating normal cells like stem cells and germ cells?

<p>They need to replicate throughout life, albeit at a low rate, to replace specific cell types and enable reproduction.</p> Signup and view all the answers

What is the G0 phase in the cell cycle?

<p>The G0 phase is a stage where cells are not dividing and may be in senescence or terminal differentiation.</p> Signup and view all the answers

Why is DNA replication initiated at multiple sites in a cell?

<p>It is essential to complete DNA synthesis within approximately 8 hours.</p> Signup and view all the answers

What consequence does a failure to complete the cell cycle correctly have?

<p>If the cell cycle is not completed correctly, the cell may undergo apoptosis.</p> Signup and view all the answers

During which phase of the cell cycle is DNA synthesized?

<p>DNA is synthesized during the S-phase of the cell cycle.</p> Signup and view all the answers

What is the average DNA replication error rate during synthesis?

<p>Only 3 to 5 errors are made by the enzymes that replicate DNA during each round of synthesis.</p> Signup and view all the answers

What is the primary direction in which DNA is synthesized during replication?

<p>DNA is synthesized only in the 5’ to 3’ direction.</p> Signup and view all the answers

What enzyme attempts to maintain telomere length during cell division?

<p>The enzyme telomerase attempts to maintain telomere length.</p> Signup and view all the answers

What are telomeres, and why are they significant to chromosomes?

<p>Telomeres are the regions at the ends of chromosomes that protect them from degradation and fusion.</p> Signup and view all the answers

What happens to telomere length with each round of cell division?

<p>Telomere length progressively shortens with each round of cell division.</p> Signup and view all the answers

What is the role of the shelterin complex at the telomeres?

<p>The shelterin complex protects telomeres and regulates their elongation.</p> Signup and view all the answers

What is the consequence of defective telomerase function in dyskeratosis congenita?

<p>Defective telomerase function in dyskeratosis congenita leads to short telomeres.</p> Signup and view all the answers

How does telomerase activity impact cancer cells?

<p>Cancer cells often exhibit high telomerase activity, allowing continuous division.</p> Signup and view all the answers

What genetic condition is associated with defects in the WRN gene?

<p>The WRN gene defect is associated with Werner syndrome.</p> Signup and view all the answers

Explain the impact of BIBR1532 on telomere extension.

<p>BIBR1532 inhibits the RNA template translocation needed for telomere extension.</p> Signup and view all the answers

What does the term ‘ALT’ stand for in telomere maintenance?

<p>ALT stands for Alternative Lengthening of Telomeres.</p> Signup and view all the answers

What role do TRF1 and TRF2 proteins play at the telomeres?

<p>TRF1 and TRF2 bind to telomeric DNA and regulate telomere extension and protection.</p> Signup and view all the answers

What is the significance of telomeres in protecting chromosomes?

<p>Telomeres protect chromosome ends from degradation and prevent fusion with other chromosomes.</p> Signup and view all the answers

Name one potential therapeutic approach targeting hTERT in cancer treatment.

<p>One approach is the development of anti-hTERT cancer vaccines.</p> Signup and view all the answers

What are the observable consequences in telomerase knockout mice by the fifth to sixth generation?

<p>They show decreased wound healing, premature aging, short telomeres, and increased cancer risk.</p> Signup and view all the answers

How does MYC regulate the expression of cyclin D2 and CDK4 during the G1-S transition?

<p>MYC increases the expression of cyclin D2 and CDK4, facilitating the progression from G1 to S phase of the cell cycle.</p> Signup and view all the answers

What role does p53 play in the regulation of p21 during the cell cycle, particularly after DNA damage?

<p>p53 upregulates the expression of p21, which helps arrest the cell cycle to allow for DNA repair or induce cell death.</p> Signup and view all the answers

How do signaling pathways like MAPK and PI3K contribute to cell cycle regulation?

<p>These signaling pathways activate the expression of cyclin D1, promoting cell proliferation and aiding in the G1-S transition.</p> Signup and view all the answers

In the context of cancer, what is a potential consequence of MYC gene amplification?

<p>MYC gene amplification can lead to uncontrolled cell cycle progression and increased cell division.</p> Signup and view all the answers

Why is the regulation of cyclin-CDK complexes important for maintaining cellular integrity?

<p>Proper regulation ensures that cells only enter DNA replication when conditions are favorable, preventing inappropriate cell division.</p> Signup and view all the answers

What are CDK inhibitors (CDKIs) and their significance in cancer treatment?

<p>CDK inhibitors are proteins like p21 and p16INK4a that regulate cell cycle progression and are targets for cancer therapies.</p> Signup and view all the answers

How do cyclin D levels impact the function of Cip/Kip inhibitors during the early G1 phase?

<p>Cyclin D levels rise and outcompete Cip/Kip inhibitors, allowing the activation of cyclin E-CDK2 complexes.</p> Signup and view all the answers

In relation to cancer cells, how does their responsiveness to external growth signals differ from non-malignant cells?

<p>Cancer cells are less responsive to external growth signals, leading to more rapid and uncontrolled proliferation.</p> Signup and view all the answers

What is the consequence of loss of Rb function in the context of cell cycle regulation?

<p>Loss of Rb allows E2F transcription factors to remain active, driving unchecked progression into the S phase.</p> Signup and view all the answers

How does telomerase activity intersect with cell cycle regulation and cancer proliferation?

<p>Telomerase activity helps maintain telomere length, enabling continued cell division and contributing to cancer cell immortality.</p> Signup and view all the answers

What is the importance of checkpoints in the cell cycle, particularly concerning DNA replication?

<p>Checkpoints ensure that errors in DNA replication are detected and corrected before the cell progresses to division.</p> Signup and view all the answers

What types of mutations can lead to the dysregulation of proliferation in cancer cells?

<p>Mutations in oncogenes and tumor suppressor genes, such as cyclins or CDKs, can lead to unregulated cell cycle progression.</p> Signup and view all the answers

Discuss the implications of targeting the cell cycle in cancer therapies.

<p>Targeting the cell cycle can selectively affect rapidly dividing cancer cells, but may also impact normal cells.</p> Signup and view all the answers

How does the interaction between cell cycle regulation and DNA repair mechanisms influence cancer therapy?

<p>Effective cell cycle regulation and DNA repair are crucial for preventing cancer cell growth and ensuring treatment efficacy.</p> Signup and view all the answers

What is the primary reason for targeting cell cycle control in cancer therapies?

<p>Cell cycle control is targeted because its disruption is a key feature of cancer, making it a critical area for therapeutic innovation.</p> Signup and view all the answers

How does apoptosis differ from necrosis in terms of cell integrity?

<p>Apoptosis is a controlled process that maintains membrane integrity until late stages, while necrosis results in loss of membrane integrity and cell lysis.</p> Signup and view all the answers

What role does ATP play in the process of apoptosis?

<p>ATP is essential in apoptosis as it drives the energy-dependent cellular machinery that regulates this process.</p> Signup and view all the answers

What is the significance of caspase activity in apoptosis?

<p>Caspase activity is vital for executing the apoptotic process, as these proteases are essential for cellular component breakdown.</p> Signup and view all the answers

In what situations is autophagy activated, and why is it relevant to cancer?

<p>Autophagy is activated under nutrient deprivation and stress conditions, and it can help cancer cells survive by removing damaged organelles.</p> Signup and view all the answers

What characterizes the process of necrosis compared to apoptosis?

<p>Necrosis is characterized by uncontrolled cell death leading to swelling and rupture, while apoptosis is controlled and maintains cellular integrity.</p> Signup and view all the answers

What are the major consequences of cancer cells evading apoptosis?

<p>By evading apoptosis, cancer cells gain the ability to survive even in the presence of damage, contributing to tumor progression.</p> Signup and view all the answers

How does the process of apoptosis contribute to tissue homeostasis?

<p>Apoptosis eliminates damaged or unnecessary cells, thus maintaining normal tissue function and cellular balance.</p> Signup and view all the answers

Why is understanding the differences in cell death types important in cancer therapy?

<p>Differentiating between cell death types informs the development of targeted treatments that exploit specific vulnerabilities in cancer cells.</p> Signup and view all the answers

What methods can be used to detect apoptosis in cells?

<p>Techniques like the TUNEL assay and caspase activity assays are used to detect apoptotic cells.</p> Signup and view all the answers

What are the implications of genetic mutations in apoptosis regulation for cancer treatment?

<p>Mutations in apoptosis-regulating genes can lead to resistance to cell death, informing the design of therapies that restore normal apoptotic processes.</p> Signup and view all the answers

What role does autophagy play in the context of both cancer progression and cancer therapy?

<p>Autophagy can promote cancer cell survival under stress, but inhibition of autophagy may enhance the effectiveness of certain cancer therapies.</p> Signup and view all the answers

Why is continuous research and clinical trials essential for cancer therapies?

<p>Ongoing research and trials are critical for improving existing therapies, minimizing side effects, and personalizing treatments for better outcomes.</p> Signup and view all the answers

Describe one characteristic that distinguishes programmed cell death from necrosis.

<p>Programmed cell death, like apoptosis, involves an orderly breakdown of the cell without eliciting inflammation, unlike necrosis which often triggers an inflammatory response.</p> Signup and view all the answers

How do cyclins D and E regulate the phosphorylation of Rb during the cell cycle?

<p>Cyclin D binds to CDK4/6 to phosphorylate Rb, while cyclin E, replacing cyclin D, continues this phosphorylation with CDK2 to promote S phase entry.</p> Signup and view all the answers

What is the role of telomerase in cancer cells?

<p>Telomerase extends the repetitive units of telomeres, allowing cancer cells to bypass normal replication limits.</p> Signup and view all the answers

What roles do p53 and p21 play in cell cycle regulation?

<p>p53 activates p21 expression in response to DNA damage, which inhibits CDK complexes and halts cell cycle progression until repairs are made.</p> Signup and view all the answers

Explain the impact of mutations in tumor suppressor genes like p53 and Rb on the cell cycle.

<p>Mutations in p53 prevent cell cycle inhibition, while Rb mutations lead to uncontrolled E2F activity, driving excessive S phase entry.</p> Signup and view all the answers

Describe the importance of the G1 to S phase checkpoint.

<p>The G1 to S phase checkpoint determines if a cell commits to replication by evaluating external signals and internal conditions.</p> Signup and view all the answers

How do cyclin-dependent kinases (CDKs) regulate the cell cycle?

<p>CDKs regulate the cell cycle by phosphorylating target proteins necessary for progression at specific phases.</p> Signup and view all the answers

Describe how oncogenes like Myc and Ras contribute to cancer progression.

<p>Oncogenes, when mutated or overexpressed, drive excess cell proliferation, acting like an accelerator stuck in the 'on' position.</p> Signup and view all the answers

What effect do CDK inhibitors have on the cell cycle?

<p>CDK inhibitors prevent progression through the cell cycle by inhibiting specific cyclin-CDK complexes.</p> Signup and view all the answers

What is the role of external signaling pathways, such as MAPK and PI3K, in cell cycle regulation?

<p>These pathways activate transcription factors and proteins that increase cyclin D levels, promoting the transition from G1 to S phase.</p> Signup and view all the answers

How do cyclins A and E act during the S phase of the cell cycle?

<p>Cyclin E-CDK2 initiates DNA replication, while cyclin A further drives this process, aiding in completing S phase efficiently.</p> Signup and view all the answers

Explain the significance of the R point in the cell cycle.

<p>The R point is critical as it marks the point of no return where a cell commits to division despite external conditions.</p> Signup and view all the answers

What are the potential benefits of targeted therapies that inhibit CDK4/6 in cancer treatment?

<p>Targeted CDK4/6 inhibitors can specifically halt the cell cycle in tumors with excess cyclin D, leading to more effective cancer control.</p> Signup and view all the answers

What happens during the S phase of the cell cycle?

<p>During the S phase, DNA replication occurs, resulting in the duplication of genetic material.</p> Signup and view all the answers

Why are cyclins important for CDK activity?

<p>Cyclins are essential for CDK activity as they activate CDKs, allowing them to phosphorylate target proteins and drive the cell cycle.</p> Signup and view all the answers

Discuss the significance of understanding the cell cycle in the context of cancer treatment.

<p>Understanding cell cycle mechanisms allows for the development of targeted therapies that can effectively disrupt tumor growth while sparing normal cells.</p> Signup and view all the answers

What role does the G2 phase checkpoint play?

<p>The G2 phase checkpoint ensures all DNA has been accurately replicated before the cell enters mitosis.</p> Signup and view all the answers

What challenges arise from traditional chemotherapy when treating cancers?

<p>Traditional chemotherapy can harm rapidly dividing normal cells, leading to side effects like nausea, hair loss, and anemia.</p> Signup and view all the answers

How do mutations in INK4 and CIP/KIP inhibitors affect cell cycle progression?

<p>Mutations in these inhibitors reduce their ability to stop the cell cycle, resulting in accelerated progression from G1 to S phase.</p> Signup and view all the answers

How do external signals influence cyclin expression?

<p>External signals, like growth factors and nutrients, can control the expression of cyclins that regulate cell cycle progression.</p> Signup and view all the answers

Explain the concept of combination therapies in cancer treatment.

<p>Combination therapies use multiple treatment modalities to target different pathways, enhancing therapeutic efficacy and overcoming resistance.</p> Signup and view all the answers

What is the function of the INK4 family of CDK inhibitors?

<p>The INK4 family inhibits CDK4 and CDK6, preventing cells from progressing through the G1 phase.</p> Signup and view all the answers

What role do biomarkers play in cancer therapy?

<p>Biomarkers help identify which patients might benefit from specific targeted therapies and monitor their responses to treatment.</p> Signup and view all the answers

What is the consequence of unchecked cell proliferation in cancer?

<p>Unchecked cell proliferation leads to tumor formation and progression of cancer, as cells continuously divide without proper regulation.</p> Signup and view all the answers

Describe the relationship between telomeres and cell division.

<p>The length of telomeres determines the number of cell divisions a somatic cell can undergo before entering senescence.</p> Signup and view all the answers

Describe the relationship between growth factor signaling and the cell cycle.

<p>Growth factor signaling activates pathways that enhance cyclin D expression, facilitating the transition from G1 to S phase in the cell cycle.</p> Signup and view all the answers

What is the primary purpose of cell cycle checkpoints?

<p>Cell cycle checkpoints serve to prevent cells from progressing through the cycle if conditions are not favorable, reducing mutation risks.</p> Signup and view all the answers

How does therapeutic resistance develop in cancer treatments?

<p>Therapeutic resistance can arise from mutations in targeted pathway components, leading to continued cell cycle progression despite treatment.</p> Signup and view all the answers

How do cancer therapeutics targeting telomerase act?

<p>Telomerase inhibitors aim to limit the ability of cancer cells to extend their telomeres, thereby reducing their replication capacity.</p> Signup and view all the answers

What role do caspases play in apoptosis?

<p>Caspases are critical proteases that mediate the events associated with apoptosis by executing the death program through the activation of effector caspases.</p> Signup and view all the answers

How does phosphatidylserine serve as a signal during apoptosis?

<p>Phosphatidylserine exposes itself on the outer leaflet of the plasma membrane, acting as an 'eat me' signal for macrophages to engulf apoptotic cells.</p> Signup and view all the answers

What distinguishes apoptosis from necrosis?

<p>Apoptosis is a controlled, non-inflammatory process that leads to cell death without harming surrounding tissues, while necrosis is an uncontrolled event resulting in inflammation.</p> Signup and view all the answers

Describe the intrinsic pathway of apoptosis.

<p>The intrinsic pathway is initiated by internal signals like DNA damage that lead to mitochondrial membrane permeabilization and the release of cytochrome c.</p> Signup and view all the answers

What is the function of pro-apoptotic proteins like Bax and Bak?

<p>Bax and Bak promote apoptosis by increasing mitochondrial permeability, facilitating the release of cytochrome c into the cytoplasm.</p> Signup and view all the answers

How can tumor suppressor genes like p53 modulate apoptosis?

<p>Tumor suppressor genes like p53 enhance the expression of pro-apoptotic genes and decrease pro-survival gene expression to promote cell death.</p> Signup and view all the answers

What happens during DNA fragmentation in apoptosis?

<p>During apoptosis, nucleases cleave DNA at specific sites, resulting in a characteristic ladder-like pattern seen on gel electrophoresis.</p> Signup and view all the answers

Explain the dual role of proteins like Bid.

<p>Bid can act both as a pro-apoptotic protein by promoting mitochondrial apoptosis and as an anti-apoptotic factor depending on the cellular context.</p> Signup and view all the answers

What is the significance of Bcl-2 family proteins in apoptosis?

<p>Bcl-2 family proteins regulate apoptosis by balancing pro-apoptotic and anti-apoptotic signals, influencing cell death and survival.</p> Signup and view all the answers

Why is apoptosis relevant in the context of cancer treatment?

<p>Apoptosis is crucial in cancer treatment because evasion of apoptosis allows cancer cells to survive; targeting apoptotic pathways can sensitize tumors to therapy.</p> Signup and view all the answers

What are the effects of anti-apoptotic factors in cancer?

<p>Anti-apoptotic factors prevent programmed cell death, allowing cancer cells to survive longer despite genomic damage.</p> Signup and view all the answers

How do feedback loops regulate apoptosis?

<p>Feedback loops involve activated caspases that can further activate other caspases or degrade inhibitors, fine-tuning the apoptotic response.</p> Signup and view all the answers

What is the primary function of INK4 family proteins in cell cycle regulation?

<p>INK4 family proteins inhibit CDK4/6-cyclin D complexes, preventing cell cycle progression from G1 to S phase.</p> Signup and view all the answers

What is the role of granzyme A in apoptosis?

<p>Granzyme A is a serine protease released by cytotoxic T cells that promotes apoptosis in target cells.</p> Signup and view all the answers

How do Cip/Kip family proteins influence cell cycle progression in early G1?

<p>Cip/Kip family proteins, such as p21 and p27, inhibit cyclin D-CDK4/6 activity, blocking cell cycle progression and maintaining quiescence.</p> Signup and view all the answers

What role does retinoblastoma protein (Rb) play in regulating the G1 to S phase transition?

<p>Rb inhibits the activation of E2F transcription factors, preventing the expression of genes necessary for S phase entry.</p> Signup and view all the answers

What triggers the hyperphosphorylation of Rb during the late G1 phase?

<p>The hyperphosphorylation of Rb is triggered by increased activity of cyclin E-CDK2 complexes that phosphorylate Rb.</p> Signup and view all the answers

How do cyclin-CDK complexes contribute to the release of E2F transcription factors?

<p>Cyclin-CDK complexes, particularly cyclin E-CDK2, phosphorylate Rb, leading to its inactivation and the release of E2F.</p> Signup and view all the answers

What is the effect of high cyclin D levels in the early to mid G1 phase?

<p>High cyclin D levels promote the formation of cyclin D-CDK4/6 complexes, enhancing G1 progression.</p> Signup and view all the answers

What happens to p21 and p27 levels as the cell progresses from G1 into S phase?

<p>As the cell transitions to S phase, p21 and p27 levels decrease, resulting in reduced inhibition of cyclin E-CDK2 complexes.</p> Signup and view all the answers

Describe the dual role of Cip/Kip inhibitors in G1 phase.

<p>Cip/Kip inhibitors can inhibit cyclin D-CDK4/6 complexes while also potentially promoting formation of these complexes in a mitogenic context.</p> Signup and view all the answers

Explain the significance of histone deacetylases (HDACs) in relation to hypophosphorylated Rb.

<p>Hypophosphorylated Rb recruits HDACs, leading to histone deacetylation and closed chromatin, which represses transcription.</p> Signup and view all the answers

How does hyperphosphorylated Rb affect chromatin structure?

<p>Hyperphosphorylated Rb does not bind E2F, allowing histone acetylases to activate transcription by opening chromatin.</p> Signup and view all the answers

What outcomes result from the disruption of Cip/Kip inhibitors during G1 phase?

<p>Disruption of Cip/Kip inhibitors leads to unregulated activity of cyclin D-CDK4/6 and cyclin E-CDK2 complexes, promoting S phase entry.</p> Signup and view all the answers

What is the relationship between cyclin E-CDK2 complexes and RB phosphorylation?

<p>Cyclin E-CDK2 complexes hyperphosphorylate Rb, inactivating it and allowing E2F to trigger S phase gene expression.</p> Signup and view all the answers

Why is Rb considered a tumor suppressor protein?

<p>Rb is a tumor suppressor because it regulates the G1 to S phase transition, inhibiting uncontrolled cell proliferation.</p> Signup and view all the answers

How do growth factor signals influence the cell cycle in G1 phase?

<p>Growth factor signals increase cyclin D levels, activating CDK4/6 complexes and promoting progression through the G1 phase.</p> Signup and view all the answers

What role do Bcl-2 family proteins play in apoptosis regulation?

<p>Bcl-2 family proteins inhibit apoptosis by preventing the activation of pro-apoptotic proteins, thereby promoting cell survival.</p> Signup and view all the answers

How do BH3-only proteins initiate apoptosis?

<p>BH3-only proteins bind to anti-apoptotic proteins, inhibiting them and allowing Bax and Bak to promote mitochondrial outer membrane permeabilization.</p> Signup and view all the answers

What is the function of caspases in the apoptotic process?

<p>Caspases, once activated, cleave various substrates to carry out the execution phase of apoptosis.</p> Signup and view all the answers

What is the role of p53 in apoptosis?

<p>p53 promotes apoptosis by increasing the expression of pro-apoptotic genes while inhibiting anti-apoptotic genes.</p> Signup and view all the answers

What mechanisms allow cancer cells to resist apoptosis?

<p>Cancer cells often overexpress anti-apoptotic proteins or downregulate pro-apoptotic proteins, allowing them to survive despite stress.</p> Signup and view all the answers

How is Granzyme A related to apoptosis?

<p>Granzyme A is released by cytotoxic T cells and induces apoptosis through caspase-independent pathways.</p> Signup and view all the answers

What is the significance of mitochondrial outer membrane permeabilization (MOMP) in apoptosis?

<p>MOMP allows the release of cytochrome c from the mitochondria into the cytoplasm, triggering the apoptosome formation.</p> Signup and view all the answers

Describe the role of IAPs in apoptosis.

<p>Inhibitors of Apoptosis (IAPs) bind to and inhibit activated caspases, thus blocking the apoptotic process.</p> Signup and view all the answers

How can the PI3K/Akt pathway influence apoptosis?

<p>The PI3K/Akt pathway promotes cell survival by phosphorylating pro-apoptotic proteins and inhibiting their activity.</p> Signup and view all the answers

What techniques are used to detect apoptosis in cells?

<p>Techniques include caspase-specific substrates for fluorescence detection and the TUNEL assay to identify DNA fragmentation.</p> Signup and view all the answers

Explain the extrinsic pathway of apoptosis.

<p>The extrinsic pathway is triggered by death receptors on the cell surface, typically mediated by caspase-8.</p> Signup and view all the answers

What are the implications of targeting anti-apoptotic proteins in cancer therapy?

<p>Targeting anti-apoptotic proteins can help induce apoptosis in cancer cells, improving treatment outcomes.</p> Signup and view all the answers

How does the TUNEL assay function in detecting apoptosis?

<p>The TUNEL assay labels fragmented DNA, indicating apoptotic cells, distinguishing them from necrotic cells.</p> Signup and view all the answers

What is the relationship between apoptosis and neurodegenerative diseases?

<p>Modulating apoptosis may help prevent neuronal loss in neurodegenerative diseases like Alzheimer's.</p> Signup and view all the answers

What is the primary role of E-cadherin in preventing cancer cell metastasis?

<p>E-cadherin facilitates cell adhesion and contact inhibition, preventing tumor cells from dissociating.</p> Signup and view all the answers

How do matrix metalloproteinases (MMPs) contribute to tumor cell invasion?

<p>MMPs degrade extracellular matrix components, allowing tumor cells to move through tissues and invade.</p> Signup and view all the answers

What is the significance of the interaction between tumor cells and the extracellular matrix (ECM)?

<p>The interaction regulates tumor cell adhesion and movement, impacting their invasive capabilities.</p> Signup and view all the answers

In what ways do tumor cells exploit integrins during metastasis?

<p>Tumor cells modify integrin expression to enhance attachment to ECM and promote migration.</p> Signup and view all the answers

Describe the role of tissue inhibitors of metalloproteinases (TIMPs) in tumor progression.

<p>TIMPs inhibit MMP activity, potentially reducing the invasive capacity of tumor cells.</p> Signup and view all the answers

What are the different modes of tumor cell migration through the ECM?

<p>Tumor cells can migrate via mesenchymal migration, collective migration, or amoeboid migration.</p> Signup and view all the answers

Explain how tumor cells can switch between different modes of migration.

<p>Tumor cells can alter their migration mode in response to environmental cues and ECM composition.</p> Signup and view all the answers

What are the implications of increased MMP expression in carcinomas?

<p>Increased MMP expression is strongly correlated with greater invasive and metastatic potential in tumors.</p> Signup and view all the answers

How does loss of contact inhibition contribute to tumor progression?

<p>Loss of contact inhibition allows tumor cells to grow uncontrollably and invade surrounding tissues.</p> Signup and view all the answers

What biological components underlie the composition of the extracellular matrix (ECM)?

<p>The ECM is primarily composed of collagens, glycoproteins, proteoglycans, and water.</p> Signup and view all the answers

How does tumor cell behavior change in the presence of promigratory factors?

<p>Promigratory factors enhance tumor cell motility and invasion through the ECM.</p> Signup and view all the answers

What role do proteases play in the context of tumor invasion?

<p>Proteases degrade ECM components, facilitating tumor cells' migration into surrounding tissues.</p> Signup and view all the answers

Why is collective migration advantageous for tumor cells?

<p>Collective migration provides structural protection for inner cells and increases efficiency in moving through tissues.</p> Signup and view all the answers

What negative effects can arise from tumor cells inducing ECM cells to secrete proteases?

<p>This induction can lead to excessive ECM degradation, promoting invasion and metastasis.</p> Signup and view all the answers

How important is the extracellular matrix in maintaining normal tissue structure?

<p>The ECM is critical for separating tissue compartments and providing mechanical support.</p> Signup and view all the answers

What is the role of p53 in apoptosis and how does its loss of function contribute to cancer development?

<p>p53 helps regulate the cell cycle and promotes apoptosis in response to DNA damage; its loss of function allows damaged cells to survive and proliferate, contributing to tumorigenesis.</p> Signup and view all the answers

Explain how Bcl-2 overexpression affects the balance of apoptosis in cancer cells.

<p>Bcl-2 overexpression inhibits pro-apoptotic signals, promoting cell survival and contributing to the resistance of cancer cells to programmed cell death.</p> Signup and view all the answers

Describe the mechanism by which HPV prevents apoptosis in cervical cancer cells.

<p>HPV produces E6 and E7 proteins that bind to and inhibit p53 function, preventing the cell from undergoing apoptosis in response to DNA damage.</p> Signup and view all the answers

What are BH3 mimetics and how do they function as cancer therapies?

<p>BH3 mimetics, such as Venetoclax, are drugs that inhibit anti-apoptotic proteins like Bcl-2, restoring pro-apoptotic signals to trigger cancer cell death.</p> Signup and view all the answers

How does the loss of pro-apoptotic signaling molecules contribute to cancer progression?

<p>The loss of pro-apoptotic signaling molecules leads to an unbalanced apoptotic pathway, allowing cancer cells to evade programmed cell death and thereby enhancing tumor survival and growth.</p> Signup and view all the answers

What is the impact of interactions with cytotoxic T cells on cancer cell survival?

<p>Cancer cells can evade destruction by downregulating MHC molecules and increasing immune suppressive proteins like PD-L1, allowing them to hide from cytotoxic T cells.</p> Signup and view all the answers

Explain how the intrinsic and extrinsic pathways differ in regulating apoptosis.

<p>The intrinsic pathway is regulated by internal signals related to cellular stress or damage, while the extrinsic pathway is activated by external signals from death receptors.</p> Signup and view all the answers

Identify two common viral mechanisms by which oncogenic viruses promote survival of cancer cells.

<p>Oncogenic viruses may produce proteins that block apoptotic pathways (like HPV's E6/E7 inhibiting p53) or mimic anti-apoptotic proteins (like EBV mimicking Bcl-2).</p> Signup and view all the answers

What role does Rb inactivation play in cancer cell apoptosis evasion?

<p>Inactivation of the Rb protein disrupts cell cycle regulation, allowing cells to progress through the cycle without undergoing apoptosis in response to stress signals.</p> Signup and view all the answers

How does Bax inactivation influence apoptosis in cancer cells?

<p>Inactivation of Bax, a pro-apoptotic protein, reduces the apoptotic response, allowing cancer cells to survive even when pro-apoptotic signals are present.</p> Signup and view all the answers

What effect does enhanced expression of immune suppressive proteins have on tumor progression?

<p>Enhanced expression of immune suppressive proteins inhibits the immune response against tumor cells, facilitating tumor growth and metastasis.</p> Signup and view all the answers

What are the potential therapeutic implications of understanding apoptotic pathways in cancer treatment?

<p>Understanding apoptotic pathways can lead to targeted therapies that reactivate apoptosis in resistant cancer cells, improving treatment efficacy.</p> Signup and view all the answers

In what way do caspase inactivating mutations affect cancer cell behavior?

<p>Caspase inactivating mutations prevent the execution of apoptosis, allowing cancer cells to avoid programmed cell death and promoting survival.</p> Signup and view all the answers

How does the concept of a 'cancer hallmark' apply to apoptosis evasion?

<p>Evasion of apoptosis is recognized as a hallmark of cancer as it allows tumors to survive and proliferate despite various cellular stresses.</p> Signup and view all the answers

What is E-cadherin and its role in normal epithelial tissue?

<p>E-cadherin is a protein that provides cell-cell adhesion in normal epithelial tissue, maintaining tissue integrity.</p> Signup and view all the answers

How do Matrix Metalloproteinases (MMPs) contribute to cancer cell invasion?

<p>MMPs are enzymes that degrade extracellular matrix components, allowing cancer cells to invade surrounding tissues.</p> Signup and view all the answers

What are integrins, and how do they affect cancer cell migration?

<p>Integrins are transmembrane receptors that mediate cell-matrix interactions, influencing cancer cell shape, movement, and signaling.</p> Signup and view all the answers

Distinguish between mesenchymal and amoeboid migration in cancer cells.

<p>Mesenchymal migration involves slow, protease-dependent movement through the ECM, while amoeboid migration is fast and protease-independent.</p> Signup and view all the answers

What role do TIMPs play in cancer metastasis?

<p>Tissue Inhibitors of Metalloproteinases (TIMPs) regulate MMP activity, affecting the balance between tissue invasion and inhibition.</p> Signup and view all the answers

Why is angiogenesis important for tumor growth?

<p>Angiogenesis is crucial for tumor growth as it provides the necessary blood supply for nutrients and waste removal.</p> Signup and view all the answers

What is the 'seed and soil' hypothesis in cancer metastasis?

<p>The 'seed and soil' hypothesis suggests that metastatic cancer cells (seeds) thrive in specific microenvironments (soil) conducive to their growth.</p> Signup and view all the answers

Describe the significance of intravasation in the metastatic process.

<p>Intravasation is the entry of tumor cells into blood vessels, which is critical for the dissemination of cancer throughout the body.</p> Signup and view all the answers

How does extravasation contribute to cancer metastasis?

<p>Extravasation is the exit of tumor cells from blood vessels into surrounding tissues, enabling the establishment of metastases.</p> Signup and view all the answers

What is the relationship between cancer cell adhesion and invasion?

<p>The loss of cell adhesion, such as through E-cadherin downregulation, facilitates cancer cell invasion into surrounding tissues.</p> Signup and view all the answers

How do tumor-platelet thrombi assist in cancer metastasis?

<p>Tumor-platelet thrombi help protect circulating tumor cells from immune detection and assist in their survival during blood flow.</p> Signup and view all the answers

What factors influence the preferred sites of cancer metastasis?

<p>The anatomical origin of the cancer, blood flow patterns, and local tissue environments influence the preferred sites for metastasis.</p> Signup and view all the answers

What is collective migration in the context of cancer progression?

<p>Collective migration refers to groups of cancer cells moving together, which can increase protection from immune responses and enhance movement efficiency.</p> Signup and view all the answers

What is meant by matrix dissolution in cancer invasion?

<p>Matrix dissolution refers to the breakdown of the extracellular matrix, which is critical for tumor cells to invade surrounding tissues.</p> Signup and view all the answers

What is the primary mode of dissemination for carcinomas?

<p>Dissemination via lymphatics is typical for carcinomas.</p> Signup and view all the answers

Describe the process by which tumor cells can metastasize through blood vessels.

<p>Tumor cells penetrate venous spaces and follow the venous flow, often depositing in the first capillary bed they encounter.</p> Signup and view all the answers

What are oncogenes, and how do they differ from proto-oncogenes?

<p>Oncogenes are mutated versions of proto-oncogenes that can transform normal cells into malignant cells, while proto-oncogenes are normal genes that regulate cellular growth.</p> Signup and view all the answers

What percentage of circulating tumor cells typically succeed in forming metastatic colonies?

<p>Only about 0.01% of circulating tumor cells successfully initiate metastatic colonies.</p> Signup and view all the answers

What role do platelets play in the metastatic process?

<p>Platelets can provide a survival advantage for tumor cells by shielding them from the immune system.</p> Signup and view all the answers

How do viral oncogenes differ from cellular oncogenes?

<p>Viral oncogenes (v-onc) are incorporated into the host genome by viruses, while cellular oncogenes (c-onc) are naturally found in the host genome.</p> Signup and view all the answers

What does the 'seed and soil' hypothesis refer to in cancer metastasis?

<p>It refers to how certain tumor cells (the seed) have an affinity for specific organs (the soil) that facilitate metastasis.</p> Signup and view all the answers

What is the role of the p53 protein in preventing tumor formation?

<p>The p53 protein regulates the cell cycle and induces cell cycle arrest or apoptosis in response to DNA damage, preventing the propagation of damaged cells.</p> Signup and view all the answers

What are some hallmarks of cancer that oncoviruses influence?

<p>Oncoviruses can influence hallmarks such as sustaining proliferative signaling, evading growth suppressors, and enabling replicative immortality.</p> Signup and view all the answers

How does hypoxia influence angiogenesis in tumors?

<p>Hypoxia induces the expression of HIF-1 and HIF-2, leading to the transcription of pro-angiogenic factors.</p> Signup and view all the answers

In what way can environmental mutagens activate oncogenes?

<p>Environmental mutagens can lead to the reactivation of endogenous retroviral sequences and genetic changes that activate oncogenes.</p> Signup and view all the answers

What is the significance of genetic alterations in the metastatic process?

<p>Specific genetic alterations are necessary for tumor cells to complete the steps of metastasis.</p> Signup and view all the answers

What factor is necessary for a tumor to exceed 1-2mm in size?

<p>Vascularization, achieved through angiogenesis, is essential for delivering oxygen and nutrients to the tumor.</p> Signup and view all the answers

Explain the significance of integrating viral genomes into host chromosomes.

<p>Integration of viral genomes into critical areas of the host genome can lead to persistent expression of viral genes, which may drive cellular transformation.</p> Signup and view all the answers

What is the significance of tumor suppressor genes in cancer regulation?

<p>Tumor suppressor genes act as negative growth regulators, helping to control cell division and ensure cellular stability.</p> Signup and view all the answers

What happens during the extravasation phase of metastasis?

<p>Tumor cells adhere to the endothelium and then egress through the basement membrane at a distant site.</p> Signup and view all the answers

How does chronic inflammation contribute to cancer development?

<p>Chronic inflammation can create an environment conducive to genetic mutations and promote oncogene activation, leading to cancer progression.</p> Signup and view all the answers

How does the loss of contact inhibition contribute to cancer cell behavior?

<p>Loss of contact inhibition leads to uncontrolled cell growth and migration due to downregulation of adhesion molecules.</p> Signup and view all the answers

What defines the relationship between proto-oncogenes and cancer?

<p>Proto-oncogenes, when activated improperly through mutations or viral integration, can become oncogenes that promote cancerous growth.</p> Signup and view all the answers

What is the significance of angiogenic factors like VEGF in cancer treatment?

<p>Angiogenic factors like VEGF facilitate the development of blood vessels, crucial for tumor growth.</p> Signup and view all the answers

What process is described by the term 'angiogenic switch'?

<p>The angiogenic switch refers to changes in the expression of pro- and anti-angiogenic factors due to genetic alterations.</p> Signup and view all the answers

Why is understanding the role of endogenous retroviral sequences significant in cancer research?

<p>Endogenous retroviral sequences can contribute to tumorigenesis if reactivated, making them important biomarkers in cancer research.</p> Signup and view all the answers

What is required for successful intravasation of tumor cells?

<p>Intravasation requires tumor cells to penetrate the basement membrane and adhere to endothelial cells.</p> Signup and view all the answers

In what way do MMP inhibitors potentially contribute to cancer treatment?

<p>MMP inhibitors may offer a modest effect in targeting tumor invasion and metastasis.</p> Signup and view all the answers

What does downregulation of anti-angiogenic inhibitors imply for tumor survival?

<p>Downregulation of these inhibitors promotes vascularization, aiding tumor survival and growth.</p> Signup and view all the answers

What factors regulate angiogenesis in tumors?

<p>Angiogenesis in tumors is regulated by hypoxia-inducible factors (HIFs) and genetic mutations in pro-angiogenic genes.</p> Signup and view all the answers

How do tumors exploit angiogenic factors like VEGF?

<p>Tumors upregulate factors like VEGF to stimulate new blood vessel growth, enhancing their blood supply.</p> Signup and view all the answers

What is the Seed and Soil Hypothesis in relation to metastasis?

<p>The Seed and Soil Hypothesis suggests that successful metastasis depends on the interaction between tumor cells (the 'seed') and the microenvironment of the target organ (the 'soil').</p> Signup and view all the answers

How does genetic instability contribute to cancer metastasis?

<p>Genetic instability enables cancer cells to accumulate mutations, facilitating their metastatic potential.</p> Signup and view all the answers

What role do combination therapies play in cancer treatment?

<p>Combination therapies aim to target multiple pathways involved in cancer, addressing the redundancy and adaptability of cancer pathways.</p> Signup and view all the answers

What type of drugs can inhibit angiogenesis, and how do they work?

<p>Angiogenesis inhibitors, like bevacizumab, work by targeting and inhibiting factors like VEGF to reduce blood supply to tumors.</p> Signup and view all the answers

How do tumor cells evade the immune system during metastasis?

<p>Tumor cells evade immune detection by binding to platelets and fibrin, which can protect them from immune responses.</p> Signup and view all the answers

What defines an oncovirus and its role in cancer development?

<p>Oncoviruses are viruses that can induce cellular transformation and contribute to cancer by integrating their genomes into the host's DNA.</p> Signup and view all the answers

What are the two basic types of tumor viruses based on their genetic material?

<p>Tumor viruses can be classified as DNA viruses, which replicate in the nucleus, or RNA viruses (retroviruses), which replicate in the cytoplasm.</p> Signup and view all the answers

How does latent viral infection contribute to cancer?

<p>Latent viral infections may lead to cancer by periodically expressing viral genes that disrupt normal cellular function.</p> Signup and view all the answers

What distinguishes a helical virus from a polyhedral virus?

<p>Helical viruses have a cylindrical shape surrounding their nucleic acid core, while polyhedral viruses possess a polyhedral (usually icosahedral) capsid.</p> Signup and view all the answers

How do oncoviruses impact cellular pathways?

<p>Oncoviruses can dysregulate pathways involved in cell proliferation and growth, leading to cancer.</p> Signup and view all the answers

What are the implications of the lytic and latent phases in the life cycle of viruses?

<p>In the lytic phase, viruses replicate actively, causing cell death, whereas in the latent phase, viruses may remain dormant within the host.</p> Signup and view all the answers

What transformation occurs in proto-oncogenes to become oncogenes?

<p>Proto-oncogenes undergo mutations or genetic alterations, leading to uncontrolled cell growth and cancer.</p> Signup and view all the answers

How do tumor suppressor genes like P53 contribute to cancer prevention?

<p>Tumor suppressor genes like P53 regulate and suppress cell growth, maintaining genomic stability by preventing damaged cells from dividing.</p> Signup and view all the answers

Explain the role of HPV's E6 and E7 proteins in cancer development.

<p>HPV's E6 and E7 proteins interfere with tumor suppressor proteins P53 and RB, which leads to uncontrolled cell proliferation.</p> Signup and view all the answers

What are the key differences between HPV types associated with benign warts and those associated with cancer?

<p>HPV types 6 and 11 are associated with benign warts, whereas types 16 and 18 are linked to cancers such as cervical and anal cancer.</p> Signup and view all the answers

What is the significance of the L1 gene in HPV?

<p>The L1 gene encodes a protein that self-assembles into the virus shell, forming virus-like particles crucial for HPV vaccines.</p> Signup and view all the answers

Describe the interplay between oncogenes and tumor suppressor genes in cancer.

<p>Oncogenes promote uncontrolled cell growth, while tumor suppressor genes normally inhibit this growth, maintaining balance.</p> Signup and view all the answers

Why is it important to identify the specific HPV serotype in patients?

<p>Identifying the specific HPV serotype helps assess the risk of cancer development and guides appropriate medical intervention.</p> Signup and view all the answers

What is the role of the Long Control Region (LCR) in the HPV genome?

<p>The LCR regulates the expression of viral genes, playing a crucial role in the replication and transcription of the HPV genome.</p> Signup and view all the answers

How does Epstein-Barr Virus (EBV) contribute to the development of Burkitt lymphoma?

<p>EBV induces Burkitt lymphoma by inhibiting apoptosis in B cells, leading to malignant transformations and enhancing proliferation, often associated with malaria reactivation.</p> Signup and view all the answers

What role does the transcription factor TCF-3 play in Burkitt lymphoma?

<p>TCF-3 is central to Burkitt lymphoma pathogenesis as it becomes constitutively active due to mutations in its negative regulator ID3 and somatic mutations that enhance its function.</p> Signup and view all the answers

What association exists between malaria infection and Burkitt lymphoma?

<p>Malarial infection can reactivate latent EBV, increasing the likelihood of developing Burkitt lymphoma in individuals with pre-existing viral infections.</p> Signup and view all the answers

What are the key features of Epstein-Barr Virus (EBV) positivity assessment?

<p>EBV positivity is assessed by EBER in situ hybridization techniques on formalin-fixed paraffin-embedded tissue sections.</p> Signup and view all the answers

Describe the mechanism by which HPV contributes to cancer development.

<p>HPV oncogenes E6 and E7 disrupt tumor suppressor proteins P53 and RB, leading to uncontrolled cell proliferation and contributing to cervical and other cancers.</p> Signup and view all the answers

What is the significance of tumor suppressor genes (TSGs) in cancer development?

<p>Tumor suppressor genes function as regulators of cell growth, and mutations that inactivate both alleles can lead to uncontrolled cell proliferation and cancer.</p> Signup and view all the answers

Explain the concept of oncogenes and how they differ from proto-oncogenes.

<p>Oncogenes are mutated proto-oncogenes that drive uncontrolled cell proliferation, while proto-oncogenes are normal genes that can become cancerous when mutated.</p> Signup and view all the answers

What characterizes the retinoblastoma (RB) gene and its function?

<p>The RB gene is a classic tumor suppressor gene that, when mutated, leads to uncontrolled cell cycle progression through hyperphosphorylation, primarily seen in retinoblastoma.</p> Signup and view all the answers

What is the significance of Gardasil in cancer prevention?

<p>Gardasil is a prophylactic vaccine against HPV, effective in reducing the incidence of HPV-related cervical and other cancers by preventing initial infection.</p> Signup and view all the answers

How do chronic infections like malaria influence cancer risk?

<p>Chronic infections can stimulate the immune system and contribute to genetic instability, thereby increasing the risk of mutations associated with cancer development.</p> Signup and view all the answers

What is the relationship between oncogenes and malignant phenotypes?

<p>Oncogenes lead to malignant phenotypes through gain-of-function mutations that enhance cellular proliferation and survival, overriding normal growth controls.</p> Signup and view all the answers

Explain the concept of mutations in the context of tumor suppressor genes.

<p>Mutations in tumor suppressor genes typically result in a loss-of-function, requiring both alleles to be affected to trigger cancerous growth.</p> Signup and view all the answers

What expression pattern is noted in EBV-associated nasopharyngeal carcinoma?

<p>Almost all carcinoma cells display nuclear positivity for EBV, characterized by strong staining intensity in tissue sections.</p> Signup and view all the answers

What impacts can viral oncoproteins have on cellular mechanisms?

<p>Viral oncoproteins, such as those from HPV, can directly interfere with key cell cycle regulators, leading to enhanced cell division and cancer progression.</p> Signup and view all the answers

What is the role of E6 and E7 in the viral oncogenesis process?

<p>E6 and E7 inactivate tumor suppressor proteins p53 and pRb, leading to cell immortalization and transformation.</p> Signup and view all the answers

How does the L1 protein contribute to the structure of the papillomavirus?

<p>The L1 protein forms the icosahedral surface of the papillomavirus virion and can self-assemble into virus-like particles (VLPs).</p> Signup and view all the answers

What is the primary function of the capsid protein L2 in papillomavirus?

<p>L2 plays a significant role in papillomavirus assembly and enhances the assembly of VLPs with L1.</p> Signup and view all the answers

What are the main factors contributing to cervical carcinogenesis associated with HPV?

<p>Persistent HPV infection leads to irreversible changes through E6 and E7 expression, with age, smoking, and genetics as additional contributors.</p> Signup and view all the answers

How has cervical cancer screening advanced since the introduction of the cervical screening test?

<p>The cervical screening test, which detects HPV, replaced the Pap smear and offers greater protective efficiency for women.</p> Signup and view all the answers

What does Gardasil 9 protect against in terms of HPV types?

<p>Gardasil 9 protects against nine types of HPV, including the most common cancer-causing types 16 and 18.</p> Signup and view all the answers

How do hepatitis B and C contribute to cancer development?

<p>Hepatitis B and C viruses are associated with liver cancer, and vaccination has reduced their incidence.</p> Signup and view all the answers

What is the mechanism by which EBV induces Burkitt's lymphoma in B cells?

<p>EBV inhibits apoptosis in premalignant tumor cells and can be reactivated by malaria infection, facilitating transformation.</p> Signup and view all the answers

Explain the significance of chromosomal translocations in Burkitt's lymphomas.

<p>Chromosomal translocations, particularly involving the c-myc gene and immunoglobulin gene loci, lead to increased expression of myc, promoting malignancy.</p> Signup and view all the answers

What is the function of the HPV vaccine in cancer prevention?

<p>The HPV vaccine stimulates the immune system to prevent infections from high-risk HPV types and reduces the incidence of related cancers.</p> Signup and view all the answers

What is the significance of regular cervical cancer screenings for sexually active women?

<p>Regular screenings help detect HPV and precancerous changes, significantly reducing the risk of developing cervical cancer.</p> Signup and view all the answers

Why is the HPV 6 and 11 considered significant in relation to genital warts?

<p>HPV 6 and 11 cause approximately 90% of genital warts, which, while not cancerous, can significantly affect quality of life.</p> Signup and view all the answers

In the context of HPV, how does the cervical screening test enhance women's health?

<p>The cervical screening test can detect high-risk HPV types that may lead to cervical cancer, improving preventive health measures.</p> Signup and view all the answers

How does hyperphosphorylation of RB contribute to cell cycle progression?

<p>Hyperphosphorylation of RB releases E2F, which is necessary for advancing the cell cycle.</p> Signup and view all the answers

What results from mutations in the RB gene?

<p>Mutated RB cannot bind E2F, leading to uncontrolled cell division.</p> Signup and view all the answers

Explain Knudson’s Two-Hit Hypothesis in the context of retinoblastoma.

<p>The hypothesis states that one inherited mutated allele requires only one additional mutation for hereditary retinoblastoma, while sporadic cases require two independent mutations.</p> Signup and view all the answers

What is loss of heterozygosity (LOH) in relation to tumor suppressor genes?

<p>LOH refers to the loss of one allele of a gene in a heterozygous individual, leading to a lack of functional tumor suppressor proteins.</p> Signup and view all the answers

What role does E2F play in the regulation of the cell cycle?

<p>E2F functions as a transcription factor that activates genes essential for DNA synthesis and cell cycle progression.</p> Signup and view all the answers

Differentiate between hereditary and sporadic retinoblastoma based on mutation requirements.

<p>Hereditary retinoblastoma requires only one additional mutation after inheriting a mutated allele, while sporadic retinoblastoma needs two independent mutations in the same cell.</p> Signup and view all the answers

What impact does mitotic recombination have on tumor suppressor genes?

<p>Mitotic recombination can eliminate the wild-type allele, causing loss of heterozygosity and possibly leading to tumorigenesis.</p> Signup and view all the answers

Describe the mechanism of gene conversion concerning tumor suppressor genes.

<p>Gene conversion involves DNA polymerase using a template from one chromosome, allowing a mutant allele to replace a wild-type allele on its homolog.</p> Signup and view all the answers

How does chromosomal nondisjunction lead to loss of heterozygosity?

<p>Chromosomal nondisjunction can result in one daughter cell acquiring both alleles of a gene, leading to homozygosity for the mutated copy.</p> Signup and view all the answers

What is the significance of tracking loss of heterozygosity (LOH) in cancer diagnostics?

<p>Tracking LOH helps identify tumor suppressor genes that may be mutated during tumor development.</p> Signup and view all the answers

What tools can be employed to analyze regions of LOH?

<p>Restriction fragment length polymorphisms (RFLPs) can be used to analyze regions of LOH effectively.</p> Signup and view all the answers

How is promoter methylation relevant to tumor suppressor gene functionality?

<p>Increased promoter methylation can silence tumor suppressor genes, leading to reduced gene expression and tumorigenesis.</p> Signup and view all the answers

What cytogenetic evidence supports the link between chromosome 13 and retinoblastoma?

<p>Deletions on the long arm of chromosome 13 (13q14) have been commonly associated with retinoblastoma.</p> Signup and view all the answers

Explain the role of genetic testing in cancer risk assessment.

<p>Genetic testing identifies mutations in tumor suppressor genes that help predict individual cancer risk.</p> Signup and view all the answers

What are the main processes that can alter gene transcription through changes in chromatin structure?

<p>Post-translational modification of histone proteins, DNA methylation, histone acetylation, and chromatin remodeling are the main processes.</p> Signup and view all the answers

How does histone acetylation affect gene expression?

<p>Histone acetylation neutralizes the positive charge of histones, decreasing their affinity for DNA and leading to transcriptional activation.</p> Signup and view all the answers

What is Knudson’s two-hit hypothesis in relation to tumor suppressor genes?

<p>It proposes that inactivation of both alleles is required for a mutant phenotype in tumor suppression.</p> Signup and view all the answers

What distinguishes driver mutations from passenger mutations?

<p>Driver mutations actively contribute to cancer development, while passenger mutations occur without affecting the cancer progression.</p> Signup and view all the answers

What is the role of DNA methylation in cancer progression?

<p>DNA methylation can lead to condensed chromatin and transcription repression, which may silence tumor suppressor genes and activate oncogenes.</p> Signup and view all the answers

How does p16 function in regulating the cell cycle?

<p>P16 inhibits cyclin D-dependent kinases, preventing phosphorylation of RB and blocking progression from G1 to S phase.</p> Signup and view all the answers

Define the basic functional unit of chromatin.

<p>The basic functional unit of chromatin is the nucleosome, consisting of DNA wrapped around histone proteins.</p> Signup and view all the answers

What is the significance of the Cancer Gene Census (CGC)?

<p>The CGC lists genes implicated in cancer, with 581 human genes identified as cancer driver genes linked to mutations.</p> Signup and view all the answers

What role does the p53 protein play in cellular processes?

<p>P53 is involved in DNA damage response, apoptosis, cell cycle arrest, and coordinating responses to cellular stress.</p> Signup and view all the answers

What happens to RB protein phosphorylation as a cell advances through the cell cycle?

<p>RB is hypophosphorylated in early G1 and becomes hyperphosphorylated at the restriction point, allowing progression to S phase.</p> Signup and view all the answers

What are 'writers', 'erasers', and 'readers' in the context of epigenetics?

<p>Writers add chemical modifications, erasers remove these modifications, and readers recognize and bind to specific modifications.</p> Signup and view all the answers

How can loss of p16 and p14Arf lead to uncontrolled cellular proliferation?

<p>Loss of p16 allows CDK4/6-mediated phosphorylation of RB, and loss of p14Arf prevents activation of p53, leading to unregulated cell cycle progression.</p> Signup and view all the answers

How is the process of histone acetylation regulated in cells?

<p>Histone acetylation is regulated by a balance of histone acetyltransferases (HAT) and histone deacetylases (HDAC).</p> Signup and view all the answers

Explain how aging is linked to changes in DNA methylation.

<p>Aging is associated with a dysregulation of methylation patterns, where unmethylated regions become more methylated, affecting gene expression.</p> Signup and view all the answers

What is the significance of loss of heterozygosity in cancer research?

<p>Loss of heterozygosity (LOH) is a key indicator for identifying other tumor suppressor genes related to cancer development.</p> Signup and view all the answers

In what way is p16 used as a diagnostic tool in cancer?

<p>P16 expression levels can indicate cellular control dysfunction and are associated with several malignancies.</p> Signup and view all the answers

What is the difference between benign and malignant tumors?

<p>Benign tumors are non-invasive and hyper-proliferative, while malignant tumors invade surrounding tissues and can metastasize.</p> Signup and view all the answers

Why is it important to study the RB1 gene in multiple cancer types?

<p>RB1 mutations are implicated in various cancers beyond retinoblastoma, including osteosarcoma and melanoma, highlighting its role as a TSG.</p> Signup and view all the answers

How do environmental factors contribute to the development of cancer?

<p>Environmental factors, such as exposure to DNA-damaging chemicals, can cause mutations that lead to cancer.</p> Signup and view all the answers

What is the effect of hypermethylation on gene expression?

<p>Hypermethylation typically leads to gene silencing, as it condenses chromatin and inhibits transcription.</p> Signup and view all the answers

What is the cellular function of cyclin-dependent kinases (CDKs)?

<p>CDKs are enzymes that phosphorylate target proteins to drive the cell cycle progression.</p> Signup and view all the answers

Describe the characteristics of leukemia.

<p>Leukemia is a type of cancer arising from blood cells, characterized by the proliferation of myeloid or lymphoid progenitor cells.</p> Signup and view all the answers

How do mutations in the CDKN2A gene affect cell cycle regulation?

<p>Mutations in CDKN2A disrupt the function of its encoded proteins, leading to loss of inhibition on cyclin D/CDK4, allowing unchecked cell cycle progression.</p> Signup and view all the answers

What does genome-epigenome interplay refer to in cancer?

<p>Genome-epigenome interplay refers to the interaction between genetic mutations and epigenetic changes that collectively drive cancer development.</p> Signup and view all the answers

What complexities arise from the role of tumor suppressor genes in cancer treatment?

<p>Tumor suppressor genes can have multifaceted roles that complicate their targeting for therapies, as their functional loss can lead to heterogeneous tumor behavior.</p> Signup and view all the answers

What is the role of chromatin structure in gene expression?

<p>Chromatin structure influences gene expression by either allowing or restricting access of transcription factors to DNA.</p> Signup and view all the answers

What is the role of the retinoblastoma protein (RB) in the cell cycle?

<p>RB regulates the cell cycle by binding E2F, controlling the transition from the G1 to S phase.</p> Signup and view all the answers

What impact does promoter methylation have on gene expression in cancer?

<p>Promoter methylation can lead to silencing of tumor suppressor genes, contributing to cancer progression by allowing uncontrolled cell growth.</p> Signup and view all the answers

How does mitotic recombination contribute to tumorigenesis?

<p>Mitotic recombination can lead to the loss of heterozygosity and potentially result in the inactivation of tumor suppressor genes.</p> Signup and view all the answers

How do mutations in TP53 and CDKN2A contribute to cancer progression?

<p>Mutations in TP53 lead to loss of apoptosis, while deletion of CDKN2A disrupts cell cycle control.</p> Signup and view all the answers

Describe the effect of CDKN2A deletion on tumor suppressor protein levels.

<p>Deletion of CDKN2A results in the loss of P16 and P14, leading to decreased tumor suppression.</p> Signup and view all the answers

What is the potential role of stress or oncogenic factors in p16 functionality?

<p>Stress or oncogenic factors may promote overexpression of p16 mutants as an attempt to restore its functions, although it might not effectively prevent cell proliferation.</p> Signup and view all the answers

In what cancers are CDKN2A deletions particularly implicated?

<p>CDKN2A deletions are notably implicated in melanoma and mesothelioma.</p> Signup and view all the answers

What are some common genetic alterations associated with cancer development?

<p>Common alterations include KMT2A-gene rearrangements, DNMT3a point mutations, and TET2 point mutations.</p> Signup and view all the answers

Identify two hallmarks of cancer that promote tumor growth.

<p>Sustaining proliferative signaling and evading growth suppressors are two key hallmarks.</p> Signup and view all the answers

What is the diagnostic significance of P16 in cancer?

<p>P16 loss or overexpression can serve as a diagnostic marker for cancer, indicating cell proliferation abnormalities.</p> Signup and view all the answers

How does P14 function relate to TP53 activity?

<p>P14 inhibits MDM2, which normally inactivates TP53, thus enhancing TP53's function.</p> Signup and view all the answers

Why is the loss of tumor suppressor genes significant in cancer development?

<p>Loss of tumor suppressor genes removes normal growth control, allowing unregulated cell proliferation.</p> Signup and view all the answers

How do mutations in proto-oncogenes lead to cancer?

<p>Mutations convert proto-oncogenes into oncogenes, causing them to induce excessive cell growth.</p> Signup and view all the answers

Explain the concept of epigenetics in relation to cancer.

<p>Epigenetics studies heritable changes in gene expression without altering the DNA sequence, often through methylation.</p> Signup and view all the answers

What is the difference between innate and adaptive immunity in the context of cancer?

<p>Innate immunity offers a rapid, non-specific response, while adaptive immunity provides a slower, specific response.</p> Signup and view all the answers

What are the primary mechanisms by which epigenetic changes occur?

<p>The primary mechanisms are DNA methylation and histone modifications.</p> Signup and view all the answers

What does Conrad Waddington's epigenetic landscape metaphor illustrate?

<p>It illustrates how cells transition from pluripotent to specialized states influenced by various factors.</p> Signup and view all the answers

Explain how the tumor microenvironment can impact cancer progression.

<p>The tumor microenvironment consists of immune cells that can either promote or inhibit tumor growth.</p> Signup and view all the answers

What role does immune surveillance play in cancer development?

<p>Immune surveillance is the immune system's process of monitoring and eliminating abnormal cells, including cancer cells.</p> Signup and view all the answers

How can therapeutic strategies aim to restore TP53 function?

<p>Therapeutics can either reactivate TP53 or inhibit its inactivators like MDM2.</p> Signup and view all the answers

Why is targeting specific signaling pathways in cancer treatment complex?

<p>Cancer cells may rely on different pathways, causing some targeted therapies to be ineffective due to resistance.</p> Signup and view all the answers

What is the significance of epigenetic modifications in cancer therapy?

<p>Epigenetic modifications can influence gene expression without changing the DNA sequence, impacting cancer progression.</p> Signup and view all the answers

How does the accumulation of genetic alterations contribute to cancer development?

<p>The multistep model of cancer posits that accumulating both genetic and epigenetic alterations lead to tumorigenesis.</p> Signup and view all the answers

What role do transcription factors play in the epigenetic landscape of cells?

<p>Transcription factors direct cellular changes and development by influencing gene expression patterns.</p> Signup and view all the answers

Describe the importance of understanding tumor suppressor gene networks.

<p>Understanding these networks is crucial for developing effective diagnostics and targeted therapies for cancer.</p> Signup and view all the answers

Describe the connection between genome instability and cancer.

<p>Genome instability increases the likelihood of mutations and chromosomal abnormalities, driving cancer progression.</p> Signup and view all the answers

What are hypomethylating agents, and how are they used in cancer treatment?

<p>Hypomethylating agents, like 5-azacytidine, inhibit DNA methyltransferase, restoring normal gene expression in cancer cells.</p> Signup and view all the answers

How do histone modifications affect gene expression?

<p>Histone modifications, like acetylation and methylation, can either promote or repress gene expression.</p> Signup and view all the answers

How does the concept of senescence relate to cancer recurrence?

<p>Senescent cells can stop dividing but may also contribute to a pro-inflammatory environment that supports recurrence.</p> Signup and view all the answers

What impact do immune deficiencies have on tumor development, according to animal studies?

<p>Immune deficiencies, demonstrated in models like SCID mice, lead to increased tumor formation due to reduced immune surveillance.</p> Signup and view all the answers

Why is it essential to understand the mechanisms behind tumor angiogenesis?

<p>Understanding tumor angiogenesis is crucial as it allows tumors to grow and metastasize by supplying necessary nutrients.</p> Signup and view all the answers

What is the role of p16 in familial melanoma?

<p>p16 is considered the 'familial melanoma gene' and is involved in germline mutations in familial atypical multiple mole/melanoma (FAMM) kindreds.</p> Signup and view all the answers

How does loss of PTEN contribute to cancer progression?

<p>Loss of PTEN leads to hyper-activation of the PI3K/AKT/MTOR pathway, resulting in increased PIP3 levels that promote cell growth and survival.</p> Signup and view all the answers

What are the mechanisms involved in Knudsen's Two-Hit Hypothesis?

<p>The hypothesis suggests that two mutations in tumor suppressor genes are required for disease, often observed through loss of heterozygosity or gene conversion.</p> Signup and view all the answers

What is the significance of methylation in gene regulation?

<p>Methylation can silence gene expression by modifying transcriptional control, typically affecting cytosines adjacent to guanines in DNA sequences.</p> Signup and view all the answers

How can we restore wild-type p53 function in cancer therapy?

<p>Wild-type p53 function can be restored by targeting its regulators, such as using nutlin to inhibit MDM2 or RITA to stabilize p53.</p> Signup and view all the answers

What is meant by 'loss of heterozygosity' (LOH)?

<p>Loss of heterozygosity refers to the loss of one functional allele, leading to disease if the remaining allele is also mutated.</p> Signup and view all the answers

How do NK cells identify stressed or malignant cells in the immune response?

<p>NK cells recognize stressed or malignant cells by detecting 'missing self' or 'altered self' markers.</p> Signup and view all the answers

Why is the CDKN2A gene significant in mesothelioma?

<p>CDKN2A loss is a critical driver mutation in mesothelioma and is frequently observed in tumor tissue compared to normal tissue.</p> Signup and view all the answers

How does the PI3K/AKT/MTOR pathway relate to cancer cell proliferation?

<p>The pathway is activated by PIP3, which leads to phosphorylation of various pro-growth targets, driving cell cycle progression and preventing apoptosis.</p> Signup and view all the answers

What role do MIC molecules play in the activity of NK cells against tumor cells?

<p>MIC molecules activate NK cells to target and destroy tumor cells by signaling stress.</p> Signup and view all the answers

What role do sirtuins play in cancer therapy?

<p>Sirtuins are protein deacetylases, and their inhibitors, like tenovin-1 and tenovin-6, are being explored for their potential to target cancer cells.</p> Signup and view all the answers

Explain the importance of MHC Class I and Class II in T cell activation.

<p>MHC Class I presents antigens to CD8+ T cells, while MHC Class II presents to CD4+ T cells, guiding the adaptive immune response.</p> Signup and view all the answers

Describe the concept of gene conversion in the context of tumor suppressor genes.

<p>Gene conversion is a process where DNA polymerase replicates genetic material from one chromatid to another, potentially duplicating a recessive allele.</p> Signup and view all the answers

Describe the three phases of tumor immunoediting.

<p>The phases are elimination, equilibrium, and escape, which describe how tumors evolve to persist despite immune responses.</p> Signup and view all the answers

What modern techniques are used for tumor tissue analysis?

<p>Techniques such as next-generation sequencing (NGS) and heat map analysis are utilized to identify genetic alterations in tumor samples.</p> Signup and view all the answers

What is T cell exhaustion, and how does it occur?

<p>T cell exhaustion is a state of dysfunction that occurs due to chronic antigen exposure, impairing effective immune responses.</p> Signup and view all the answers

How does immunotherapy aim to reverse T cell exhaustion?

<p>Immunotherapy seeks to rejuvenate exhausted T cells, enhancing their ability to combat tumors.</p> Signup and view all the answers

What does the presence of MYC probes indicate in mesothelioma cases?

<p>The presence of MYC probes in mesothelioma cases indicates the homozygous loss of p16 signaling in the absence of p16.</p> Signup and view all the answers

How does chronic inflammation contribute to tumorigenesis?

<p>Chronic inflammation can lead to DNA damage and promote an environment conducive to tumor progression and survival.</p> Signup and view all the answers

What is the principle behind Adoptive Cell Therapy (ACT)?

<p>ACT involves transferring immune cells from a patient's tumor back into the patient to target cancer more effectively.</p> Signup and view all the answers

What are the major challenges faced by CAR T cell therapy?

<p>Challenges include lower effectiveness against solid tumors and the risk of off-target effects.</p> Signup and view all the answers

Why is early identification of tumor suppressor gene mutations critical?

<p>Early identification facilitates timely intervention and may significantly improve patient outcomes by informing treatment decisions.</p> Signup and view all the answers

What is the importance of RFLP in gene discovery?

<p>Restriction Fragment Length Polymorphism (RFLP) is employed to identify changes in DNA band patterns, helping locate genes associated with tumors.</p> Signup and view all the answers

How does the process of preconditioning support T cell therapies?

<p>Preconditioning, often through chemotherapy or irradiation, depletes existing T cells to create space for reintroduced T cells.</p> Signup and view all the answers

List one advantage and one disadvantage of using tumor vaccines.

<p>An advantage is the ability to stimulate a targeted immune response; a disadvantage is variability in patient response.</p> Signup and view all the answers

How can genetic engineering improve T cell therapies?

<p>Genetic engineering can optimize T cells to enhance their specificity and potency against tumors.</p> Signup and view all the answers

What is the role of dendritic cells in T cell activation?

<p>Dendritic cells are crucial for antigen presentation and are required for effective T cell activation and differentiation.</p> Signup and view all the answers

Describe how chronic antigen exposure affects T cell effectiveness.

<p>Chronic antigen exposure leads to T cell exhaustion, reducing their ability to respond to tumors effectively.</p> Signup and view all the answers

How does CAR T cell therapy differ from traditional T cell therapies?

<p>CAR T cell therapy involves genetically modifying T cells to target specific tumor antigens, while traditional therapies do not.</p> Signup and view all the answers

What role do NK cells play in tumor prevention?

<p>NK cells recognize and kill tumor cells, producing interferon-gamma to recruit additional immune cells.</p> Signup and view all the answers

How does age-related immunosenescence contribute to cancer risk?

<p>Older individuals have a reduced immune response, which increases their susceptibility to cancer.</p> Signup and view all the answers

What role does immunosuppressive therapy play in cancer risk for transplant recipients?

<p>Immunosuppressive drugs increase cancer risk in transplant patients by weakening their immune response.</p> Signup and view all the answers

What are immune checkpoints and why are they significant in cancer treatment?

<p>Immune checkpoints like PD-1 and CTLA-4 regulate immune responses and, when targeted, enhance the immune system's ability to destroy cancer cells.</p> Signup and view all the answers

What is the importance of T cell activation signals in the immune response?

<p>T cell activation requires two signals: recognition of the antigen-MHC complex and co-stimulation from APCs.</p> Signup and view all the answers

Explain the process of cancer immunoediting.

<p>Cancer immunoediting consists of three phases: elimination, equilibrium, and escape, where the immune system interacts with tumor cells.</p> Signup and view all the answers

What is the role of MHC molecules in the immune response?

<p>MHC Class I presents endogenous antigens to CD8+ T cells, while MHC Class II presents exogenous antigens to CD4+ T cells.</p> Signup and view all the answers

How can tumors evade immune detection?

<p>Tumors may evade detection by modulating antigens, producing immunosuppressive cytokines, or expressing immune checkpoint molecules.</p> Signup and view all the answers

What advancements have been made in immunotherapy for cancer treatment?

<p>Recent advances include checkpoint inhibitors and CAR-T cell therapies, which enhance the body's immune response against cancer.</p> Signup and view all the answers

How does thymic selection influence T cell maturation?

<p>Thymic selection eliminates T cells that recognize self-antigens, ensuring that mature T cells can distinguish between self and non-self.</p> Signup and view all the answers

What is peripheral tolerance and its significance in cancer?

<p>Peripheral tolerance involves regulatory T cells (Tregs) suppressing self-reactive T cells that escape thymic selection.</p> Signup and view all the answers

What is the relationship between immunodeficiency disorders and cancer incidence?

<p>Patients with immunodeficiency disorders often have a higher incidence of cancer due to compromised immune surveillance.</p> Signup and view all the answers

Why is understanding the tumor microenvironment critical for successful immunotherapy?

<p>The tumor microenvironment influences the presence and effectiveness of immune cells, impacting tumor clearance.</p> Signup and view all the answers

Describe the significance of adaptive immunity in cancer response?

<p>Adaptive immunity, particularly through CD8+ cytotoxic T cells, specifically targets tumor-associated antigens, leading to tumor cell death.</p> Signup and view all the answers

How do T cell differentiation and function relate to antigen recognition?

<p>T cell differentiation into effector and memory cells depends on the strength and duration of antigen recognition.</p> Signup and view all the answers

What is the role of MHC-I in T cell activation?

<p>MHC-I presents tumor antigens to CD8+ T cells, facilitating their activation and subsequent killing of tumor cells.</p> Signup and view all the answers

Describe the Two Signal Model of T cell activation.

<p>Signal 1 is the recognition of antigen-MHC by the T cell receptor, while Signal 2 involves co-stimulatory molecules that enhance T cell activation.</p> Signup and view all the answers

How does immune tolerance help prevent autoimmunity?

<p>Immune tolerance eliminates or inactivates self-reactive T cells, thus reducing the risk of autoimmunity.</p> Signup and view all the answers

What strategies do tumors use to evade the immune system?

<p>Tumors can downregulate MHC-I expression, induce immunosuppression, and modulate antigens to evade detection.</p> Signup and view all the answers

Explain the concept of cancer immunoediting.

<p>Cancer immunoediting refers to the process where the immune system shapes tumor cells, selecting for more aggressive and immune-evasive variants.</p> Signup and view all the answers

What is the function of immune checkpoint molecules like CTLA-4?

<p>CTLA-4 competes with CD28 for binding to CD80/86, providing a negative regulatory signal that prevents excessive T cell activation.</p> Signup and view all the answers

Describe how chronic antigen exposure affects T cell function.

<p>Chronic antigen exposure can lead to T cell dysfunction, causing decreased effectiveness in the immune response against tumors.</p> Signup and view all the answers

What are tumor-infiltrating lymphocytes (TIL) and their significance?

<p>TIL are immune cells extracted from tumors, expanded, and reinfused into patients to enhance anti-tumor immunity.</p> Signup and view all the answers

How do cancer vaccines stimulate an immune response?

<p>Cancer vaccines target specific tumor antigens to provoke an immune response, educating T cells to recognize and attack tumor cells.</p> Signup and view all the answers

What is the role of TGF-β in tumor immunosuppression?

<p>TGF-β is a cytokine produced by tumors that suppresses immune responses, facilitating tumor evasion.</p> Signup and view all the answers

What step is critical for the successful activation of T cells?

<p>Successful T cell activation requires both the recognition of antigen-MHC and co-stimulatory signals.</p> Signup and view all the answers

What is the significance of adoptive cell transfer (ACT) in cancer therapy?

<p>ACT enhances the number of tumor-specific T cells in patients, acting as a personalized treatment strategy.</p> Signup and view all the answers

How do immune checkpoint inhibitors enhance anti-tumor responses?

<p>They block inhibitory signals like CTLA-4 and PD-1, restoring T cell function and boosting the immune response against tumors.</p> Signup and view all the answers

What is the significance of immunoediting in tumor evolution?

<p>Immunoediting leads to the selection of tumor variants that can survive immune pressure, often making them more aggressive.</p> Signup and view all the answers

What is the Warburg effect and how does it relate to cancer cell metabolism?

<p>The Warburg effect describes the increased glucose uptake and lactate production in cancer cells, even in the presence of adequate oxygen, indicating a shift from oxidative phosphorylation to glycolysis.</p> Signup and view all the answers

How do tumors create an immunosuppressive tumor microenvironment?

<p>Tumors utilize factors such as TGF-β to inhibit immune responses and convert immature myeloid cells into myeloid-derived suppressor cells (MDSCs) that suppress antitumor immunity.</p> Signup and view all the answers

What role do HIF1α and HIF2α play in glucose metabolism under hypoxic conditions?

<p>HIF1α and HIF2α are transcription factors that upregulate glucose transporters and glycolysis in response to hypoxia, enhancing glucose availability for cancer cells.</p> Signup and view all the answers

What is chromosomal instability (CIN) and how is it associated with cancer?

<p>Chromosomal instability (CIN) refers to an increased rate of chromosomal changes and mutations, contributing to the acquisition of new capabilities in cancer cells.</p> Signup and view all the answers

Describe the relationship between inflammation and tumor progression.

<p>Inflammation supports tumor progression by providing growth factors and creating an environment conducive to metastasis through immune cell recruitment.</p> Signup and view all the answers

What is the general mechanism by which immune checkpoint inhibitors function?

<p>They block immune checkpoints like CTLA-4 and PD-1, helping the immune system recognize and attack cancer cells.</p> Signup and view all the answers

How do tumor-derived factors affect the function of immune cells?

<p>Tumor-derived factors impair T cell function and convert immune cells into MDSCs, which suppress effective immune responses against the tumor.</p> Signup and view all the answers

What are some challenges associated with immune checkpoint blockade therapies?

<p>They can cause autoimmune side effects, have high costs, and only a subset of patients responds effectively.</p> Signup and view all the answers

What is the effect of mutations in DNA repair genes like BRCA1 on cancer risk?

<p>Mutations in DNA repair genes such as BRCA1 lead to genomic instability, significantly increasing the risk of developing hereditary cancers, particularly breast and ovarian cancer.</p> Signup and view all the answers

What role does tumor mutational burden play in targeted cancer therapies?

<p>A higher tumor mutational burden may indicate a greater likelihood of response to immunotherapy.</p> Signup and view all the answers

Explain how the extracellular matrix (ECM) can influence tumor behavior.

<p>The extracellular matrix (ECM) can impair antigen presenting cells and inhibit T-cell activation, thus suppressing the immune response against the tumor.</p> Signup and view all the answers

How does personalized medicine enhance cancer treatment approaches?

<p>By tailoring treatments based on the unique tumor features and patient-specific factors.</p> Signup and view all the answers

Define immunoediting in relation to tumor development.

<p>It refers to the process by which the immune system shapes tumor cell populations, allowing some variants to survive.</p> Signup and view all the answers

What mechanisms do tumors use to avoid immune recognition?

<p>Tumors avoid immune recognition by altering the expression of antigens, secreting immunosuppressive factors, and educating immune cells to become suppressive.</p> Signup and view all the answers

Why is tumor mutational burden significant in targeted therapy?

<p>Tumor mutational burden reflects the number of mutations within a tumor, which may correlate with the likelihood of response to immunotherapy and targeted treatments.</p> Signup and view all the answers

What is the significance of tumor-infiltrating lymphocytes in cancer prognosis?

<p>Their presence, especially T cells, often correlates with a better prognosis for patients.</p> Signup and view all the answers

How do innate and adaptive immunity differ in their response times to tumors?

<p>Innate immunity responds quickly and non-specifically, while adaptive immunity is slower and highly specific.</p> Signup and view all the answers

What historical findings led to the development of immunotherapy?

<p>William Coley's observation that bacterial infections could trigger the immune system to combat certain cancers.</p> Signup and view all the answers

What are predictive biomarkers and why are they important in immunotherapy?

<p>Predictive biomarkers are indicators used to identify which patients are likely to benefit from specific treatments.</p> Signup and view all the answers

What evidence supports the immune system's interaction with tumors?

<p>Immunosuppressed individuals show higher cancer risks, and tumor infiltrating T cells can signal better survival outcomes.</p> Signup and view all the answers

Explain the concept of immune tolerance in the context of tumors.

<p>Immune tolerance refers to mechanisms that prevent the immune system from attacking tumor cells, similar to preventing autoimmunity.</p> Signup and view all the answers

What impact does combining immunotherapy with chemotherapy or radiotherapy have?

<p>This combination may enhance treatment efficacy and overcome resistance mechanisms in tumor cells.</p> Signup and view all the answers

How do Major Histocompatibility Complexes (MHC) contribute to the adaptive immune response?

<p>MHC molecules present tumor antigens to T cells, facilitating their activation and specific targeting of cancer cells.</p> Signup and view all the answers

Discuss the implications of immune surveillance in cancer prevention.

<p>The immune system helps detect and eliminate early tumors before they grow into clinically significant cancers.</p> Signup and view all the answers

What are immune checkpoint inhibitors and their potential adverse events?

<p>Immune checkpoint inhibitors are therapies that enhance the immune response against cancer, but they can cause immune-related adverse events like autoimmune symptoms.</p> Signup and view all the answers

What role did the DREAM trial play in advancing treatment for mesothelioma?

<p>The DREAM trial demonstrated the effectiveness of combining chemotherapy with an immune checkpoint inhibitor, aPDL1, in treating mesothelioma.</p> Signup and view all the answers

What are the recently confirmed hallmarks of cancer according to the 2022 publication?

<p>The 2022 publication confirmed the 2011 emerging hallmarks as established hallmarks and introduced new emerging hallmarks alongside enabling characteristics.</p> Signup and view all the answers

How do tumor-associated stroma cells influence tumor growth?

<p>Tumor-associated stroma comprises non-tumor cells that interact with cancer cells, promoting tumorigenesis and influencing the tumor microenvironment.</p> Signup and view all the answers

What is the significance of TP53 in cancer biology?

<p>TP53 is a tumor suppressor gene involved in regulating cell growth and apoptosis, frequently mutated in various cancers.</p> Signup and view all the answers

What mechanisms allow cancer cells to evade growth suppressors?

<p>Cancer cells inactivate critical tumor suppressor genes such as RB and TP53, disrupting normal cellular controls over growth and division.</p> Signup and view all the answers

Explain how cancer cells resist apoptosis.

<p>Cancer cells resist apoptosis through mechanisms such as mutations in TP53, increased expression of anti-apoptotic proteins, and reduced pro-apoptotic signals.</p> Signup and view all the answers

What is the primary benefit of CAR T-cell therapy in treating blood cancers?

<p>CAR T-cell therapy is notably effective in hematological cancers due to its ability to bypass typical antigen-MHC interactions and directly activate T cells.</p> Signup and view all the answers

What are enabling characteristics facilitating cancer hallmarks?

<p>Enabling characteristics include genome instability and mutation, as well as tumor-promoting inflammation, which support the acquisition of hallmark capabilities.</p> Signup and view all the answers

Describe sustained proliferative signaling and its impact on cancer.

<p>Sustained proliferative signaling occurs when cancer cells continuously stimulate their growth by hijacking growth-promoting signals and disrupting regulatory mechanisms.</p> Signup and view all the answers

What are the major challenges when using CAR T-cell therapy for solid tumors?

<p>The major challenges include antigen limitations, as CAR T-cells are not effective for solid tumors and require cancer-specific antigens that are commonly expressed.</p> Signup and view all the answers

What is the effect of mutations in ras genes on proliferative signaling?

<p>Mutations in ras genes can lead to inactive Ras GTPase, disrupting negative-feedback mechanisms and resulting in unregulated proliferative signaling.</p> Signup and view all the answers

How do immune checkpoints such as CTLA-4 and PD-1 affect T-cell activation?

<p>CTLA-4 and PD-1 serve as negative regulators, preventing T-cell activation and leading to immune suppression when engaged by their ligands.</p> Signup and view all the answers

What innovative techniques are being explored to improve T-cell therapies?

<p>Genetic engineering techniques like CRISPR/Cas9 and the delivery of therapeutic payloads using T cells are being researched to enhance T-cell therapies.</p> Signup and view all the answers

What emerging hallmarks of cancer have been identified in the 2022 report?

<p>The 2022 report introduced new emerging hallmarks, but specific details on what they are would need to be detailed further.</p> Signup and view all the answers

How does tumor-promoting inflammation contribute to cancer progression?

<p>Tumor-promoting inflammation creates an environment that supports cancer cell survival, proliferation, and metastasis.</p> Signup and view all the answers

What is the role of cytokine release syndrome (CRS) in CAR T-cell therapy?

<p>Cytokine release syndrome is a significant side effect of CAR T-cell therapy, resulting from the rapid activation and proliferation of the modified T cells.</p> Signup and view all the answers

What are the primary pros of cancer vaccinations?

<p>Cancer vaccinations offer ease of administration, the potential for preventative treatment, and relatively lower costs.</p> Signup and view all the answers

What is the relationship between autophagy and cancer cell survival?

<p>Autophagy allows cancer cells to degrade and recycle cellular components, aiding survival under stress conditions.</p> Signup and view all the answers

What are two major cons associated with cancer vaccinations?

<p>Major cons include challenges in vaccine formulation and the need for selecting appropriate antigenic targets and adjuvants.</p> Signup and view all the answers

In what ways can targeting immune checkpoint inhibitors improve cancer treatment outcomes?

<p>Targeting immune checkpoint inhibitors can enhance T cell immunity against tumors, potentially increasing responses to therapy in previously resistant cancers.</p> Signup and view all the answers

What advancements in T-cell therapies are anticipated for the future?

<p>Future advancements include engineering T cells with 'suicide switches' to prevent toxicity and improving their persistence in patients.</p> Signup and view all the answers

How does checkpoint blockade therapy benefit patients with tumors?

<p>Checkpoint blockade therapy restores T-cell functionality, potentially leading to tumor regression in some patients.</p> Signup and view all the answers

What characteristics define CD8+ T cells that are targeted by anti-PD-1 therapy?

<p>Anti-PD-1 therapy primarily targets tumor-infiltrating CD8+ T cells exhibiting stem-like features.</p> Signup and view all the answers

What are the potential autoimmune side effects associated with immune checkpoint blockade?

<p>Immune-related adverse events can range from mild to severe, resembling autoimmune symptoms due to T-cell activation.</p> Signup and view all the answers

What type of cells are used for natural killer (NK) cell therapies?

<p>Natural Killer (NK) cell therapies utilize NK cells, which are a part of the innate immune system and target cancerous cells without prior sensitization.</p> Signup and view all the answers

What are potential future applications of mRNA vaccines in immunotherapy?

<p>mRNA vaccines tailored to patient-specific tumor mutations are being explored as customizable options for cancer immunotherapy.</p> Signup and view all the answers

How does the presence of tumor-infiltrating lymphocytes (TILs) impact cancer therapy?

<p>The presence of TILs reflects the immune response within the tumor microenvironment and can indicate the potential effectiveness of immunotherapies.</p> Signup and view all the answers

What factors can predict the likelihood of a patient responding to immune checkpoint blockade?

<p>Increased tumor mutational burden and the presence of tumor-infiltrating CD8+ T cells can indicate a higher likelihood of response to immune checkpoint blockade.</p> Signup and view all the answers

How does the TP53 gene contribute to the process of apoptosis in cancer cells?

<p>TP53 induces apoptosis by upregulating the expression of Noxa and Puma BH3-only proteins in response to DNA breaks and chromosomal abnormalities.</p> Signup and view all the answers

What strategies do tumor cells employ to evade apoptosis?

<p>Tumor cells avoid apoptosis by losing TP53 function, increasing antiapoptotic factors like Bcl-2, and downregulating proapoptotic factors.</p> Signup and view all the answers

What is the role of autophagy in cancer cell survival?

<p>Autophagy helps cancer cells survive by recycling cellular components during nutrient starvation and under stress conditions.</p> Signup and view all the answers

Describe the difference between apoptosis and necrosis in cancer biology.

<p>Apoptosis is a controlled, programmed cell death, whereas necrosis is uncontrolled cell death caused by severe external stress and leads to inflammation.</p> Signup and view all the answers

How do tumor-associated macrophages (TAMs) contribute to tumor progression?

<p>TAMs can promote tumor progression through processes like angiogenesis, immune evasion, and remodeling of the extracellular matrix.</p> Signup and view all the answers

What is the Warburg effect and its significance in cancer cells?

<p>The Warburg effect refers to cancer cells preferring glycolysis for energy production even in the presence of oxygen, supporting rapid growth.</p> Signup and view all the answers

Explain the importance of the Epithelial-Mesenchymal Transition (EMT) in cancer metastasis.

<p>EMT facilitates cancer cell mobility and invasiveness, essential for local invasion and spread to distant tissues.</p> Signup and view all the answers

What role do transcription factors like Snail and Twist play in cancer progression?

<p>Transcription factors such as Snail and Twist inhibit E-cadherin expression and promote EMT, increasing tumor cell motility and invasiveness.</p> Signup and view all the answers

What are the key features of the angiogenic switch in tumors?

<p>The angiogenic switch involves the continuous formation of new blood vessels, primarily regulated by VEGF-A and TSP-1, leading to abnormal vascular structures.</p> Signup and view all the answers

How does telomerase contribute to the replicative immortality of cancer cells?

<p>Telomerase activation maintains telomere length, allowing cancer cells to divide indefinitely and resist apoptosis.</p> Signup and view all the answers

What consequences arise from the loss of E-cadherin in tumors?

<p>Loss of E-cadherin disrupts cell adhesion, removing contact inhibition and enabling uncontrolled proliferation and invasion.</p> Signup and view all the answers

Discuss the impact of nutrient starvation on cancer cells' autophagy levels.

<p>Nutrient starvation can elevate autophagy levels in cancer cells, which can provide a cytoprotective effect, promoting survival during stress.</p> Signup and view all the answers

What role does the extracellular matrix (ECM) play in tumor biology?

<p>The ECM provides structural support and influences cell behavior, and its remodeling by cancer-associated cells can facilitate tumor invasion and metastasis.</p> Signup and view all the answers

How do cancer cells exploit the inflammatory response during necrosis?

<p>Cancer cells can use the inflammatory response triggered by necrosis to recruit immune cells that may promote tumor growth.</p> Signup and view all the answers

What percentage of breast cancer cases occurs in women over the age of 50?

<p>77%</p> Signup and view all the answers

Which genes are primarily associated with hereditary breast cancer and what is their mutation pattern?

<p>BRCA1 and BRCA2 mutations; they have an autosomal dominant pattern.</p> Signup and view all the answers

What effect does prolonged estrogen exposure have on breast cancer risk?

<p>It increases the risk of developing breast cancer.</p> Signup and view all the answers

How does nulliparity or late pregnancy affect the risk of breast cancer?

<p>It increases the risk of breast cancer.</p> Signup and view all the answers

What is the lifetime risk percentage for breast cancer in women with BRCA1 mutations?

<p>50-85%</p> Signup and view all the answers

What proportion of breast cancer cases is considered hereditary?

<p>5-10%</p> Signup and view all the answers

Name a risk factor for breast cancer associated with previous medical treatment.

<p>Radiation exposure.</p> Signup and view all the answers

What tool is used to estimate a woman's risk of developing breast cancer within the next five years?

<p>Breast Cancer Risk Assessment Tool.</p> Signup and view all the answers

What factors contribute to the staging of breast cancer according to the AJCC system?

<p>The staging is based on tumor size, nodal involvement, and the presence of metastasis.</p> Signup and view all the answers

What are the risks associated with axillary surgery in breast cancer management?

<p>Axillary dissection carries a high risk of lymphoedema.</p> Signup and view all the answers

How is the histological grade of breast cancer determined?

<p>The histological grade is determined using the modified Bloom and Richardson method based on tubule formation, nuclear atypia, and mitotic activity.</p> Signup and view all the answers

What role do ER and PR positivity play in breast cancer prognosis and treatment response?

<p>ER and PR positive breast cancers show improved survival and stronger responsiveness to hormone therapy.</p> Signup and view all the answers

What is the significance of HER2 positivity in breast cancer?

<p>HER2 positive breast cancer is often more aggressive but can be treated with targeted therapies like trastuzumab.</p> Signup and view all the answers

What are the four distinct breast cancer molecular subtypes identified through gene expression profiling?

<p>The four subtypes are Luminal A, Luminal B, HER2 enriched, and Basal-like.</p> Signup and view all the answers

What are the clinical features that characterize melanoma?

<p>Asymmetry, irregular borders, color variability, a diameter greater than 6mm, and evolving characteristics.</p> Signup and view all the answers

How do surgical options differ in breast cancer treatment?

<p>Surgical options include lumpectomy or mastectomy, depending on the cancer's extent.</p> Signup and view all the answers

What does a dysplastic naevus indicate regarding melanoma risk?

<p>It is associated with an increased risk of developing melanoma, especially in familial cases.</p> Signup and view all the answers

What is the purpose of using radiotherapy in breast cancer treatment?

<p>Radiotherapy is used post-surgery to reduce the risk of cancer recurrence.</p> Signup and view all the answers

Describe the radial growth phase of melanoma.

<p>It involves melanoma in situ with superficial dermal invasion, characterized by single cells or small nests without metastatic potential.</p> Signup and view all the answers

What are common risk factors for the development of melanoma?

<p>Common risk factors include fair skin, UV radiation exposure, and a family history of melanoma.</p> Signup and view all the answers

What histological feature distinguishes benign naevus from melanoma?

<p>A benign naevus features a symmetrical structure with cells in nests, while melanoma shows irregularities.</p> Signup and view all the answers

What is the significance of BRAF mutations in melanoma?

<p>BRAF mutations are found in approximately 66% of melanomas and are crucial for targeted therapy development.</p> Signup and view all the answers

What is the primary microscopic feature of melanoma during the vertical growth phase?

<p>It shows expansive growth into the dermis with larger nests and the presence of mitotic figures indicating metastatic potential.</p> Signup and view all the answers

What is the clinical significance of the Nottingham grading system in breast cancer?

<p>The Nottingham grading system assesses tumor aggressiveness, aiding in the prognosis and treatment planning.</p> Signup and view all the answers

How can the presence of ulceration in melanoma affect prognosis?

<p>Ulceration is associated with poorer outcomes in melanoma cases.</p> Signup and view all the answers

Explain the significance of prognostic and predictive biomarkers in breast cancer treatment.

<p>Prognostic biomarkers indicate overall survival, while predictive biomarkers forecast treatment responses.</p> Signup and view all the answers

What are the implications of a high mitotic rate in melanoma prognosis?

<p>A higher mitotic rate correlates with a worse prognosis, indicating more aggressive disease.</p> Signup and view all the answers

What impact does molecular profiling have on breast cancer management?

<p>Molecular profiling identifies specific cancer subtypes and informs targeted therapy options.</p> Signup and view all the answers

What is the role of CDKN2A in melanoma?

<p>CDKN2A encodes proteins that regulate the cell cycle and promote tumor suppression.</p> Signup and view all the answers

How do invasive breast cancer markers like ER and PR influence treatment options?

<p>ER and PR positivity suggests a better response to anti-hormonal treatments like tamoxifen.</p> Signup and view all the answers

How do TERT promoter mutations contribute to melanoma?

<p>TERT promoter mutations, found in approximately 70% of melanomas, increase telomerase activity, helping cells bypass senescence.</p> Signup and view all the answers

What factors determine the need for chemotherapy in breast cancer treatment?

<p>Chemotherapy is indicated based on high-risk clinicopathological features.</p> Signup and view all the answers

What is meant by 'Pagetoid spread' in melanoma?

<p>Pagetoid spread refers to the invasion of melanoma cells into the upper epidermal levels with a 'buckshot' scatter pattern.</p> Signup and view all the answers

Why is testing for BRAF mutations important in treating melanoma?

<p>Testing helps identify patients who may benefit from specific BRAF inhibitors, improving treatment outcomes.</p> Signup and view all the answers

What cellular changes are associated with cytological atypia in melanoma?

<p>Cytological atypia includes nuclear enlargement, hyperchromasia, irregularity, and prominent nucleoli.</p> Signup and view all the answers

What role do KIT mutations play in melanoma?

<p>KIT mutations are associated with melanomas in certain sites, especially in skin with chronic sun exposure.</p> Signup and view all the answers

What does the Clark level indicate in melanoma prognosis?

<p>The Clark level measures the invasion depth of melanoma, providing insights into the prognosis.</p> Signup and view all the answers

What characteristic features of melanoma are noted in older patients?

<p>Incidence rises with age in melanoma, and features include a lentiginous growth pattern and poorly circumscribed margins.</p> Signup and view all the answers

What is the difference in breast cancer risk between usual hyperplasia without atypia and atypical hyperplasia?

<p>Usual hyperplasia without atypia is associated with a mild increase in breast cancer risk (1.5-2x), while atypical hyperplasia has a moderate increased risk of 4-5 times.</p> Signup and view all the answers

What is Ductal Carcinoma In Situ (DCIS) and how is it classified?

<p>DCIS is a non-invasive breast cancer confined to the ducts, classified by the grade of nuclear atypia into low, intermediate, or high.</p> Signup and view all the answers

Describe the characteristics and clinical presentation of Paget’s Disease of the Nipple.

<p>Paget’s Disease presents with red, weeping, 'eczematous' nipple lesions, and is almost always associated with underlying DCIS.</p> Signup and view all the answers

What is Lobular Carcinoma In Situ (LCIS) and what is its clinical significance?

<p>LCIS is a risk factor for lobular invasive carcinoma, often diagnosed incidentally and has bilateral implications for future breast cancer development.</p> Signup and view all the answers

What is the leading risk factor for lung cancer?

<p>Tobacco smoking.</p> Signup and view all the answers

What are the treatment options for Ductal Carcinoma In Situ?

<p>Treatment typically involves surgical excision with clear margins, and may require radiotherapy depending on the case.</p> Signup and view all the answers

What is the 5-year survival rate for lung cancer patients in Australia?

<p>17%.</p> Signup and view all the answers

Explain the significance of histological atypia in proliferative breast disease.

<p>Histological atypia indicates a greater risk of breast cancer, with atypical hyperplasia presenting a 4-5 fold increased risk compared to benign lesions.</p> Signup and view all the answers

Name a common sampling technique used for lung cancer diagnosis.

<p>Transbronchial Fine-Needle Aspiration (FNA).</p> Signup and view all the answers

How is invasive breast cancer defined and what are common clinical presentations?

<p>Invasive breast cancer is defined by the invasion of malignant cells beyond the myoepithelial layer into the stroma, often presenting as a discrete lump, pain, or nipple changes.</p> Signup and view all the answers

Which type of lung cancer is most associated with smoking?

<p>Small Cell Lung Carcinoma (SCLC).</p> Signup and view all the answers

What is a defining histological feature of Squamous Cell Carcinoma?

<p>Keratinization and intercellular bridges.</p> Signup and view all the answers

What distinguishes invasive ductal carcinoma from invasive lobular carcinoma?

<p>Invasive ductal carcinoma is the most common type, accounting for about 80% of cases, while invasive lobular carcinoma accounts for approximately 10%.</p> Signup and view all the answers

What factors influence the prognosis of breast cancer?

<p>Prognosis is influenced by tumor grade, extent of the lesion, completeness of excision, and biological markers.</p> Signup and view all the answers

In what scenario is a patient more likely to present with an EGFR mutation?

<p>Non-smokers, especially in East Asian populations.</p> Signup and view all the answers

What is the significance of Programmed cell death ligand-1 (PD-L1) in lung cancer treatment?

<p>It determines eligibility for pembrolizumab therapy.</p> Signup and view all the answers

What is the primary mechanism of progression from in situ to invasive breast cancer?

<p>The primary mechanism involves the invasion of malignant cells beyond the ductal or lobular confines, potentially extending to adjacent stromal tissues.</p> Signup and view all the answers

What is the role of anti-estrogen therapy in the management of lobular carcinoma in situ?

<p>Anti-estrogen therapy can be considered for patients with lobular carcinoma in situ to reduce the risk of future invasive breast cancer.</p> Signup and view all the answers

How does the prognosis differ between small cell lung carcinoma and non-small cell lung carcinoma?

<p>SCLC has a worse prognosis than NSCLC.</p> Signup and view all the answers

What does an adenocarcinoma typically look like in a CT scan?

<p>A ground-glass nodule.</p> Signup and view all the answers

What histological features characterize invasive breast cancer?

<p>Histologically, invasive breast cancer shows malignant cells penetrating the stroma, with variations in growth patterns, necrosis, and cellular atypia.</p> Signup and view all the answers

Discuss the importance of clear margins during the surgical excision of breast lesions.

<p>Clear margins during surgical excision are crucial to ensure complete removal of the tumor and reduce the risk of local recurrence.</p> Signup and view all the answers

What is the clinical approach when non-small cell lung carcinoma is deemed unresectable?

<p>Look for 'druggable' targets for targeted therapy or administer chemoradiotherapy.</p> Signup and view all the answers

How are calcifications relevant in the diagnosis of ductal carcinoma in situ?

<p>Calcifications are common radiological findings in DCIS and can indicate the presence of malignant changes within the ducts.</p> Signup and view all the answers

What role do environmental and occupational carcinogens play in lung cancer risk?

<p>They are additional risk factors contributing to lung cancer development.</p> Signup and view all the answers

What is the recommended treatment for early-stage adenocarcinoma that is completely resected?

<p>100% 5-year disease-free survival.</p> Signup and view all the answers

Name one method used for ancillary studies on neoplastic specimens.

<p>Immunohistochemistry (IHC).</p> Signup and view all the answers

What is a common metastatic site for adenocarcinoma?

<p>Adrenal glands, bones, and brain.</p> Signup and view all the answers

What characteristic features are observed in small cell lung carcinoma cytology?

<p>Small cells with scant cytoplasm, granular chromatin, and nuclear molding.</p> Signup and view all the answers

What are the primary treatments for acute promyelocytic leukemia (APL)?

<p>The primary treatments for APL include all-trans retinoic acid and arsenic trioxide.</p> Signup and view all the answers

Describe the significance of the Philadelphia Chromosome in Chronic Myeloid Leukaemia (CML).

<p>The Philadelphia Chromosome results from a t(9;22) translocation that creates the BCR-ABL1 gene fusion, which is a hallmark of CML.</p> Signup and view all the answers

What is the SLiM CRAB criteria used for in multiple myeloma diagnosis?

<p>The SLiM CRAB criteria are used to diagnose multiple myeloma based on plasma cell levels, light chain abnormalities, and CRAB features like calcium elevation.</p> Signup and view all the answers

What role do targeted therapies, such as TKIs, play in the treatment of CML?

<p>Targeted therapies like TKIs, specifically Imatinib, have revolutionized CML treatment, improving survival rates significantly.</p> Signup and view all the answers

Identify two common genetic mutations associated with poor prognosis in multiple myeloma.

<p>Common mutations associated with poor prognosis include del17p and del13.</p> Signup and view all the answers

What is the average 5-year survival rate for multiple myeloma in Australia?

<p>The average 5-year survival rate for multiple myeloma in Australia is approximately 55%.</p> Signup and view all the answers

How does chronic lymphocytic leukaemia (CLL) typically differ in presentation among various age groups?

<p>CLL is more common in the elderly and is often asymptomatic at diagnosis, presenting with symptoms like lymphadenopathy and anemia in progressive stages.</p> Signup and view all the answers

What is the relevance of multi-agent chemotherapy in the management of CLL?

<p>Multi-agent chemotherapy is initiated upon symptom progression in CLL to manage the disease effectively.</p> Signup and view all the answers

What role does the genetic background, such as deletion syndromes, play in CLL patient prognosis?

<p>Specific genetic deletions, like del17p, can inform prognosis and guide treatment strategies in CLL.</p> Signup and view all the answers

Mention one of the key diagnostic tests for detecting bone lesions in multiple myeloma.

<p>A skeletal survey using CT or X-ray is a key diagnostic test for detecting bone lesions in multiple myeloma.</p> Signup and view all the answers

What are the most common mutations in EGFR-mutated lung adenocarcinoma?

<p>Mutations in exon 19 and 21 are the most common.</p> Signup and view all the answers

What is the significance of detecting ALK rearrangements in lung adenocarcinoma?

<p>ALK rearrangements are typically found in younger, never-smoking patients and guide targeted therapy options.</p> Signup and view all the answers

How does KRAS mutation impact the prognosis of lung cancer?

<p>KRAS mutation is associated with a poor prognosis and is more common in smokers.</p> Signup and view all the answers

What role do immune checkpoint inhibitors play in treating lung cancer?

<p>They block the PD-1/PD-L1 pathway to enhance immune detection of tumors.</p> Signup and view all the answers

What qualifies a patient for pembrolizumab therapy in terms of PD-L1 expression?

<p>Patients with high PD-L1 expression (≥50%) qualify for pembrolizumab.</p> Signup and view all the answers

What are the key differences between acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML)?

<p>ALL typically affects younger patients and is characterized by immature lymphoblasts, while AML is more common in adults with diverse subtypes.</p> Signup and view all the answers

What cytogenetic changes are associated with better prognosis in ALL?

<p>Hyperdiploidy (increased whole chromosomes) in young children is associated with the best prognosis.</p> Signup and view all the answers

Describe the typical immunophenotype of B-cell lineage in ALL.

<p>B-cell lineage in ALL commonly expresses antigens such as CD10, CD19, and weak CD45.</p> Signup and view all the answers

What is the clinical approach for treating acute myeloid leukaemia (AML)?

<p>Treatment typically involves chemotherapy and may include stem cell transplantation.</p> Signup and view all the answers

Explain the role of small biopsy samples in diagnosing unresectable NSCLC.

<p>Small biopsy samples are crucial for diagnosing and determining targeted therapies for unresectable NSCLC.</p> Signup and view all the answers

What is the primary mechanism through which tumors evade immune detection?

<p>Tumors exploit the PD-1/PD-L1 pathway to evade immune detection.</p> Signup and view all the answers

What patterns of adenocarcinomas are associated with ALK positive lung cancer?

<p>ALK positive lung cancer frequently presents as solid-signet ring or mucinous cribriform patterns.</p> Signup and view all the answers

What chromosomal translocation is commonly associated with Acute Promyelocytic Leukaemia?

<p>The translocation is t(15;17).</p> Signup and view all the answers

How does the replacement of normal cells impact leukaemia progression?

<p>In leukaemia, malignant 'blast' cells replace normal cells, leading to a reduction in functional blood cells.</p> Signup and view all the answers

What are the common characteristics of lymphoblasts in acute lymphoblastic leukaemia?

<p>Lymphoblasts are small cells with minimal basophilic cytoplasm and fine homogeneous nuclear chromatin.</p> Signup and view all the answers

What are two poor prognosis indicators in cytogenetic studies for AML?

<p>Monosomy 3, 5, or 7 and complex karyotypes.</p> Signup and view all the answers

Describe the typical presentation symptoms of Chronic Myeloid Leukaemia (CML).

<p>Symptoms include fatigue, splenomegaly, and bleeding due to thrombocytosis.</p> Signup and view all the answers

Why is early detection significant in treating leukaemia?

<p>Early detection improves the chances of effective treatment and potential cure, especially in acute forms.</p> Signup and view all the answers

What is the role of next-generation sequencing in Acute Myeloid Leukaemia?

<p>It provides important prognostic information by identifying gene mutations.</p> Signup and view all the answers

What is a key feature of Chronic Lymphocytic Leukaemia (CLL) found in blood tests?

<p>Lymphocytosis, specifically monoclonal B cells exceeding 5 x 10^9/L.</p> Signup and view all the answers

Which treatment is typically used for targeting the BCR-ABL fusion in CML?

<p>Tyrosine Kinase Inhibitors (TKIs) like Imatinib.</p> Signup and view all the answers

What are common symptoms experienced by patients with Chronic Lymphocytic Leukaemia?

<p>Symptoms include lymphadenopathy, recurrent infections, and fatigue.</p> Signup and view all the answers

What is the significance of the Philadelphia chromosome in CML?

<p>It results from the t(9;22) translocation and is crucial for diagnosis.</p> Signup and view all the answers

How does Acute Myeloid Leukaemia typically differ from Acute Lymphoblastic Leukaemia in terms of cell markers?

<p>AML often presents with myeloid markers, while ALL presents with B-cell markers like CD10 and CD19.</p> Signup and view all the answers

What is the treatment approach for patients with Acute Leukaemia experiencing Bone Marrow Failure?

<p>Remission induction therapy followed by consolidation therapy.</p> Signup and view all the answers

Which laboratory finding is characteristic of blast cells in Acute Promyelocytic Leukaemia?

<p>Abnormal promyelocytes with an eccentric bilobed nucleus and hypergranularity.</p> Signup and view all the answers

What therapy has been shown to improve the prognosis for Acute Promyelocytic Leukaemia?

<p>All-trans Retinoic Acid and Arsenic Trioxide.</p> Signup and view all the answers

What genetic marker is associated with a good prognosis in AML?

<p>Mutations in the NPM1 gene.</p> Signup and view all the answers

What role does supportive care play in the management of Acute Leukaemia?

<p>It involves transfusions, antibiotics, and growth factors to support patient recovery.</p> Signup and view all the answers

What is the common management strategy for early-stage Chronic Lymphocytic Leukaemia?

<p>The 'watch and wait' strategy if asymptomatic.</p> Signup and view all the answers

What is the significance of the SLiM CRAB criteria in diagnosing multiple myeloma?

<p>The SLiM CRAB criteria highlight significant findings including abnormal monoclonal paraprotein and elevated serum free light chains, essential for diagnosing multiple myeloma.</p> Signup and view all the answers

How does serum protein electrophoresis aid in the diagnosis of multiple myeloma?

<p>Serum protein electrophoresis separates blood proteins based on charge and size, allowing for the identification of monoclonal spikes indicative of conditions like multiple myeloma.</p> Signup and view all the answers

What role does immunofixation play after identifying an M-spike in serum protein electrophoresis?

<p>Immunofixation helps identify and quantify the specific monoclonal paraprotein behind the M-spike, providing more accurate diagnostic information.</p> Signup and view all the answers

What are the distinguishing features of plasma cells identified in a bone marrow biopsy?

<p>Plasma cells in a bone marrow biopsy are characterized by an eccentric nucleus, coarsely 'clockface' chromatin, and basophilic cytoplasm.</p> Signup and view all the answers

Describe how flow cytometry is utilized in the assessment of multiple myeloma.

<p>Flow cytometry quantifies plasma cells and detects prognostic markers, which aids in differentiating between multiple myeloma and other conditions like MGUS.</p> Signup and view all the answers

Explain the significance of cytogenetic analysis in multiple myeloma diagnosis.

<p>Cytogenetic analysis, including karyotyping and FISH, detects chromosomal abnormalities that can influence prognosis and guide treatment decisions.</p> Signup and view all the answers

What treatment options are commonly used in managing multiple myeloma?

<p>Common treatments include combination chemotherapy, monoclonal antibodies, and autologous stem cell transplantation, tailored to the patient's prognosis.</p> Signup and view all the answers

How does the Revised International Staging System (R-ISS) contribute to managing multiple myeloma?

<p>The R-ISS combines genetic markers and clinical features to assess disease severity, guiding treatment plans and predicting patient outcomes.</p> Signup and view all the answers

What imaging techniques are utilized in the skeletal survey for multiple myeloma?

<p>CT and X-ray imaging are used in skeletal surveys to identify bone lesions and assess the extent of skeletal involvement in multiple myeloma.</p> Signup and view all the answers

Why is monitoring paraprotein levels important in multiple myeloma management?

<p>Monitoring paraprotein levels helps assess treatment response and detect potential relapses early in multiple myeloma patients.</p> Signup and view all the answers

What factors are considered in determining prognosis for multiple myeloma patients?

<p>Prognostic factors include genetic abnormalities, patient fitness, and clinical features outlined in the Revised International Staging System.</p> Signup and view all the answers

How does the presence of circulating plasma cells manifest on a blood film in multiple myeloma?

<p>A blood film may show anemia, rouleaux formation, and a blueish tinge in the background indicating monoclonal paraprotein.</p> Signup and view all the answers

What are the clinical consequences of hyperviscosity symptoms in multiple myeloma?

<p>Hyperviscosity symptoms can lead to complications such as impaired blood flow, which may cause neurological deficits or organ dysfunction.</p> Signup and view all the answers

What advantages does targeted therapy offer in the treatment of multiple myeloma?

<p>Targeted therapies, such as monoclonal antibodies, specifically attack cancer cells, reducing damage to normal cells and improving treatment effectiveness.</p> Signup and view all the answers

What are the two main pathways involved in the development of colorectal cancer (CRC)?

<p>The two main pathways are the Chromosomal Instability pathway and the Serrated pathway.</p> Signup and view all the answers

How does microsatellite instability (MSI) contribute to colorectal cancer development?

<p>MSI is caused by defects in DNA mismatch repair genes, leading to high mutation rates that can accelerate the accumulation of mutations in key cancer-related genes.</p> Signup and view all the answers

What is the clinical significance of Familial Adenomatous Polyposis (FAP)?

<p>FAP is an autosomal dominant condition associated with a 100% risk of colorectal cancer by age 40, necessitating early screening and prophylactic colectomy.</p> Signup and view all the answers

Describe the difference between the adenoma-carcinoma sequence and the serrated pathway in CRC development.

<p>The adenoma-carcinoma sequence involves chromosomal instability and a progression through adenomas to carcinoma, while the serrated pathway is characterized by microsatellite instability and accumulation of mutations without a clear adenoma stage.</p> Signup and view all the answers

What are the genetic abnormalities commonly found in sporadic colorectal cancer (CRC)?

<p>Common mutations in sporadic CRC include APC, TP53, and KRAS mutations, which impact key signaling pathways.</p> Signup and view all the answers

What are the key components involved in the pathobiology of myeloma?

<p>The key components include multiple abnormalities that interact within the Cancer Model.</p> Signup and view all the answers

What role does desmoplastic reaction play in the histological appearance of colorectal adenocarcinoma?

<p>Desmoplastic reaction results in a fibrotic stroma that is often observed with infiltrative and irregular gland architecture in colorectal adenocarcinoma.</p> Signup and view all the answers

How does the evolution of myeloma disease impact treatment options?

<p>Disease evolution can lead to relapsing and treatment refractory cases, complicating therapeutic approaches.</p> Signup and view all the answers

Explain the significance of the 'Amsterdam criteria' for genetic testing in familial colon cancer.

<p>The Amsterdam criteria provide a guideline for identifying families at risk for Lynch Syndrome by requiring specific familial cancer patterns, particularly with early onset colorectal cancer.</p> Signup and view all the answers

Why is personalized treatment important in myeloma management?

<p>Personalized treatment allows for targeted interventions tailored to the patient's unique disease profile.</p> Signup and view all the answers

What is bowel cancer primarily defined as?

<p>Bowel cancer is primarily defined as a malignant neoplasm of the large bowel, commonly manifesting as adenocarcinoma.</p> Signup and view all the answers

What is the relationship between DNA polymerase proofreading defects and the POLE pathway?

<p>Defects in DNA polymerase proofreading lead to a very high mutation rate, mostly resulting in silent mutations, yet some can affect driver genes critical for tumorigenesis.</p> Signup and view all the answers

How does the presence of CpG island hypermethylation relate to colorectal cancer?

<p>CpG island hypermethylation is commonly associated with the Microsatellite Instability pathway and contributes to gene silencing, impacting tumor development.</p> Signup and view all the answers

Identify two types of pre-malignant polyps associated with bowel cancer.

<p>Tubular adenomas and sessile serrated lesions are two types of pre-malignant polyps.</p> Signup and view all the answers

Why is understanding the stages of colon cancer development important for patient management?

<p>Understanding the stages from normal mucosa to carcinoma helps in the assessment of risk, early detection, and appropriate treatment strategies.</p> Signup and view all the answers

What role do growth promoting proto-oncogenes play in colorectal cancer?

<p>They contribute to cancer through gain of function mutations, promoting uncontrolled cell growth.</p> Signup and view all the answers

How does obesity impact the risk of developing colorectal cancer?

<p>Obesity is a recognized risk factor and is associated with inflammatory processes that can increase cancer risk.</p> Signup and view all the answers

What is the lifetime risk of developing bowel cancer?

<p>The lifetime risk of developing bowel cancer is approximately 1 in 10.</p> Signup and view all the answers

Which genetic syndrome significantly affects the susceptibility to colorectal cancer?

<p>Lynch syndrome is a genetic syndrome that significantly increases the risk of colorectal cancer.</p> Signup and view all the answers

Why is early detection critical in the management of bowel cancer?

<p>Early detection is critical as it significantly increases the chances of curability.</p> Signup and view all the answers

Explain the adenoma-carcinoma sequence.

<p>The adenoma-carcinoma sequence is a progression where benign adenomas develop into malignant carcinomas through multiple genetic mutations.</p> Signup and view all the answers

How does chronic inflammation contribute to colorectal cancer risk?

<p>Chronic inflammation can lead to cellular mutations and an environment conducive to cancer development.</p> Signup and view all the answers

Statistically, how does bowel cancer incidence differ by sex?

<p>Bowel cancer is more common in males, although recent trends show rising incidence in females.</p> Signup and view all the answers

What is the significance of tumor suppressor genes in colorectal cancer?

<p>Tumor suppressor genes inhibit cell proliferation and their loss of function leads to unchecked growth, contributing to cancer progression.</p> Signup and view all the answers

Study Notes

Introduction to Neoplasia

  • Neoplasms are abnormal masses of tissue that grow uncontrollably.
  • Key characteristics include clonal cells arising from a single progenitor cell with mutations and reactive stroma surrounding them.
  • Neoplasms are classified based on morphology, molecular genetics, site of origin, and behavior.
  • Benign tumors are localized and don't metastasize, while malignant tumors invade locally and spread.
  • Examples of benign and malignant tumors are colonic adenomas and adenocarcinomas.

Tumor Classification

  • WHO Blue Books are the standard for tumor classification, updated periodically to incorporate new findings.
  • Neoplasms are generally named with the suffix "-oma," where tissue type + "oma" indicates a benign tumor and cell/tissue type + "carcinoma" or "sarcoma" indicates a malignant tumor.

Clinical Presentation of Neoplasia

  • Differentiation refers to the extent to which tumor cells resemble normal tissue.
  • Anaplasia refers to the lack of differentiation in tumor cells, meaning they have reverted to a more primitive state.
  • Anaplastic tumors are difficult to classify based solely on morphology, making immunophenotyping crucial.
  • Metaplasia is the replacement of one cell type with another, often in response to chronic irritation or damage.
  • Dysplasia is a pre-cancerous condition with abnormal cell growth.

Tumor Grading Systems

  • Grading by differentiation evaluates the tumor's resemblance to normal tissue.
  • The Nottingham Grading System for breast cancer assesses tubule formation, nuclear grade, and mitotic rate.
  • The Gleason Scoring System for prostate cancer assesses the architecture of glandular structures.

Metastasis

  • Metastasis is the spread of cancer cells from the primary site to distant locations.
  • Mechanisms of spread include local invasion, lymphatic spread, hematogenous spread, and spread within body cavities.
  • Common metastatic sites include lungs, liver, bone, brain, and lymph nodes.

Cancer Staging

  • The AJCC Staging System uses the TNM classification (Tumor, Node, Metastasis) to assess the extent of the cancer.
  • Staging guides treatment decisions and predicts prognosis.
  • Staging criteria can evolve, as seen with thyroid cancer.

Cancer Prognosis and Therapy

  • Prognostic factors include stage, grade, and molecular characteristics.
  • Early detection through screening programs improves prognosis.
  • Systemic therapy is used for advanced stages or high-risk cases.

Hallmarks of Cancer

  • Cancer development involves multiple stages, starting with genomic instability and mutations.
  • Hallmarks of cancer include sustained proliferative signaling, tumor-promoting inflammation, and altered cell energetics.

Aetiology of Carcinogenesis

  • Cancer arises from mutations in normal cells, which can be lethal, passenger, or driver mutations.
  • Driver mutations confer a selective advantage to tumor cells, enabling them to grow uncontrollably.
  • Tumor suppressor genes normally inhibit cell growth, and mutations in these genes can lead to cancer.

Heterogeneity and Mechanisms of Tumor Evolution

  • Tumors are genetically diverse, with subpopulations of cells with different mutations and characteristics.
  • This heterogeneity can affect tumor behavior and response to treatment.
  • Resistance to therapy can arise from the presence of resistant clones within the tumor.

Feedback Loop

  • LESS tumor cell death, MORE proliferation, MORE rounds of DNA replication, MORE chance of mutations, MORE opportunities for instability.

Gene Classes Involved

  • Oncogenes promote cancer development by driving cell proliferation.
  • Tumor suppressor genes normally inhibit cell growth, and mutations in these genes can lead to cancer.

Hallmarks of Cancer

  • Tumors can exhibit several hallmarks, including sustained proliferation, evading apoptosis, and angiogenesis.
  • These hallmarks result from alterations in existing cellular pathways.

Oncogenes

  • Oncogenes are genes that, when mutated or overexpressed, fuel cancer progression.
  • They act as accelerators for cell proliferation.

MYC

  • Transcription factor involved in numerous cancers.
  • Coordinates various cellular processes.
  • Overexpressed/activated in over 50% of cancers.
  • Induces stemness and blocks senescence and differentiation.
  • MYC addiction: tumors often rely heavily on MYC for survival.

Ras

  • GTPase involved in signaling pathways.
  • Mutations in Ras, especially K-Ras, lead to uncontrolled activation of these pathways, promoting cancer development.

Tumor Suppressor Genes

  • Act as brakes on cell proliferation.
  • Mutations or deletions in these genes can lead to the loss of cell growth control, contributing to cancer.
  • Often require a "two-hit" effect (both alleles need to be inactivated) for complete loss of function.
  • Commonly involved in controlling proliferation, initiating apoptosis in response to DNA damage, and regulating cell adhesion to prevent metastasis.

Tumor Evolution and Therapy

  • Genomic instability creates a feedback loop where increased mutations lead to further instability and tumor progression.
  • Tumors can develop resistance to treatments through genetic mutations, allowing them to evade therapy.

Tumorigenesis and Mutations

  • Mutations can occur at large or small scales.
  • Large-scale mutations are less common and can involve chromosome gain/loss, translocations, duplications, or deletions.
  • Small-scale mutations are more frequent and include point mutations, which may prevent a specific protein function, or frame shifts, which can prevent protein production altogether.

Random Mutation and Carcinogenesis

  • Tumors evolve through random mutations that give cells a selective advantage, allowing them to proliferate uncontrollably.

Clonal Expansion and Heterogeneity

  • Clonal expansion occurs when mutations in subpopulations of cells provide them with a growth advantage.
  • Tumor heterogeneity stems from genetic diversity within the tumor, posing challenges for treatment, as different clones may respond differently to therapies.

Oncogenes vs. Tumor Suppressor Genes

  • Oncogenes: Drive cancer progression when mutated. Often overexpressed or mutated to become hyperactive, leading to uncontrolled cell growth.
  • Tumor Suppressor Genes: Normally inhibit cell growth or induce apoptosis. Inactivation or loss of these genes removes growth controls, promoting cancer.

Carcinogenesis: Endogenous and Exogenous Causes

  • Endogenous Causes:
    • Hereditary Mutations
    • Direct Tissue Damage
    • Synergistic Effects with Tobacco
    • Hormonal Influence

Alcohol Consumption

  • Acetaldehyde, a potent carcinogen produced by alcohol dehydrogenase, damages DNA and inhibits DNA repair.
  • Ethanol can directly harm tissues like the mouth and throat.
  • Alcohol acts as a solvent, enhancing the carcinogenic effects of tobacco smoke components.
  • Chronic alcohol consumption can raise hormone levels (estrogen, insulin), linked to increased cancer risk.

Radiological Carcinogen: Ultraviolet (UV) Radiation

  • UV radiation from the sun and artificial sources causes most non-melanoma skin cancers and melanomas.
  • UV Radiation Types:
    • UVA: Penetrates the dermis, causing genetic damage, photoaging, and immune suppression.
    • UVB: Affects the epidermis, causing DNA damage and sunburn.

Biological Carcinogen: Human Papillomavirus (HPV)

  • Over 100 types of HPV exist, with ~14 capable of causing cancer.
  • HPV types 16 and 18 are responsible for approximately 70% of cervical cancers globally.
  • Persistent infections can lead to pre-cancerous lesions and invasive cancers.

Gene Expression Regulation

  • Transcription:
    • Initiation: RNA polymerase binds to promoters, influenced by regulatory elements like enhancers and response elements.
    • Cis-regulating elements: DNA sequences near the gene that influence expression.
    • Trans-activating factors: Factors that bind to cis-acting sequences to control expression (transcription factors).

Transcription Factors

  • Proteins that bind to specific DNA sequences to promote or inhibit transcription.
  • Often require other molecules (e.g., hormones) to become active.
  • Regulation can be spatial (tissue-specific expression), temporal (specific timing), or based on activity (protein modification, ligand binding, sequestration).

Post-Transcriptional Regulation

  • RNA Processing: Involves capping, adding a poly-A tail, and splicing out introns, stabilizing mRNA.
  • Alternative Splicing: One gene can produce multiple proteins by varying the included exons, increasing protein diversity.

Export and Stability

  • Nuclear Export: mRNA transported from the nucleus to the cytoplasm through pores, at varying rates.
  • mRNA Stability: Lifespan of mRNA affects gene expression, with some hormones/proteins influencing its longevity.

Non-coding RNA and Post-Transcriptional Regulation

  • Most RNA is non-coding, with examples like ribosomal RNA (rRNA).

miRNA and Post-Transcriptional Regulation

  • miRNA bind to protein complexes to form RNA-Induced Silencing Complexes (RISC), which inhibit mRNA translation.
  • RISC binding interferes with translation, decreasing gene expression.

Translation

  • mRNA Translation: mRNA is translated into proteins by ribosomes, using codons (3-nucleotide sets) that specify amino acids.
  • tRNA: Transfer RNAs match mRNA codons and bring the corresponding amino acids to the ribosome for polypeptide chain formation.

Regulation at the Translational Level

- **Physical Regulation (Blockage):** Proteins (even miRNA) can bind to mRNA, preventing ribosome binding and translation.
- **Initiation Factors:** Help assemble the ribosome complex, and their availability can influence translation efficiency.
- **tRNA Heterogeneity and Codon Usage Bias:** Relative abundance of tRNA can vary between tissues, influencing translation rate.

Post-Translational Modifications

  • These modifications increase the functional diversity of the proteome and can include:
    • Covalent addition of functional groups or proteins
    • Proteolytic cleavage of regulatory subunits
    • Degradation of entire proteins (proteasomes degrade ubiquitinated proteins)

Functional Implications of Post-Translational Modifications

  • Chaperones: Assist in the folding and stabilization of other proteins, influencing their function and stability.
  • Activation: Some proteins require post-translational modifications to become active.

Examples of Post-Translational Modifications

  • Phosphorylation: Addition of phosphate groups, often for protein activation.
  • Glycosylation: Addition of carbohydrate groups, affecting folding, stability, and interactions.
  • Methylation: Addition of methyl groups, influencing protein function and interactions.
  • Acetylation: Addition of acetyl groups, usually at the protein's N-terminus.

Epigenetic Regulation

  • Changes in gene expression without altering the DNA sequence itself, affecting how DNA is accessed and read.

Key Mechanisms of Epigenetic Regulation

  • DNA Methylation:
    • Methyl groups added to cytosine residues in CpG islands, leading to gene silencing.
    • Condenses DNA, reducing gene expression.
    • Plays a role in silencing tissue-specific genes.
  • Histone Modification:
    • Acetylation: Addition of acetyl groups to histones, leading to an open chromatin structure (euchromatin), accessible for transcription.
    • Deacetylation: Removal of acetyl groups, resulting in a compact chromatin structure (heterochromatin), less accessible.

Histone Deacetylases (HDACs)

  • Enzymes that remove acetyl groups, potentially leading to gene silencing, linked to cancer progression.
  • HDAC inhibitors are valuable cancer therapeutics by increasing transcription and leading to cell cycle arrest and apoptosis.

Cancer

  • Cancer typically originates from a single abnormal cell, caused by genetic mutations or epigenetic changes.
  • These changes lead to dysregulated cell growth and/or death.

Mutation and Error Correction

  • Cells constantly undergo mutations, but most are corrected by DNA repair mechanisms.
  • Mutations in non-coding regions might not affect cell function, while those in coding regions can impact cell behavior.

Stages of Tumor Development

  • Initiation: An initial mutation occurs, often corrected without consequence.
  • Promotion: If the mutation provides a growth advantage, the cell proliferates.
  • Progression: Further mutations lead to changes in cell behavior, allowing cells to invade tissues and metastasize.

Dysregulated Gene Expression in Cancer

  • Cancer can be viewed as a disease of dysregulated gene expression that gives the cell a survival advantage.
  • This involves:
    • Increased expression of genes promoting cell growth and proliferation.
    • Decreased expression of genes regulating cell death (apoptosis).

Types of Genes Involved in Cancer Development

  • Proto-Oncogenes: Normally regulate cell growth and division. Mutations can activate them as oncogenes, causing uncontrolled cell growth.
  • Tumor Suppressor Genes: Normally inhibit cell division, respond to DNA damage, and promote DNA repair. Mutations can inactivate them, removing growth controls.

Gene Expression Alterations in Cancer

  • Oncogenes: Gain-of-function mutations increase activity and promote proliferation.
  • Tumor Suppressor Genes: Loss-of-function mutations reduce their ability to suppress growth.

Epithelial-Mesenchymal Transition (EMT)

  • The process where epithelial cells lose their cell polarity and cell-cell adhesion, gaining migratory and invasive properties.
  • Facilitates invasion and metastasis in cancer.

Practical Applications of Studying Gene Expression in Cancer

  • Understanding gene expression pathways can inform cancer diagnosis, treatment, and prevention strategies.

  • Identifying specific gene expression signatures may help predict cancer risk or response to therapies.

  • Developing targeted therapies that modulate specific gene expression pathways may enhance treatment efficacy and reduce side effects.### Gene Expression Profiling

  • Captures total gene activities, including increases and decreases, across a genome as patterns of gene expression.

  • Defines cancer subtypes based on their unique gene expression profiles.

  • Aids in personalized medicine by revealing deregulated pathways in specific cancers, leading to customized treatment options.

Breast Cancer

  • A heterogeneous group of cancers with varied molecular features, prognoses, and responses to therapy.
  • Classified into three subtypes based on gene expression profiling: Luminal, HER2-positive, and Basal-like.
  • Subtyping helps in selecting targeted therapies, such as hormonal therapy for Luminal types and HER2 inhibitors for HER2-positive types.

Bone Marrow Cancer (Myelofibrosis)

  • A bone marrow cancer causing extensive scarring and affecting blood cell production.
  • Gene expression profiling of platelets, readily accessible compared to bone marrow, classifies disease subtypes and predicts progression.
  • This information guides treatment choices and monitors disease status.

Tumor Heterogeneity

  • A major challenge in cancer treatment, hindering the development of cures.
  • Inter-tumor heterogeneity: Differences between tumors in different patients.
  • Intra-tumor heterogeneity: Variation within a tumor, affecting both morphology and molecular level, resulting in tumor subpopulations.

Gene Regulation in Cancer

  • Loss or alteration of gene expression regulation can drive cancer through impacts on cell survival, proliferation, invasion, and metastasis.

Transcriptional Regulation and Cancer

  • Mutations or aberrant expression of genes regulating cell growth can trigger cancer.
  • Overexpression of oncogenes or loss of tumor suppressor genes can lead to uncontrolled cell division.

Post-Transcriptional Dysregulation

  • Abnormal splicing can create protein variants contributing to cancer progression.
  • Dysregulation of mRNA stability factors can affect levels of cancer-related proteins, promoting tumor growth and treatment resistance.

Key Non-Coding RNAs and Their Functions

  • MicroRNAs (miRNAs): Small non-coding RNAs that regulate gene expression post-transcriptionally by binding to target mRNAs.
  • Ribosomal RNA (rRNA): Essential for ribosome structure and function, involved in translating mRNA into proteins.
  • Long Non-Coding RNAs (lncRNAs): Play roles in gene regulation through chromatin remodeling, transcriptional regulation, and splicing.
  • Circular RNAs (circRNAs): Function as decoys for RNA-binding proteins or miRNAs, indirectly affecting gene expression.

Epidemiology: The Study of Disease Distribution and Determinants

  • An observational science used to understand health-related states and events, including diseases like cancer.
  • Two main branches:
    • Descriptive epidemiology: Focuses on disease distribution in a population, examining patterns in time, place, and person.
    • Analytical epidemiology: Seeks to understand disease determinants, exploring relationships between exposures and disease outcomes.

Key Epidemiological Terms

  • Incidence: The rate or risk of developing a condition.
    • Cumulative incidence: Measures risk, showing how many people will develop the disease within a specific timeframe.
    • Incidence Rate: Considers how long individuals are at risk, focusing on the speed at which new cases occur.
  • Prevalence: The proportion of the population with a condition at a specific time.
    • Point prevalence: Existing cases at a single point in time.
    • Period prevalence: Existing cases over a set period.
  • Population at Risk: Refers to the study population including only those susceptible to the health event being studied.
  • Different cancer types exhibit distinct epidemiological profiles, with rates varying by age and sex.
  • Age-standardized rates are used to compare cancer rates over time, adjusting for changes in the age structure of the population.

Screening Programs

  • Aim to detect asymptomatic cancers early, improving treatment outcomes and survival rates.
  • Limitations include detecting indolent cancers and being less effective for conditions with no cure.

Analytical Epidemiology: Searching for Causes

  • Used to understand the relationship between risk factors and disease outcomes, with the goal of establishing causation.
  • Key features include comparison groups, such as those with versus without cancer (case-control) or exposed versus unexposed (cohort studies).

Research Methodologies

  • Ecological Studies: Use aggregate data to explore associations with disease rates, but are limited by the ecological fallacy.
  • Case-Control Studies: Compare people with the disease (cases) to those without (controls) to identify potential exposures.
  • Cohort Studies: Follow a group of people over time to assess the relationship between exposure and disease development.
  • Randomized Controlled Trials (RCTs): The gold standard for determining causation, where participants are randomly assigned to intervention or control groups.

Cancer Epidemiology

  • Epidemiology is the study of the distribution and determinants of health-related states or events in specified populations, and the application of this study to the control of health problems.
  • Epidemiological studies are observational studies that aim to investigate the association between a potential risk factor and a disease in a population.
  • Types of epidemiological studies:
    • Case-control studies compare individuals with a disease (cases) to those without the disease (controls) to examine past exposures to a potential risk factor.
    • Cohort studies follow a group of people over time to observe how many develop the disease and compare the incidence between those exposed to a potential risk factor and those who are not.
  • Strengths of case-control studies:
    • Efficient for studying rare diseases or diseases with long latency periods.
    • Allows researchers to identify potential associations without waiting for new cases to develop over time.
  • Limitations of case-control studies:
    • Retrospective nature can introduce biases like recall bias.
    • Difficulties in accurately measuring past exposures.
  • Strengths of cohort studies:
    • Provides a clear temporal sequence (exposure before disease), which is crucial for establishing causation.
    • Good for studying rare exposures.
  • Limitations of cohort studies:
    • Time-consuming and expensive, especially for diseases with long latency periods.
    • Requires large sample sizes to observe sufficient cases of the disease.
  • Bias in epidemiological studies:
    • Selection bias: If the cases and controls are not representative of the general population.
    • Recruitment bias: If the participants are not selected randomly from the population.
    • Response bias: If participants respond differently to questionnaires depending on their exposure status or disease status.
    • Recall bias: If cases remember exposures differently than controls.
  • Confounding in epidemiological studies:
    • A confounder is a variable that is related to both the exposure and the outcome.
    • Can distort associations between exposure and disease.
  • Causation criteria:
    • Strength of Association: Stronger associations are less likely to be due to confounding.
    • Consistency: Findings should be replicable across different studies and populations.
    • Temporality: The exposure must precede the disease.
    • Biological gradient: There should be a reasonable biological mechanism explaining the relationship.
    • Dose-Response: An increased level of exposure should be associated with an increased risk of disease.
  • IARC (International Agency for Research in Cancer):
    • Classifies carcinogens based on the strength of evidence of carcinogenicity to humans.
    • Group 1: Carcinogenic to humans (e.g., smoking, asbestos)
    • Group 2A: Probably carcinogenic (e.g., diesel engine exhaust)
    • Group 2B: Possibly carcinogenic (e.g., certain night shift work)
    • Group 3: Not classifiable (e.g., some chemicals with limited data)
    • Group 4: Probably not carcinogenic (e.g., caprolactam)
  • Benefits of epidemiological studies:
    • Provides us with information on the distribution of cancer and risk factors.
    • Helps in understanding the prognosis of diseases.
    • Assists policymakers in planning services, screening programs, and preventive strategies.

Signal Transduction and Cancer Development

  • Signal transduction is the process by which a cell responds to external signals through a series of molecular events that often involve changes in protein activity and gene expression.
  • Key components of signal transduction pathways:
    • Ligands: Extracellular signals that bind to receptors (e.g., growth factors, cytokines, hormones, neurotransmitters)
    • Receptors: Proteins on the cell surface or inside the cell that bind specific ligands activating cellular responses
    • Second Messengers: Amplify the signal from the receptor (e.g., cAMP, calcium ions, diacylglycerol, and inositol triphosphate)
    • Targets: Kinases and phosphatases modify protein activity through phosphorylation and dephosphorylation.
  • Hallmarks of cancer:
    • Sustained Proliferation: Cancer cells continue to divide uncontrollably.
    • Evading Growth Suppression: Avoiding mechanisms that normally halt cell growth.
    • Invasion and Metastasis: Ability to invade surrounding tissues and spread to other parts of the body.
    • Replicative Immortality: Cancer cells avoid cellular aging and death.
    • Inducing Angiogenesis: Formation of new blood vessels to supply the growing tumor.
    • Resisting Cell Death: Evading programmed cell death (apoptosis).
  • Key pathways involved in cancer development:
    • Growth Factor Receptor Pathways: (EGFR, PDGFR)
    • Cytokine Receptor Pathways: (JAK-STAT)
    • G-Protein Coupled Receptors (GPCRs): Involved in numerous physiological processes, can affect cell growth and survival through various second messengers and intracellular signaling pathways.

Key Pathways in Cancer Proliferation

  • Ras-Raf-MEK-ERK Pathway:
    • Key pathway for cell proliferation that is frequently dysregulated in cancer.
    • Involves sequential activation of Ras, Raf, MEK, and ERK leading to the activation of transcription factors that drive cell proliferation.
    • Mutations in Ras, Raf, or MEK can lead to uncontrolled cell proliferation and cancer development.
  • EGF-Receptor (HER2) Family:
    • Receptor tyrosine kinases often overexpressed or mutated in cancers such as breast, gastric, and lung cancer.
    • Can activate both the ras-raf-Erk and the PI3K/Akt pathways.
    • Targeted by antibodies (e.g., Trastuzumab) or tyrosine kinase inhibitors (e.g., Erlotinib) for cancer treatment.
  • JAK-STAT Pathway:
    • Important for cytokine signaling and involves the activation of JAK (Janus Kinase) proteins, which then phosphorylate STAT (Signal Transducer and Activator of Transcription) proteins.
    • Phosphorylated STATs move to the nucleus to drive gene expression associated with cell proliferation and survival.
    • Abnormal activation of this pathway can be found in certain leukemias and lymphomas.

Specific Case Studies and Therapeutic Strategies

  • Melanoma: BRAF mutations, especially V600E, are commonly found in melanoma. Vemurafenib, a BRAF V600E inhibitor, is effective in treating melanoma initially, but resistance often develops.
  • Targeting the Ras-Raf-Erk Pathway in Cancers:
    • Drug targets: MEK1/2 inhibitors (e.g., Trametinib) have shown success in treating cancers with mutations in the pathway.
  • Targeting the PI3K/Akt Pathway in Cancers:
    • Akt is crucial for cell survival and metabolism.
    • Inhibitors of PI3K or downstream targets are being developed as cancer therapies.
    • Akt also controls protein synthesis, making it a target for cancer therapies as they need to produce more proteins to support their increased growth rate.
  • Therapeutic Strategies:
    • Inhibitors of Receptor Tyrosine Kinases (RTKs): Block the activity of RTKs like EGFR, preventing activation and downstream signaling (e.g., Gefitinib, Erlotinib).
    • Small Molecule Inhibitors: Target specific kinases within cancer pathways (e.g., MEK inhibitors).
    • Monoclonal Antibodies: Bind to specific receptors or their ligands to prevent activation (e.g., Cetuximab targets EGFR).### Ras-Raf-MEK-ERK Pathway (MAPK Pathway)
  • Regulates cell proliferation
  • Dysregulation can lead to unchecked cell growth and cancer
  • Components:
    • EGFR (Epidermal Growth Factor Receptor)
    • Ras
    • Raf
    • MEK
    • ERK
  • Inhibitors
    • BRAF Inhibitors
    • MEK Inhibitors

PI3K-AKT Pathway

  • Regulates cell survival and metabolism
  • Dysregulation often contributes to cancer cell survival and resistance to apoptosis
  • Components:
    • PI3K (Phosphoinositide 3-Kinase)
    • AKT
    • mTOR
  • Inhibitors:
    • AKT Inhibitors
    • PI3K Inhibitors

BCR-ABL Fusion Protein in Chronic Myeloid Leukemia (CML)

  • The BCR-ABL fusion is a result of the Philadelphia chromosome
  • The fusion protein has an active kinase domain
  • The fusion protein activates both the MAPK and PI3K pathways, leading to increased proliferation and survival of leukemia cells
  • Therapeutic Target: Gleevec (Imatinib)
  • Imatinib effectively treats CML by preventing the kinase activity of the fusion protein
  • Mechanism: Gleevec binds to the ATP-binding site of the ABL kinase, blocking its activity

Summary of Therapeutic Approaches

  • Targeting Proliferation: Focus on inhibitors that block critical components of the Ras-Raf-MEK-ERK pathway.
  • Targeting Survival: Focus on inhibitors that target the PI3K-AKT pathway
  • Targeting Specific Fusion Proteins: Inhibitors like Gleevec that target specific oncogenic fusions.

Resistance and Combination Therapies

  • Resistance: Mutations or amplifications can occur within the targeted pathways
  • Combination Therapies: Combining drugs targeting different pathways or different components within the same pathway can help overcome resistance and improve treatment efficacy

Clinical Applications and Research

  • Clinical Use: Several inhibitors are already in clinical use for treating various cancers based on specific mutations and dysregulations in these pathways.
  • Ongoing Research: New inhibitors and combination therapies are continually being developed and tested to address resistance mechanisms and improve treatment outcomes.

Conclusions

  • Signal transduction transmits messages from the cell surface to the cytoplasm &/ or nucleus of cells
  • Cell signaling regulates many biological processes such as proliferation, apoptosis, angiogenesis, migration
  • Hyperactivation of signalling pathways is a common cause of carcinogenesis
  • Targeting specific signalling components is an effective strategy for the treatment of many cancers

Telomere Overview

  • Telomeres are regions of repetitive DNA found at the ends of chromosomes.
  • They protect against chromosome degradation and fusion.
  • Telomeres shorten with each cell division.
  • Telomerase, an enzyme with reverse transcriptase activity, helps to maintain telomere length.
  • Cancer cells often have high telomerase activity, allowing them to divide continuously.
  • Shortened telomeres can contribute to a cell entering senescence, inhibiting further cell division.
  • Several genetic disorders like Dyskeratosis congenita, Werner syndrome, and Bloom syndrome involve defective telomerase function.
  • Telomerase knockout mice exhibit premature aging and increased cancer susceptibility.

DNA Replication

  • DNA replication occurs in the S phase of the cell cycle.
  • Requires unwinding of the double helix using helicase activity.
  • DNA is synthesized in the 5' to 3' direction.
  • Leads to a lagging and leading strand due to the antiparallel nature of the DNA double helix.
  • Multiple origins of replication are needed to complete replication in a timely manner.

Cell Cycle

  • Cells progress in a cyclical manner with distinct phases: G1, S, G2, and M.
  • G1: Cell growth and preparation for DNA synthesis.
  • S: DNA replication.
  • G2: Preparation for mitosis.
  • M: Cell division.
  • G0: A resting state where cells are not actively dividing.
  • Checkpoints ensure accurate replication and division at specific points in the cycle.

Cell Cycle Regulation

  • Cell cycle progression is regulated by cyclin-dependent kinases (CDKs) and cyclins.
  • CDKs are enzymes phosphorylating target proteins, requiring cyclins for activation.
  • Formation of specific CDK/cyclin complexes at different cell cycle stages, allowing sequential progression.
  • The activity of CDK/cyclin complexes is regulated by CDK inhibitors (CDKIs).
  • Two types of CDKIs: INK4 family (inhibits CDK4/6) and CIP/KIP family (inhibits broader range of CDKs).

Retinoblastoma Protein (Rb) and Cell Cycle Control

  • RB is a tumor suppressor protein controlling G1-S transition.
  • RB binds to E2F transcription factors, preventing gene activation necessary for DNA synthesis.
  • Phosphorylation of RB by CDK4/6 and CDK2 releases E2F, initiating S phase.

Telomeres are not Free and Open

  • Telomeres form protective structures, like the T-loop and D-loop.
  • Telomere-associated protein complexes (shelterin) control telomere elongation and protect against unwanted responses from single-stranded DNA (ssDNA).

Telomerase Inhibitors

  • BIBR1532 inhibits RNA template translocation during telomere extension.
  • Nucleoside analogues like AZT block DNA extension, preventing telomere elongation.
  • Anti-hTERT cancer vaccines utilize hTERT peptides to elicit T-cell mediated cancer cell apoptosis.
  • Competitive RNA binding antisense oligonucleotides prevent telomere extension by binding to the RNA template.
  • G-quadruplex-stabilizing ligands block DNA elongation, inhibiting telomere extension.

Inhibiting Telomerase Activity for Cancer Therapy

  • Telomerase inhibitors are being explored as cancer therapeutics.

  • They show promising results in combination with other anti-cancer drugs.### Types of Cell Death

  • Apoptosis:

    • A programmed cell death process, meaning it's regulated and controlled, involving the activation of specific proteases and nucleases that break down cellular components
    • Morphology: Cells shrink, the nucleus condenses, and the cell fragments into apoptotic bodies
    • Biological features: ATP dependent, DNA fragmentation occurs in a ladder pattern, alteration in membrane asymmetry
    • Physiological significance: Essential for development and maintaining tissue homeostasis (e.g. eliminating autoreactive immune cells)
    • Other: It's energy-dependent, strictly regulated, and triggers phagocytosis without causing inflammation
  • Autophagy:

    • Meaning "self-eating"
    • Involves degradation of cellular components through lysosomal digestion
    • Activated under nutrient deprivation and stress conditions
    • Helps protect cells by removing damaged organelles and proteins
    • Can be involved in cancer progression and neurodegenerative diseases
  • Necrosis:

    • An uncontrolled cell death process often resulting from acute damage or injury
    • Morphology: Cells swell then burst, release contents into surrounding tissue
    • Biological features: loss of regulation of ion homeostasis, no energy requirement, a smear pattern of DNA, postlytic DNA fragmentation
    • Physiological significance: Evoked by non-physiological disturbance, affects groups of cells, triggers phagocytosis by macrophages, causes inflammation

Distinguishing Apoptosis from Necrosis

  • Apoptosis is controlled, orderly, cell maintains membrane integrity until a late stage, and non-inflammatory
  • Necrosis is uncontrolled, chaotic, loss of membrane integrity leads to leakage, and leads to inflammation

Apoptosis Mechanism

  • DNA Fragmentation: During Apoptosis, chromatin condenses and nucleases cleave DNA at specific sites, which results in a characteristic ladder-like pattern of DNA fragmentation
  • Membrane Asymmetry: During Apoptosis, phosphatidylserine on the inside of the cell membrane flips to the outer layer which acts as a signal for macrophages to engulf the apoptotic cells

Extrinsic and Intrinsic Pathways of Apoptosis

  • Extrinsic Pathway: Initiated by external signals through death receptors like TNF receptor and FAS receptor which activates caspase-8 (initiator caspase), caspase-8 then activates caspase-3, -7 (effector caspases)
  • Intrinsic Pathway: Initiated by intracellular signals like DNA damage and growth factor withdrawal. It involves the release of cytochrome c which activates caspase-9, caspase-9 then activates caspase-3, -7

Cancer and Cell Death

  • Evasion of Apoptosis: Cancer cells often have mutations in genes that regulate apoptosis, which allows them to survive despite damage
  • Mechanisms of Evasion: Cancer cells overexpress anti-apoptotic proteins or underexpress pro-apoptotic factors
  • Therapeutic Implications: Drugs that restore the normal apoptotic process in cancer cells or bypass the mechanisms of resistance are being developed

Other Key Facts

  • Caspases: Mediate events associated with apoptosis
  • Cyclin D-CDK4/6: Activates the cell cycle by phosphorylating Rb, releasing E2F, and promoting S phase entry
  • Cyclin E-CDK2: Further drives the cell cycle by continuing Rb phosphorylation and activating DNA replication machinery
  • Growth factor receptors: EGFR, HER2, activate intracellular signaling pathways that drive cyclin D expression and cell cycle progression

Cancer Implications

  • Oncogenes: When mutated or overexpressed, these drive uncontrolled cell proliferation (e.g., Myc, Ras, EGFR, HER2)
  • Tumor suppressor genes: Normally inhibit cell proliferation, mutations lead to loss of function, contributing to unchecked cell cycle progression (e.g., p53, Rb, CDKN2A, CDKN2B)

Therapeutic Strategies

  • Traditional chemotherapy: Targets rapidly dividing cells, impacting both cancerous and normal healthy cells
  • Targeted therapies: Focus on specific defects in cancer cells, examples include CDK inhibitors
  • Challenges and considerations: Side effects, precision medicine

Educational Focus

  • Cancer research: Emphasize the importance of understanding cell cycle control in the context of cancer and how this knowledge drives therapeutic innovation
  • Clinical application: Understanding the mechanisms behind current and emerging therapies helps in their application and optimization in clinical settings

Conclusion

  • The control of the cell cycle is fundamental to maintaining normal cell function

  • Disruptions in this balance are a key feature of cancer

  • Advances in understanding cell cycle regulation and its alteration in cancer have led to the development of targeted therapies aimed at specifically addressing these defects

  • Continuous research and clinical trials are essential for improving these therapies and minimizing side effects, moving towards more effective and personalized cancer treatments### Neoplasia

  • Definition: Uncontrolled cell growth that continues even after the initial stimulus is gone.

  • Benign Neoplasms: Non-cancerous, well-defined, slow growth, do not invade or spread to other tissues.

    • Characteristics: Well-circumscribed, encapsulated, uniform cells, well-differentiated.
    • Clinical Significance: Generally non-life-threatening but can cause issues based on location.
  • Malignant Neoplasms: Cancerous, invade surrounding tissues, can spread to distant sites.

    • Characteristics: Infiltrative, poorly circumscribed, pleomorphic cells, anaplastic, high mitotic activity.
    • Clinical Significance: Potentially aggressive with high mortality due to invasion and metastasis.

Invasion and Metastasis

  • Invasion: Tumor cells cross organ boundaries and invade neighboring tissues.
  • Metastasis: Tumor cells establish secondary tumors at distant sites from the primary tumor.
  • Steps in Tumor Invasion:
    • Altered Cell-Cell Interactions: Tumor cells downregulate adhesion molecules (e.g., E-cadherin), leading to loss of contact inhibition and allowing cells to dissociate.
    • Matrix Dissolution: Tumor cells secrete enzymes (e.g., matrix metalloproteinases (MMPs)) that degrade the extracellular matrix (ECM), facilitating movement through tissues.
    • Altered Cell-ECM Interactions: Tumor cells change their interactions with the ECM, affecting their ability to attach and move.
    • Movement Through ECM: Tumor cells migrate through the ECM towards blood vessels or lymphatics for dissemination.

Extracellular Matrix (ECM)

  • Function: Separates tissue compartments; composed of basement membrane (BM) and interstitial matrix.
  • Components:
    • Basement Membrane (BM): Dense matrix of collagens, glycoproteins (e.g., laminins), and proteoglycans.
    • Interstitial Matrix: Loose matrix of fibrous structural proteins (e.g., collagens, elastins), adhesive glycoproteins, proteoglycans, and water.

Matrix Metalloproteinases (MMPs)

  • Function: Degrade ECM components, facilitating tumor invasion.
  • Classes:
    • Collagenases: Degrade collagens type I, II, and III.
    • Gelatinases: Degrade collagen IV.
    • Stromelysins: Degrade collagen IV and proteoglycans.
  • Regulation: Activity is regulated by tissue inhibitors of MMPs (TIMPs).

Integrins

  • Function: Transmembrane receptors that connect the cell to the ECM.
  • Structure: Heterodimers consisting of α and β subunits.
  • Roles:
    • Regulate cell shape, orientation, and movement.
    • Trigger intracellular signaling cascades that alter gene expression.

Cell-Cell and Cell-Matrix Interactions in Cancer

  • Normal Cells: Tight cell-cell adhesions (E-cadherin) and integrin interactions with ECM constituents, maintaining differentiation, regulating growth, and preventing cytoskeletal remodeling.
  • Cancer Cells: Downregulation of adhesion molecules (e.g., E-cadherin), altered integrin expression, and increased ECM degradation, promoting invasion and metastasis.### Locomotion
  • Invasion is the final stage before metastasis
  • Involves a range of receptors and signaling proteins which affect the cytoskeleton
  • MMPs, integrins, and catenins are important proteins in cellular migration
  • Fibronectin, laminin, and collagen IV are key ECM constituents
  • Tumors can invade as individual cells or in groups
  • Mesencymal migration refers to single cells moving through the ECM
  • Collective migration involves groups of cells and may be more effective
  • Movement occurs by attaching to the ECM, detaching at the trailing edge, and contracting the cytoskeleton
  • Promigratory factors can direct and motivate movement including cytokines, ECM cleavage products and GFs
  • Collective migration allows for multi-cellular movement and protection of inner cells from immune attack
  • Collective migration also increases autocrine factor concentrations
  • Amoeboid migration is a faster alternative form of invasion
  • Amoeboid movement involves shape changes rather than ECM degradation
  • Cells may be able to switch between different forms of invasion

Metastasis

  • Invasion opens up access to blood vessels, lymphatics, and body cavities
  • Most cancers are able to metastasize
  • Tumour dissemination can occur via direct seeding of body cavities, lymphatic spread, or hematogenous spread
  • Direct seeding into a body cavity, such as the pleural or pericardial cavity, can allow for spread
  • Lymphatic spread is typical of carcinomas and involves entry into the lymphatic vessels
  • Lymphatic vessels drain into lymph nodes where tumour cells may arrest and form deposits
  • Haematogenous spread occurs when tumour cells enter blood vessels and travel to distant organs
  • Tumour cells often penetrate venous spaces and follow blood flow to deposit in the first capillary bed they encounter
  • Metastasis is an inefficient process. Only a small fraction of circulating tumour cells successfully establish colonies.
  • A variety of steps must be successfully completed to initiate metastasis including invasion, intravasation, survival, extravasation, and colonization.
  • Tumour cells require specific genetic mutations to successfully metastasize
  • Primary tumours are heterogeneous and contain subclones of cells, some of which are better prepared to metastasize
  • Many of the genes involved in metastasis are acquired early in tumour evolution

Intravasation

  • Intravasation into blood vessels involves penetration of the basal membrane and adhesion to the endothelium
  • Requires ECM-integrin interactions and proteolytic enzymes
  • Few cancer cells survive after entering the bloodstream
  • Mechanical stressors and immune response are detrimental to tumour cells
  • Aggregation with platelets and fibrin offers survival advantages
  • Tumour-platelet thrombi shield cancer cells from the immune system
  • Tumour-platelet thrombi also reduce mechanical stress and facilitate extravasation
  • Expression of adhesion molecules like CD44 and surface mucins are involved in tumour-platelet aggregation

Extravasation

  • Tumour cell arrest and extravasation at distant sites involve adhesion to endothelium and egress through the basal membrane
  • Facilitated by tumour-platelet thrombi that express endothelium and ECM adhesion molecules
  • Requires ECM-integrin interactions and proteolytic enzymes

Colonization

  • Often the site of metastasis is the first capillary bed
  • Some cancers prefer certain sites
  • The “Seed and Soil” theory proposes that tumor cells have a preference for microenvironmentally suitable soils
  • Examples include CD44-expressing tumours preferring LN deposition because LN venules express high levels of hyaluronate
  • Breast cancer cells overexpressing CXCR4 hone to bone marrow where its ligand, SDF1, is highly expressed
  • CD44 is a hyaluronate receptor
  • CXCR4 is a chemokine receptor and SDF1 is its ligand
  • Metastasis sites are determined by the tumour cells, the surrounding microenvironment, and circulatory patterns

Angiogenesis

  • Tumours larger than 1-2mm require a new vascular network for survival
  • Angiogenesis is the process of creating new blood vessels
  • Angiogenesis is induced by the tumour via upregulation of angiogenic factors like VEGF and bFGF
  • Angiogenesis is also induced by the downregulation of antiangiogenic inhibitors
  • Hypoxia and the “angiogenic switch” are two key mechanisms that trigger angiogenesis
  • Hypoxia results in HIF-1 and HIF-2 expression which trigger the transcription of pro-angiogenic factors
  • The “angiogenic switch” results in altered expression of pro- and anti-angiogenic factors due to genetic aberrations
  • Mutations in RAS and MYC can induce angiogenesis
  • MMPs can release angiogenic factors such as bFGF
  • Mutant p53 does not induce synthesis of anti-angiogenic molecules such as thrombospondin

Contact Inhibition

  • Normal cells exhibit contact inhibition which prevents excessive cell growth and movement
  • Cancer cells have lost this inhibition due to downregulation of adhesion molecules
  • The lack of contact inhibition allows for uncontrolled growth and migration

Clinical Relevance

  • Invasion depth is a prognostic indicator. Deeper invasion is associated with poorer prognosis.
  • The presence of metastasis significantly reduces survival rates
  • Anti-MMP treatment has had modest effects
  • Angiogenesis inhibitors are in common use
  • Bevacizumab (VEGF inhibitor) is a common treatment and is associated with improved outcomes in several cancers

Complexity of Cancer Pathways

  • Cancer biology involves complex and redundant pathways
  • Understanding these pathways is necessary for developing effective cancer therapies ### Hallmarks of Cancer
  • Oncoviruses influence several hallmarks of cancer, including:
    • Sustaining proliferative signaling
    • Evading growth suppressors
    • Resisting cell death
    • Enabling replicative immortality
    • Inducing angiogenesis
    • Activating invasion and metastasis

Oncogenes and Proto-Oncogenes

  • An oncogene is a mutated version of a proto-oncogene.
  • Proto-oncogenes are present in normal cells and act as positive growth regulators.
  • Cellular (proto-)oncogenes, such as c-Myc, c-Cbl, and c-Src, are found within the human genome.
  • Viral oncogenes, such as v-Myc and v-Src, are transmitted by viruses.
  • 803 human proto-oncogenes have been identified.
  • Oncogenes can be activated by various mechanisms:
    • Gene amplification
    • Viral transduction/insertion
    • Mutation of repressor/control region
    • Chromosomal translocations
    • Activation of endogenous retroviral (ERV) sequences
    • Environmental mutagens (tobacco, chemicals etc.)

Tumor Suppressor Genes

  • Tumor suppressor genes are negative growth regulators that control cellular proliferation, acting as 'controllers.'
  • They regulate the cell cycle, apoptosis, and genomic stability.
  • Key tumor suppressor genes include:
    • p53 protein (TP53)
    • Retinoblastoma protein (Rb; pRb)

p53 Pathway

  • In a normal cell, p53 is inactivated by its negative regulator, mdm2.
  • When DNA damage or other stresses occur, p53 is activated, leading to:
    • Cell cycle arrest to allow repair and survival or
    • Apoptosis to discard the damaged cell.

Proto-Oncogenes

  • Proto-oncogenes are normal genes that can become oncogenes when activated improperly through mechanisms like viral integration.
  • Proto-oncogenes act as positive growth regulators.

Oncogene Types

  • Cellular Oncogenes (c-onc): Found in the host genome.
  • Viral Oncogenes (v-onc): Incorporated into the host genome by viruses.

Historical Context

  • The concept of oncoviruses evolved in the 20th century.
  • Key milestones include:
    • The discovery of the Rous sarcoma virus in chickens in 1908
    • The identification of EBV in 1964

Recent Developments

  • Merkel cell polyomavirus was discovered in 2008.

Implications

  • About 18% of human cancers are caused by infections, with viruses being the second most significant risk factor after tobacco use.
  • Approximately 8% of the human genome consists of endogenous retroviral sequences that may contribute to cancer reactivation.

Key Takeaways

  • Oncoviruses can alter normal cellular processes, including growth control, adhesion, motility, and invasion.
  • Understanding these processes is crucial for cancer research and therapeutic development.

Proto-oncogenes and Oncogenes

  • Proto-oncogenes are normal genes involved in cellular growth and differentiation.
  • Oncogenes arise from mutations in proto-oncogenes, leading to uncontrolled cell growth and cancer.
  • Transformation can occur through mechanisms like gene amplification, viral insertion, or chromosomal translocations.

Tumor Suppressor Genes

  • Tumor suppressor genes function to regulate and suppress cell growth, maintaining cellular homeostasis.
  • P53 and RB are key tumor suppressor genes.
  • P53 maintains genomic stability by halting the cell cycle in response to DNA damage and initiating repair or apoptosis if damage is irreparable.
  • RB (Retinoblastoma protein) regulates the cell cycle by controlling the progression from G1 to S phase.

HPV and Viral Contributions to Cancer

  • HPV is a non-enveloped DNA virus with over 150 serotypes; only certain types, such as HPV 16 and 18, are strongly associated with cancers.
  • HPV's E6 and E7 proteins interfere with tumor suppressor proteins like P53 and RB, leading to uncontrolled cell proliferation and potential cancer development.
  • HPV 6 and 11 are associated with warts (benign).
  • HPV 16 and 18 are associated with cancer (cervical, vulvar, uterine, penile, anal, laryngeal, oesophageal).
  • E6 and E7 genes code for proteins that inactivate human tumor suppressor proteins (p53 and Rb).
  • L1 gene codes for a protein that self-assembles into the shell (capsid) of the virus.
  • Empty (L1) capsids are called virus-like particles (VLPs), which are the basis of the HPV vaccines.
  • HPV replicates and assembles exclusively in the nucleus.
  • The HPV vaccine targets several HPV types to prevent cancer and contains virus-like particles (VLPs) without viral DNA, stimulating the immune system to protect against actual HPV infection.

Cervical Carcinogenesis

  • Persistent infection with HPV can cause irreversible changes leading to invasive cancer.
  • Viral integration into the host genome results in expression and production of E6 and E7 oncoproteins, binding and inactivating p53 and pRb respectively.
  • Other co-factors are important in disease progression such as smoking, age at first intercourse, contraception use, genetics and family history.
  • Cervical screening tests are used to detect HPV and prevent cervical cancer.

EBV (Epstein-Barr Virus)

  • EBV is associated with Burkitt lymphoma and other malignancies.
  • EBV induces chromosomal translocation in Burkitt's Lymphoma.
  • EBV inhibits the apoptosis of premalignant tumor cells, allowing transforming events to occur.
  • EBV is associated with Hodgkin’s lymphoma, nasopharyngeal carcinoma, B cell lymphoma and X-linked lymphoproliferative disease.
  • EBV positivity is assessed by EBER—in situ hybridisation in formalin-fixed paraffin-embedded tissue sections.

Kaposi's Sarcoma and Merkel Cell Polyomavirus

  • Kaposi's Sarcoma (HHV-8) is often seen in immunocompromised individuals, such as those with HIV/AIDS.
  • Merkel Cell Polyomavirus is linked to Merkel cell carcinoma, a rare and aggressive skin cancer.

Key Takeaways

  • Oncogenes and tumor suppressor genes work in tandem to regulate cell growth; mutations or viral interference can disrupt this balance.
  • HPV, through its oncogenes (E6 and E7), disrupts tumor suppression and contributes significantly to cervical cancer and other malignancies.
  • Vaccines targeting HPV have proven effective in reducing cancer incidence.

Tumor Suppressor Genes

  • Tumor suppressor genes (e.g., P53, RB) normally regulate cell growth and suppress tumor formation.
  • Loss or mutation in these genes leads to unregulated cell growth, contributing to cancer development.

Retinoblastoma (RB)

  • Type: Rare childhood cancer.
  • Inheritance: Can be hereditary (bilateral) or sporadic (unilateral).
  • Mechanism: Involves hyperphosphorylation of RB protein, disrupting its function in regulating cell cycle progression.
  • Normal Role: RB protein binds to transcription factor E2F, preventing uncontrolled cell proliferation.
  • Hyperphosphorylation of RB releases E2F, allowing cell cycle progression.
  • Mutations: Mutated RB can no longer bind E2F, leading to unchecked cell division.
  • Knudson’s Two-Hit Hypothesis : Hereditary Retinoblastoma requires only one additional mutation to cause disease; Sporadic Retinoblastoma requires two independent mutations occurring in the same cell.

Loss of Heterozygosity (LOH)

  • LOH occurs when there is a loss of the wild-type allele of a tumor suppressor gene.
  • LOH can occur through mitotic recombination, gene conversion, and chromosomal nondisjunction.
  • LOH is a significant mechanism for the inactivation of tumor suppressor genes and can be used to identify new tumor suppressor genes.

Tumor Suppressor Genes in Cancer Therapy and Diagnostics

  • Genetic Testing: Identification of TSG mutations in patients helps diagnose and predict cancer risk.
  • Therapeutic Strategies: Drugs that target specific pathways affected by TSG mutations or restore their normal function.

Tumor Suppressor Genes (TSGs)

  • TSGs regulate cell proliferation and suppress tumor formation.
  • Inactivation of both alleles of a TSG is required for a mutant phenotype (Knudson's two-hit hypothesis).
  • Mechanisms of TSG inactivation include:
    • Two independent mutations within the same cell
    • Mitotic recombination
    • Gene conversion
    • Chromosomal nondisjunction and loss of heterozygosity (LOH)
    • Promoter methylation
  • LOH is crucial for identifying other TSGs.

RB1: "Cell Cycle Clock"

  • RB1 is a key regulator of the cell cycle, acting as a "cell cycle clock".
  • RB1 integrates signals from inside and outside the cell to regulate cell cycle entry.
  • RB1 controls the phosphorylation of E2F (a transcription factor), which regulates the G1 to S phase transition.
  • RB1 phosphorylation state is tightly coordinated with cell cycle progression:
    • Unphosphorylated RB1 (active) binds E2F, preventing cell cycle entry.
    • Phosphorylated RB1 (inactive) releases E2F, allowing cell cycle progression.

p53 Pathway

  • p53 is a tumor suppressor protein that responds to DNA damage and regulates apoptosis, cell cycle arrest, senescence, cell growth inhibition, and metabolic stress adaptation.
  • p53 is negatively regulated by MDM2.
  • p14ARF inhibits MDM2, thus activating p53.
  • Activated p53 arrests the cell cycle by interacting with p21, preventing CDK1/CyclinA-induced cell cycle progression.
  • Inactivation of p16 or p14ARF can lead to uncontrolled cell proliferation.

CDKN2A and Its Roles

  • CDKN2A encodes p16 and p14ARF.
  • p16 inhibits cyclinD/CDK4/6 complex, blocking RB phosphorylation and preventing cell cycle progression.
  • p14ARF inhibits MDM2, activating p53.
  • Loss of CDKN2A function (both p16 and p14ARF) leads to unregulated cell cycle progression and promotes tumor development.
  • P16 is a diagnostic marker for melanoma and mesothelioma.
  • P16 deletion or mutation are frequently observed in various cancers.
  • Overexpression of p16 (wild-type or mutant) can have negative implications for cell proliferation in some cancers.

Targeting TSGs for Cancer Therapy

  • Restoring wild-type p53 function is a potential therapeutic strategy for cancer.
  • Targeting MDM2 and p53 interaction using drugs like nutlin and RITA can reactivate p53.
  • Nuclear export inhibitors like leptomycin B can increase p53 levels in the nucleus.
  • PRIMA-1 can restore the wild-type conformation of mutant p53.
  • Targeting PTEN, another tumor suppressor gene, can inhibit the PI3K/AKT/MTOR pathway, which is hyperactivated in cancers with PTEN mutations.

### Epigenetics and Cancer

  • Epigenetics refers to heritable changes in gene expression without altering DNA sequence.
  • Primary epigenetic mechanisms include DNA methylation and histone modifications.
  • Epigenetic alterations in cancer include changes in DNA methylation patterns and histone modifications, leading to aberrant gene expression.
  • Epigenetic alterations can be targeted therapeutically to restore normal gene function and inhibit tumor growth.

Histone Acetylation

  • Histone acetylation is an epigenetic modification that affects chromatin structure and gene expression.
  • Acetylation of histone tails neutralizes their positive charge, loosening their interaction with DNA and increasing gene accessibility.
  • Acetylated lysine residues are associated with transcriptional activation, while deacetylated lysine residues are associated with transcription repression.
  • Histone acetyltransferases (HATs) add acetyl groups, while histone deacetylases (HDACs) remove them.
  • Histones near active genes are often hyperacetylated.

Epigenetic Regulators

  • Epigenetic modifications are controlled by specific enzymes:
    • Writers (add modifications): acetyltransferases
    • Erasers (remove modifications): deacetylases
    • Readers (recognize and bind modifications)
  • Histones are subject to various post-translational modifications, including methylation, acetylation, phosphorylation, and ubiquitination.
  • These modifications influence chromatin structure and gene expression.

Epigenetic Changes in Cancer:

  • Normal epigenetic regulation can be disrupted in cancer, affecting gene expression and contributing to tumor development.
  • Targeting epigenetic alterations is a promising strategy for cancer therapy.
  • Therapeutic approaches aim to restore normal gene expression by reversing aberrant epigenetic changes.

DNA Methylation

  • DNA methylation is a process that adds methyl groups to cytosine residues in DNA.
  • It typically occurs at CpG dinucleotides and affects gene expression by altering chromatin structure or interfering with transcription factor binding.
  • Methylation leads to condensed chromatin and repressed transcription.
  • Demethylation leads to expanded chromatin and permitted transcription.
  • Regions of chromosomes with fewer CpG sites are usually dense in regulatory elements like promoter regions.
  • Genes with CpG-rich promoters are typically unmethylated because repetitive sequences like LINE, SINE, and LTRs are scattered throughout them.
  • This unmethylation prevents genome instability caused by these repetitive structures.

Epigenetics and Aging

  • Epigenetic changes, including DNA methylation patterns, are affected by aging.
  • These changes can lead to the silencing of tumor suppressor genes or the activation of oncogenes, contributing to cancer progression.
  • Methylation patterns can become dysregulated with age, resulting in hypermethylation (more methylation) in previously unmethylated regions and hypomethylation (less methylation) in previously methylated regions.

DNA Methylation and Histone Modification

  • DNA methylation and histone modification are linked.
  • Higher levels of methylation (hypermethylation) are often found in areas with denser chromatin, which is inactive.
  • Hypomethylation is associated with less dense chromatin, which is active.

Cancer Overview

  • Cancer is a diverse group of diseases characterized by unregulated cell proliferation driven by genetic and epigenetic alterations.
  • It arises through a multi-step process that disrupts anti-cancer defense mechanisms.
  • Benign tumors are non-invasive but hyper-proliferative.
  • Primary tumors refer to the initial tumor cells.
  • Malignant tumors are invasive and invade surrounding tissues.
  • Metastatic tumors have spread to distant organs via blood or lymph.

Leukemia and Lymphoma

  • These are hematological malignancies arising from blood cells.
  • Leukemia originates from myeloid or lymphoid progenitor cells and is found in bone marrow and blood.
  • Leukemia cells can infiltrate other organs.
  • Lymphoma originates from lymphatic tissue, primarily in lymph nodes.

Origins of Cancer

  • Cancer arises from a complex interplay of environmental exposures, biological factors, and genetic predisposition.
  • Environmental factors include exposure to DNA-damaging chemicals such as cigarette smoke, formaldehyde, and asbestos.
  • Genetic factors involve inherited predispositions to certain cancers, like breast, colon, endometrial, and ovarian cancers.
  • Infectious diseases can also contribute to cancer development, such as lymphoma, carcinoma, and leukemia.

Genetic Drivers of Cancer

  • Cancer is a disease of the genome, characterized by genetic and epigenetic alterations.
  • Mutations accumulate over a lifetime, leading to cancer development.
  • Inherited mutations account for a small percentage of all cancers (~5-10%).
  • Cancer heterogeneity is significant, with varying mutations and genomic profiles observed in different stages of cancer.
  • The Cancer Gene Census (CGC) identifies human genes implicated in cancer through mutations.
  • The vast majority of cancer driver genes (~90%) contain somatic mutations.
  • A significant proportion (~20%) have germline mutations that predispose individuals to cancer.
  • Some genes (~10%) exhibit both somatic and germline mutations.

Epigenomic Dysfunction in Cancer Cells

  • Cancer cells often exhibit epigenetic dysregulation, including alterations in DNA methylation patterns and chromatin structure.
  • These changes significantly contribute to cancer development.
  • Many cancers demonstrate global hypomethylation and focal hypermethylation of unmethylated CpG islands.
  • Epigenetic regulatory genes are frequently mutated in various cancer subtypes.

Hallmarks of Cancer

  • Cancer progression is characterized by a series of hallmarks, including:

    • Sustaining proliferative signaling
    • Evading growth suppressors
    • Resisting cell death
    • Enabling replicative immortality
    • Inducing angiogenesis
    • Activating invasion and metastasis
    • Cellular metabolism
    • Immune evasion
  • Enabling characteristics further support these hallmarks, such as:

    • Genome instability
    • Inflammation

The Cell Intrinsic Barrier to Tumorigenesis

  • Multi-cellular organisms have evolved complex mechanisms to prevent uncontrolled cell growth.
  • Under normal circumstances, most adult cells are in a non-dividing state (G0).
  • A limited pool of cells maintains tissue and organ homeostasis.
  • Cells are maintained in a quiescent state by inhibitory signals and the absence of stimulatory signals.
  • Growth factors can stimulate cells to enter the cell cycle.

Tumor Suppressor Genes and Cancer

  • The multistep model of cancer development proposes that tumors arise from accumulated genetic and epigenetic changes.
  • Oncogenes are activated through various mechanisms like amplification, point mutation, and translocation, providing excessive growth signals.
  • Tumor suppressor genes are inactivated through processes like chromosomal loss, mutation, methylation, and viral protein binding, disrupting growth control.

Tumor Suppressors and Oncogenes

  • Tumor suppressor genes function to suppress growth or promote apoptosis.
  • Oncogenes often activate growth signaling pathways.
  • Tumor cells accumulate mutations in these critical genes, leading to the development of cancer.

Features of Oncogenes

  • Oncogenes are dominant, gain-of-function mutations of proto-oncogenes.
  • Proto-oncogenes are positive regulators of the cell cycle that are normally regulated by extracellular or intracellular mechanisms.
  • Mutations in proto-oncogenes remove these regulatory mechanisms, leading to overactive signaling and increased proliferation.
  • Mutations in proto-oncogenes can result from:
    • Mutations in the coding region, enhancing protein activity.
    • Gene duplication, leading to increased protein production.
    • Mutations in the regulatory region, enhancing transcription.
    • Translocations, resulting in a fusion gene with altered functionality.

Tumor Suppressor Genes and Oncogene Interactions

  • The presence of an oncogene alone may not lead to cancer if tumor suppressor genes are functional.
  • Inactivation of a tumor suppressor gene without an oncogene may not immediately cause cancer due to the lack of a growth-promoting force.

Genes Downregulated in Cancer

  • Hypermethylation can lead to the downregulation of genes crucial for cancer suppression.

Hypomethylating Agents

  • Hypomethylating agents, such as 5-azacytidine and decitabine, inhibit DNA methyltransferase enzymes, reducing methylation levels.

Targeted Small Molecule Epigenetic Drugs

  • Targeted small molecule epigenetic drugs have emerged as promising therapeutic agents in cancer treatment.

Immunotherapy and Cancer

  • Immunotherapy has revolutionized cancer treatment, particularly with the advent of checkpoint blockade therapies.
  • The concept of using the immune system to fight cancer dates back to the late 19th century, initially observed by William Coley.
  • The theory of immune surveillance, proposed by Sir Macfarlane Burnet and others, suggested that the immune system constantly monitors and eliminates abnormal cells.
  • Tumors arise when immune surveillance fails.

Immune System Basics

  • The immune system comprises innate and adaptive branches.
  • Innate immunity provides a rapid, non-specific response to pathogens, acting as the first line of defense.
  • Innate immune cells include macrophages and natural killer (NK) cells.
  • Adaptive immunity is slower and highly specific, involving T cells and B cells.

Tumor Microenvironment

  • Tumors are surrounded by a microenvironment that includes various immune cells, such as macrophages, T cells, and NK cells.
  • The presence of these cells does not necessarily indicate a successful immune response against the tumor.

Evidence from Animal Studies

  • Animal models have been instrumental in understanding how the immune system interacts with tumors.
  • Studies on immunodeficient mice demonstrate that the absence of essential immune components (T cells, B cells, NK cells) increases tumor development.
  • Depletion of NK cells in mice leads to higher tumor incidence, highlighting the role of different immune cells in tumor prevention.

Human Evidence and Observations

  • Immunosuppression is linked to increased cancer risk in humans.
  • Older individuals often have a weaker immune response, increasing their susceptibility to cancer.
  • Transplant recipients, who take immunosuppressive drugs to prevent organ rejection, have a higher risk of developing cancer.
  • Immunodeficiency disorders are associated with increased cancer rates, despite shorter lifespans and more severe illnesses.

Recent Advances and Immunotherapy

  • Checkpoint blockade therapies target immune checkpoints (like PD-1 and CTLA-4) to enhance the immune system’s ability to recognize and destroy cancer cells.
  • Clinical success of these therapies has proven that stimulating the immune response can be an effective cancer treatment.

NK Cells in Innate Immunity

  • NK cells recognize tumor cells through molecules like MICA that bind to NK cell receptors.
  • They produce interferon-gamma to recruit other immune cells and release perforin and granzymes to induce apoptosis in tumor cells.

CD8+ Cytotoxic T Cells in Adaptive Immunity

  • CD8+ T cells recognize tumor antigens presented by MHC Class I molecules.
  • They kill tumor cells by releasing perforin and granzymes.

Antigen Presentation

  • MHC Class I presents endogenous antigens (from inside the cell) to CD8+ T cells.
  • MHC Class II presents exogenous antigens (taken up from outside the cell) to CD4+ T cells.
  • Dendritic cells can present antigens on MHC Class I, even if they were taken up from outside the cell, through a process called cross-presentation.

T Cell Activation

  • T cell activation requires two signals:
    • Recognition of antigen-MHC complex (signal 1).
    • Co-stimulation (signal 2), involving CD28 on T cells binding to CD80/86 on antigen-presenting cells (APCs).
  • Without signal 2, T cells may become anergic or undergo apoptosis.

T Cell Differentiation

  • Naive T cells differentiate into various subtypes:
    • Effector cells
    • Memory cells
    • Terminally differentiated cells
  • T cell differentiation and function depend on the strength and duration of antigen recognition.

Immune Tolerance and Self vs. Non-Self Discrimination

  • Thymic selection eliminates or deactivates T cells that recognize self-antigens, preventing autoimmunity.
  • Peripheral tolerance involves regulatory T cells (Tregs) that suppress self-reactive T cells that escape thymic selection.

Cancer Immunoediting

  • Cancer immunoediting describes the interplay between the immune system and tumors in three phases:
    • Elimination: The immune system successfully eliminates malignant cells.
    • Equilibrium: The immune system controls tumor growth, but tumors are not eradicated.
    • Escape: Tumors evolve mechanisms to evade immune detection and destruction, leading to clinical cancer.

Tumor Evasion Strategies

  • Tumors can evade immune responses by:
    • Altering or downregulating antigen presentation.
    • Producing immunosuppressive cytokines.
    • Recruiting regulatory T cells.
    • Expressing checkpoint molecules, inhibiting T cell activation.

Chronic Antigen Exposure and T Cell Exhaustion

  • Continuous antigen exposure can lead to T cell exhaustion, decreasing immune effectiveness.
  • Immunotherapy research focuses on reversing T cell exhaustion to boost anti-tumor responses.

T Cell Therapies

  • T cell therapies fall under the umbrella of adoptive cell therapy (ACT) and chimeric antigen receptor (CAR) T cell therapy.

Adoptive Cell Therapy (ACT)

  • ACT involves transferring immune cells from the tumor microenvironment back into the patient.
  • Steps involve harvesting T cells from the tumor, culturing and expanding them in the lab, and reintroducing them into the patient.
  • Preconditioning with chemotherapy or irradiation may be necessary to deplete existing T cells and make space for the introduced T cells.
  • Advantages include personalized therapy and the potential for tumor eradication.
  • Disadvantages include limited applicability to patients who can tolerate preconditioning, high costs, labor-intensive procedures, and potential inefficiencies for tumors lacking T cells or with unknown antigen specificity.

CAR T Cell Therapy

  • CAR T cell therapy involves genetically modifying T cells to express chimeric antigen receptors (CARs), enabling them to specifically target tumor antigens.
  • T cells are harvested from the patient's blood, engineered to express CARs, expanded in the lab, and reintroduced into the patient.
  • Effective for hematological cancers.

Tumor Vaccines

  • Tumor vaccines aim to stimulate the immune system to recognize and target tumor-specific antigens.

Immune Checkpoint Blockade

  • Checkpoint blockade therapies target immune checkpoints to enhance the immune system's ability to recognize and attack cancer cells.
  • They have revolutionized cancer treatment, offering durable responses in select cancer types.

Tumor Immunology

  • Cancer cells evade the immune system, forming malignant tumors with unique properties.
  • Hallmarks of cancer include evading immune destruction, promoting inflammation, and sustaining proliferative signals.
  • Immunotherapy became prominent around 2013 with FDA approvals of therapies like checkpoint blockade.
  • Key questions in tumor immunology include how tumors interact with the immune system, how tumors are eliminated, and how tumors evade immune detection.

Innate and Adaptive Immunity

  • Innate immunity is rapid and non-specific, while adaptive immunity is slow and specific.
  • Immunosuppressed individuals, transplant recipients, and the elderly are at higher cancer risk.
  • Presence of tumor-infiltrating lymphocytes, especially T cells, correlates with better prognosis.

Antigen Presentation and T Cell Activation

  • Tumor cells present antigens via MHC-I (for CD8+ T cells) or MHC-II (for CD4+ T cells), allowing the immune system to recognize them.
  • T cell activation requires two signals: T cell receptor recognition of antigen-MHC and co-stimulatory molecules.
  • Without Signal 2, T cells may become tolerant (anergy).
  • Successful T cell activation leads to cell differentiation, critical for maintaining a memory T cell response.

Immune Tolerance and Checkpoints

  • Central and peripheral tolerance mechanisms ensure that self-reactive T cells are eliminated or rendered non-functional.
  • T cell activation is negatively regulated by immune checkpoints, such as CTLA-4, to prevent autoimmunity.

Cancer Immunoediting and Evasion Strategies

  • Tumors can evolve to avoid immune detection through low immunogenicity, immunosuppression, and immune checkpoint hijacking.
  • Tumors may downregulate MHC-I expression and release factors like TGF-β to suppress immune responses.
  • Immune checkpoint hijacking allows tumors to exploit checkpoints to inhibit T cell responses.

Recap and Summary

  • The immune system has both innate and adaptive components crucial for tumor control.
  • Immunosurveillance is the initial immune response that can eliminate some cancers.
  • Immunoediting is the adaptation of tumors to immune pressure, which can lead to more aggressive, immune-evasive variants.

Overview of Immunotherapy in Cancer

  • Immunotherapy targets the immune system rather than the cancer cells directly.
  • Successful T cell responses against tumors are the goal of immunotherapy.
  • Immunotherapy includes T cell therapies (TIL and CAR T cell therapy), tumor vaccines, and immune checkpoint blockade.

Evolution of Cancer Treatment Paradigms

  • Traditional cancer therapy targets tumor growth, while immunotherapy aims to target the immune system for long-lasting defense against cancer cells.

Types of Cancer Immunotherapy

  • Adoptive Cell Transfer (ACT) includes TIL and CAR T-cell therapy to enhance the number of tumor-specific T cells.
  • Cancer Vaccines aim to stimulate immune responses against tumor antigens.
  • Immune Checkpoint Inhibitors block molecules like CTLA-4 and PD-1/PD-L1 to restore T-cell function.

T-Cell Based Immunotherapies

  • Adoptive cell therapy (ACT) involves transferring immune cells with anti-tumor activity into patients.
  • TIL therapy involves extracting T cells from tumors, expanding them in the lab, and reinfusing them.
  • CAR T-cell therapy uses genetically engineered T cells with chimeric antigen receptors targeting specific tumor antigens.

Advantages and Challenges of T-Cell Therapies

  • TIL and CAR T therapy are highly effective in hematologic cancers.
  • They bypass typical antigen-MHC interactions, directly activating T cells.
  • They are less successful in solid tumors, expensive, and require specialized facilities.
  • They can cause side effects, such as cytokine release syndrome.

Future Directions in T-Cell Therapy

  • Advanced engineering techniques are being explored to improve T-cell therapies.
  • CRISPR/CAS9 is used for personalized T cells.
  • T cells are being utilized to carry therapeutic molecules.
  • Techniques are being developed to prolong T-cell survival.

Immune Checkpoints and Blockade Therapies

  • CTLA-4 and PD-1/PD-L1 are checkpoints that tumors can exploit to inhibit T-cell activity.
  • Checkpoint blockade therapies inhibit CTLA-4 and PD-1/PD-L1 to restore T-cell functionality.

Challenges of Immune Checkpoint Inhibitors

  • Immune checkpoint inhibitors can cause immune-related adverse events (IRAEs), including autoimmune-like symptoms.
  • Only a subset of patients benefits from these therapies, and identifying predictive biomarkers is an active area of research.

Combination Therapy in Immunotherapy

  • Combining immunotherapy with other treatments, such as chemotherapy, has shown promise.

Conclusion

  • Immunotherapy holds potential for cancer treatment when combined with other treatments.
  • Research is ongoing to refine immunotherapy techniques and develop predictive markers.

Hallmarks of Cancer

  • Cancer cells acquire six hallmark capabilities:
    • Sustained proliferative signaling
    • Evading growth suppressors
    • Resisting cell death
    • Enabling replicative immortality
    • Inducing angiogenesis
    • Activating invasion and metastasis
    • Deregulating cellular metabolism
    • Avoiding immune destruction

Enabling Characteristics

  • Two enabling characteristics facilitate the acquisition of hallmark capabilities:
    • Genome instability and mutations
    • Tumor-promoting inflammation

Sustained Proliferative Signaling

  • Normal tissues control cell growth and division by regulating growth-promoting signals.
  • Cancer cells deregulate these signals, often through:
    • Increased growth factor sensitivity
    • Constitutive activation of downstream signaling pathways
    • Mutations in genes like Ras, disrupting negative feedback mechanisms

Evading Growth Suppressors

  • Tumor suppressor genes (e.g., RB and TP53) regulate cell growth and division.
  • Inactivation of these genes allows cancer cells to evade growth suppression.

Resisting Cell Death

  • Apoptosis is a programmed cell death mechanism that cancer cells often avoid.
  • Mechanisms include:
    • Mutations in TP53, the "Guardian of the Genome"
    • Increased anti-apoptotic proteins (e.g., Bcl-2)
    • Reduced pro-apoptotic factors
  • Autophagy, a cellular process for organelle breakdown and recycling, can both aid in survival and induce death depending on the stress level for cancer cells.
  • Necrosis, uncontrolled cell death, can promote tumor-supportive inflammation by releasing factors that activate immune cells.

Enabling Replicative Immortality

  • Telomerase, an enzyme that maintains telomere length, is activated in cancer cells, enabling unlimited cell division.
  • Telomerase also contributes to DNA repair, resistance to apoptosis, and signaling by the Wnt pathway.

Inducing Angiogenesis

  • Angiogenesis, the formation of new blood vessels, is essential for tumor growth.
  • Cancer cells produce pro-angiogenic factors like VEGF-A, stimulating blood vessel formation, while anti-angiogenic factors like TSP-1 are suppressed.

Activating Invasion and Metastasis

  • Metastasis occurs in multiple steps, including local invasion, intravasation, extravasation, and colonization of distant tissues.
  • The Epithelial-Mesenchymal Transition (EMT) is a key process that allows cancer cells to become more mobile and invasive, changing their cell-cell and cell-matrix interactions.

Deregulating Cellular Metabolism

  • Cancer cells exhibit the Warburg effect, utilizing glycolysis for energy even in the presence of oxygen.
  • This metabolic shift supports rapid growth and is often driven by oncogenes like RAS and MYC.

Avoiding Immune Destruction

  • Cancer cells evade immune destruction by:
    • Creating an immunosuppressive tumor microenvironment
    • Utilizing factors like TGF-β to inhibit immune responses
    • Recruiting and educating immune cells to create a permissive environment
    • Producing exosomes that impair T-cell function
  • Cancer cells can suppress the immune system by:
    • Avoiding immune recognition: Hiding tumor-associated antigens or expressing immune checkpoint molecules that inhibit immune cells
    • Instigating an immunosuppressive tumor microenvironment: Producing immunosuppressive cytokines and chemokines, recruiting suppressive immune cells like regulatory T cells and myeloid-derived suppressor cells (MDSCs)

Genome Instability and Mutation

  • Cancer cells frequently exhibit genome instability and mutations, leading to increased variation and acquisition of new capabilities.
  • These mutations can occur in DNA repair genes, such as BRCA1, or through chromosomal instability (CIN).

Tumor-Promoting Inflammation

  • Inflammation in the tumor microenvironment can contribute to cancer progression by:
    • Providing growth factors and survival factors
    • Aiding in metastasis
    • Suppressing immune responses.
    • Creating a pro-tumor environment, where inflammatory cells can promote angiogenesis, invasion, and metastasis.

Introduction to Breast Cancer

  • Breast cancer is the most common cancer in women, excluding non-melanoma skin cancers.
  • 31% of all cancers in women with an estimated 18,000 new cases diagnosed in Australia annually.
  • Second leading cause of cancer-related deaths in women (15%)
  • 95% five-year survival rate, improved significantly from 72% in 1998.

Risk Factors for Breast Cancer

  • 99% of cases occur in women, with an increasing risk with age (77% of cases in those over 50).
  • Previous breast cancer diagnosis increases recurrence risk.
  • Estrogen exposure through early menarche, late menopause, obesity, and contraceptives increases risk.
  • Pregnancy: Nulliparity or late pregnancy increases risk as pregnancy induces terminal differentiation in breast tissue.
  • Genetics: Family history, BRCA1/BRCA2 mutations, and other genetic abnormalities increase risk.
  • Dense breasts on mammograms correlate with higher risk.
  • Past radiation exposure increases risk.

Hereditary Breast Cancer

  • 5-10% of cases have a genetic basis.
  • More likely to present at a younger age and be bilateral.
  • BRCA1/BRCA2 mutations account for 47% of hereditary breast cancer cases.
  • BRCA1/BRCA2 mutations are autosomal dominant tumor suppressor genes, increasing the risk of breast, ovarian, prostate, colon, pancreas cancers.
  • BRCA1/BRCA2 mutations are rare in sporadic breast cancer.
  • Other syndromes associated with breast cancer include Li-Fraumeni (P53 mutation), Cowden's disease (P10), and others.

Pathology of Breast Cancer

  • Breast cancer progresses from benign lesions and proliferative conditions to pre-cancerous and cancerous states.
  • Benign Lesions: Fibrocystic change, adenosis, fibroadenomas (no increased cancer risk).
  • Proliferative Conditions:
    • Usual hyperplasia, papillomas, radial scars (slightly increased risk).
    • Without Atypia - Mild increased risk of breast cancer (1.5-2x above general population)
    • With Atypia - Moderate increased risk (4-5 times) of breast cancer

In Situ Breast Cancer

  • Malignant breast cancer cells confined to the ductal-lobular system without invasion through the basement membrane into stroma.
  • Cells are morphologically identical and genetically similar to invasive breast cancer.
  • Constitutes 20-25% of newly diagnosed breast cancer cases.
  • Associated with a high increased risk of invasive breast cancer (10x above general population).
  • Classified into two main categories: Ductal (DCIS) and Lobular (LCIS).

Ductal Carcinoma In Situ (DCIS)

  • Non-invasive, confined within ducts but with potential to become invasive.
  • Accounts for 20-25% of newly diagnosed cases.
  • High-risk of progressing to invasive cancer if untreated.
  • Treated with surgical excision, clear margins, and often radiotherapy.
  • Classified by grade of nuclear atypia: low, intermediate, high.

Paget’s Disease of the Nipple

  • Breast cancer cells within epidermis of the nipple.
  • Almost always associated with underlying high grade DCIS.
  • Clinical: Red, weeping, "eczematous" nipple.
  • Mx: Surgical excision with clear margins including associated DCIS (+/- invasive)

Lobular Carcinoma In Situ (LCIS)

  • Risk factor for developing lobular invasive carcinoma.
  • Can be bilateral and associated with future invasive cancer in either breast.
  • Managed through surveillance, anti-estrogen therapy, or rarely, mastectomy.
  • "Non-obligate precusor" to invasive lobular carcinoma.

Invasive Breast Cancer

  • Invasion of malignant epithelial cells beyond myoepithelial layer/ basement membrane into stroma.
  • Potential to metastasize through vessels and lymphatics.
  • Most deaths result from distant metastases to organs with impairment of function.

Clinical Presentation of Invasive Breast Cancer

  • Discrete mass (lump)/ lumpiness
  • Pain
  • Nipple changes/discharge
  • Skin changes (tethering, peau d’orange, ulceration etc)
  • Other (including distant manifestations)

Workup for Invasive Breast Cancer

  • Examination – breast, axilla, general
  • Pathology – Fine needle aspiration or core biopsy
  • Radiology – MMG, US, MRI

Histological Types of Invasive Breast Cancer

  • 80% of cases are invasive ductal carcinoma (IDC) of 'no special type' (NST).

  • About 10% are invasive lobular carcinoma (ILC).
  • Remainder are ‘special’ types of carcinoma, most considered variants of IDC.
  • Common types:
    • Mucinous
    • Tubular
    • micropapillary (different prognoses).

Spread & Metastasis of Invasive Breast Cancer

  • Through lymphatics, commonly to axillary lymph nodes, liver, brain, lungs.
  • Staging based on tumor size, node involvement, and presence of metastasis.
  • Higher stages predict worse prognosis.
  • Staging is by the AJCC system, latest revision 2017 (8th edition).

Grading of Invasive Breast Cancer

  • Based on tubule formation, nuclear atypia, and mitotic activity (Grade 1-3).
  • Grading is by the modified Bloom and Richardson method (often referred to as Nottingham grade).

Prognostic and Predictive Markers in Breast Cancer

  • Prognostic Factors: Determine overall survival and disease progression.
  • Predictive Factors: Predict treatment response.
  • Three commonly used in Breast Cancer:
    • Estrogen receptor (ER)
    • Progesterone receptor (PR)
    • HER2

Estrogen and Progesterone Receptors (ER/PR)

  • Oestrogen and progesterone bind to ER/PR in cytoplasm, migrate to nucleus, transcribe DNA to protein to exert physiological effects.
  • Promote growth and differentiation in normal breast tissue.
  • Promote a growth advantage for overexpressing malignant cells.
  • ER/PR positive: Indicates better response to hormone therapy (tamoxifen, etc.).
  • ER/PR negative: 10% response to anti-oestrogen therapy (e.g.tamoxifen).

HER2/neu

  • Transmembrane tyrosine kinase (TK) protein.
  • Binds ligand (growth factors), forms heterodimers with other HER family proteins, activates intracellular signals.
  • Upregulates the RAS-MAPK pathway: Proliferation and invasiveness.
  • Upregulates the PI3K pathway: Inhibits cell death.
  • Promote growth and differentiation in normal breast tissue.
  • HER2 gene amplification and receptor overexpression in ~15-30% BCs.
  • HER2 positive: Often more aggressive but can be targeted by specific therapies (trastuzumab).

Molecular Profiling in Breast Cancer

  • Early gene expression profiling identified four distinct breast cancer subtypes.
    • Luminal A
    • Luminal B
    • HER2 enriched
    • Basal-like
  • Prognostic and predictive significance.
  • Cost-effective molecular profiling panels (Oncotype DX, Prosigna, Mammaprint) are accepted in clinical use.

Breast Cancer Treatment

  • Surgical Options: Lumpectomy, mastectomy depending on extent.
  • Radiotherapy: Often used post-surgery to reduce recurrence risk.
  • Hormonal Therapy: For ER/PR-positive tumors.
  • Chemotherapy and Targeted Therapy: For HER2-positive and high-risk cases.

Overview of Melanoma

  • A malignant tumor derived from melanocytes, the cells responsible for melanin production.
  • Most commonly arises in the skin.

Importance of Early Detection of Melanoma

  • Early-stage melanoma has significantly higher survival rates compared to late-stage detection.

Risk Factors for Melanoma

  • Fair skin complexion
  • Ultraviolet (UV) radiation exposure
  • Large numbers of benign or atypical moles (naevi)
  • Family history of melanoma
  • History of previous melanoma
  • Immunosuppression
  • Exposure to harmful chemicals

Development Model for Melanoma

  • Benign Naevi: Small, well-circumscribed, even coloration; symmetrical structure, cells predominantly in nests, round to oval, even nuclei.
  • Dysplastic Naevi: Larger than benign naevi, irregular borders, and varied coloration; associated with increased melanoma risk, especially in familial cases.
  • Melanoma: Asymmetry, irregular borders, color variation, diameter >6mm, evolving characteristics; asymmetrical growth, poorly circumcised, predominant single-cell over nests, disorganized pattern, and invasion into upper epidermal levels.

Growth Phases of Melanoma

  • Radial Growth Phase: Melanoma in situ with superficial dermal invasion, characterized by single cells or small nests. Generally lacks metastatic potential.
  • Vertical Growth Phase: Expansive growth into the dermis with the formation of larger nests. Presence of mitotic figures indicates metastatic potential.

Prognostic Indicators in Melanoma

  • Tumor Thickness: Measured as Breslow thickness.
  • Invasion Level: Clark level.
  • Ulceration: Associated with poorer outcomes.
  • Mitotic Rate: Higher rate correlates with worse prognosis.
  • Lymphovascular/Perineural Invasion: Indicates aggressiveness.
  • Satellite Lesions: Presence signals potential spread.

Key Genetic Mutations in Melanoma

  • BRAF: Mutated in ~66% of melanomas, particularly V600E mutation, activating the MAPK pathway.
  • NRAS: Mutations found in ~15% of melanomas.
  • KIT: Mutation associated with melanomas in certain sites (e.g., mucosa, nail).

Clinical Implications of BRAF Mutation

  • Testing helps identify candidates for BRAF inhibitor therapy, improving survival in metastatic cases.

Overview and Epidemiology of Lung Cancer

  • Leading cause of cancer death and the fifth most diagnosed cancer in Australia.
  • Higher incidence in females, with a rising trend, and declining incidence in males.
  • 5-year survival rate is 17%.

Lung Cancer Risk Factors

  • Primary risk factor: Tobacco smoking
  • Additional risk factors:
    • Environmental and occupational carcinogens (e.g., asbestos, silica, radon)
    • Radiation exposure
    • Chronic inflammation (e.g., tuberculosis)
    • Pulmonary fibrosis
    • Family history (relative diagnosed at a young age, multiple family members)
    • Specific inherited conditions (e.g., Li-Fraumeni syndrome, alpha-1 antitrypsin deficiency)

Diagnostic Sampling Techniques for Lung Cancer

  • Transbronchial Fine-Needle Aspiration (FNA):
    • Often guided by Endobronchial Ultrasound (EBUS).
  • Percutaneous Transthoracic FNA/Core Biopsy:
    • Typically CT-guided.
  • Other Methods:
    • Bronchial washings/brushings
    • Pleural fluid aspiration
    • Endobronchial biopsy
    • Sputum collection.

Preparation Techniques

  • FNA smear preparation
  • Cell block preparation
  • Histological techniques (e.g., immunohistochemistry, molecular tests)

Ancillary studies on neoplastic cytology/biopsy specimens

  • Histochemical stains (e.g., mucin stains)
  • Immunohistochemistry (IHC)
  • Sanger and next-generation sequencing (NGS)
  • Polymerase chain reaction (PCR)-based techniques
  • Fluorescence in-situ hybridisation (FISH)
  • Electron microscopy
  • Flow cytometry

Major Categories of Lung Cancer

  • Small Cell Carcinoma (14%):

    • Usually non-resectable, treated with chemoradiotherapy
    • Highly aggressive, linked to smoking, typically in the central lung.
    • Characterized by neuroendocrine differentiation, frequent ectopic hormone production, and a high metastatic potential.
    • Cytological features: Small cells with scant cytoplasm, granular chromatin, nuclear molding, frequent mitosis, and necrosis.
    • Immunohistochemistry Markers: CD56, synaptophysin, chromogranin, and TTF-1.
  • Non-Small Cell Lung Carcinoma (NSCLC):

    • Resected if possible.
    • Look for “druggable” targets, otherwise, treated with chemoradiotherapy.

NSCLC Types

  • Adenocarcinoma (38%):

    • Common in both smokers and non-smokers, with increasing incidence.
    • Peripheral origin, commonly metastasizes to adrenal glands, bones, and brain.
    • In-Situ Form: Defined by lepidic growth along alveolar walls without invasion, typically non-mucinous with ground-glass appearance on CT.
  • Squamous Cell Carcinoma (20%):

    • Strongly linked to smoking, usually central in location, tends to be locally aggressive.
    • Histology: Keratinization and intercellular bridges.
  • Large Cell and Other Carcinomas:

    • Includes less common types like adenosquamous and sarcomatoid carcinoma.

Oncogenic Drivers and Molecular Subtypes in Lung Cancer

  • The Importance of Small Samples:

    • 70% of patients with NSCLC present with unresectable disease.
    • A small biopsy/cytology sample may be all that is available.
    • Refining a diagnosis is crucial for patient management.
    • Careful tissue management for diagnosis, IHC & molecular studies.
  • Subtyping of NSCLC:

    • Combining morphology & ancillary studies is feasible and accurate.
    • Periodic acid-Schiff + diastase (PASD) for mucin.
    • Immunohistochemistry:
      • TTF-1: primary lung adenoca
      • p40 and CK5/6: squamous markers

EGFR Mutation

  • Common in non-smokers, especially in East Asians.
  • Exon 19 and 21 mutations predict responsiveness to tyrosine kinase inhibitors (TKIs), which can improve patient outcomes.
  • EGFR-mutated lung adenocarcinoma:
    • 10-20% in Western and 30-50% of East Asian patients, particularly women & never smokers.
    • Adenocarcinomas with lepidic growth pattern.
    • Mutations in exon 19 and 21 are most common.
    • Detected by real-time PCR, Sanger sequencing, and next-generation sequencing.
    • Predicts response to EGFR tyrosine kinase inhibitors.

ALK Rearrangement

  • Found in younger, light or never-smoking patients.
  • Frequently co-occurs with solid-signet ring or mucinous patterns; typically detected by FISH, IHC, or NGS.
  • ALK-rearranged lung adenocarcinoma:
    • Uncommon, ~4% of all NSCLC.
    • Almost always mutually exclusive with other driver mutations.
    • Younger patients, light or never smokers.
    • Adenocarcinoma with solid-signet ring or mucinous cribriform pattern.
    • Detection by IHC, FISH and NGS (but FISH is the “gold standard”).
    • Targeted therapy (e.g., crizotinib) has shown significant efficacy in ALK-positive patients.

KRAS Mutation

  • Associated with poor prognosis; common in smokers.

Importance of Small Biopsy Samples in Molecular Testing

  • Small samples from unresectable NSCLC are crucial for diagnosing and selecting targeted therapies.
  • Subtyping and tissue management are essential for optimal diagnosis and molecular testing.

Immune Checkpoint Inhibitor Therapy

  • Tumors can evade immune detection by exploiting inhibitory immune checkpoints such as the PD-1/PD-L1 pathway.
  • Antibodies that block this pathway offer a new approach to treatment in advanced/metastatic NSCLC.

PD-L1 Expression

  • High PD-L1 expression (≥50%) in NSCLC qualifies patients for pembrolizumab, which is effective in prolonging survival.
  • Testing for PD-L1:
    • Routine in advanced NSCLC to guide immunotherapy.

Conclusion - Key Focus Areas:

  • Risk factors and types of lung cancer.
  • The role of molecular diagnostics, including subtyping NSCLC and identifying actionable mutations.
  • Application of checkpoint inhibitors in advanced NSCLC based on PD-L1 status.
  • **

Overview of Leukaemia

  • Definition: Cancer of white blood cells, originates in bone marrow from a precursor cell.
  • Cause: Genetic defects leading to uncontrolled growth of abnormal cells, overtaking normal blood cell development.

Categories of Leukaemia

  • Acute (rapid progression, immature cells) vs. Chronic (slow progression, mature cells).
  • Myeloid or Lymphoid lineage.

Types of Leukaemia

  • Acute:

    • Any age: neonate - adult.
    • Mutation in primitive cell.
    • Continue to replicate.
    • Do not mature.
    • Leukaemia cells are all immature (“blast”) cells; no function.
    • Without treatment, short survival.
    • With treatment, some can be cured.
  • Chronic:

    • Adults.
    • Mutation in primitive cell.
    • Low replication rate.
    • Cells mature.
    • Leukaemia resembles normal blood cell; but do not have normal function.
    • Without treatment, can have long survival.
    • With treatment, few are cured.

ALL (Acute Lymphoblastic Leukaemia)

  • Often affects children, high cure rate in young patients (85% in ages 2-5), with B-cell lineage common (85%).
  • Cell Markers:
    • Expresses B-cell associated antigens: CD10, CD19, cytoCD79a.
    • Expresses markers of immaturity: CD34, nuclear TdT.
    • Gating on cells with weak CD45 expression and low side scatter.
  • Cytogenetics: Prognosis varies with age and genetic changes; hyperdiploidy and specific translocations (e.g., t(12;21)) linked to better outcomes.

AML (Acute Myeloid Leukaemia)

  • More common in adults, diverse subtypes, characterized by high replication of myeloblasts without maturation.
  • Morphology and Subtypes: Myeloblasts vary in appearance, from myeloblastic to promyelocytic forms.
  • Genetic Markers: Specific chromosomal abnormalities (e.g., t(8;21), t(15;17)) inform prognosis; next-gen sequencing is used for detailed molecular analysis.
  • Promyelocytic Subtype: Notable for clotting complications, treated effectively with all-trans retinoic acid and arsenic trioxide.

Management of Acute Leukaemia

  • Treatment: Chemotherapy, stem cell transplant, and supportive care (e.g., blood transfusions, antibiotics).
  • Targeted Therapy: Antibodies and small molecule inhibitors (e.g., FLT3 inhibitors for AML with FLT3 mutations).
  • Prognosis: Varies widely, with factors like cytogenetics influencing survival.

CML (Chronic Myeloid Leukaemia)

  • Affects adults, often asymptomatic initially, marked by the Philadelphia chromosome (t(9;22)), treated with Tyrosine Kinase Inhibitors (TKIs).
  • Clinical Phases:
    • Chronic phase (longer survival), progresses to blast phase (acute, aggressive phase).
  • Treatment: TKIs like Imatinib revolutionized treatment, improving survival rates from 45% to around 90%.
  • Monitoring: Blood tests showing increased neutrophils, eosinophils, basophils, and immature cells indicate disease stage.

CLL (Chronic Lymphocytic Leukaemia)

  • Common in elderly, often asymptomatic at diagnosis.
  • Symptoms: Lymphadenopathy, splenomegaly, anemia, susceptibility to infections.
  • Cell Markers: Expresses B-cell markers (CD19, CD5, CD23).
  • Genetic Risk Factors: Specific deletions (e.g., del17p, poor prognosis) guide treatment strategy.
  • Management: Often "watch and wait," treatment initiated upon symptom progression using multi-agent chemotherapy, anti-CD20 antibodies (e.g., Rituximab), or newer inhibitors like Venetoclax.

Summary and Learning Objectives

  • Differentiation between acute and chronic leukaemias and myeloid vs. lymphoid lineages.
  • Recognition of genetic and cytogenetic markers in diagnosis and prognosis.
  • Treatment approaches vary widely from supportive care to targeted therapies and stem cell transplantation.
  • Knowledge of different presentation patterns, disease pathology, and outcomes in leukaemia types.
  • **

Introduction to Multiple Myeloma

  • Plasma cell malignancy arising in the bone marrow causing destruction of:
    • Bone
    • Kidneys
    • Other organs (heart, nervous system)
  • Part of the plasma cell dyscrasias including:
    • MGUS (Monoclonal Gammopathy of Uncertain Significance)
    • Smouldering Multiple Myeloma
    • Multiple Myeloma
    • Plasma Cell Leukaemia
    • Plasmacytomas
    • Waldenstrom’s Macroglobulinemia
    • Others: POEMS disease, TEMPI disease, Amyloidosis

Plasma Cell Dyscrasias

  • MGUS affects 1-3% of people aged >50 years old.
  • Risk of MGUS → Myeloma is ~1% per year.
  • Risk of MGUS → SMM or SMM → Myeloma is ~10% per year.

Haematopoiesis & Plasma Cells

Epidemiology

  • Usually affects people aged 60-70 years old.
  • Affects 2,600 Australians every year.
  • 13% of all blood cancer diagnoses in Australia (1% of all cancers).
  • 5-year average survival rate is ~55%.

Risk Factors:

  • Elderly age
  • Male gender
  • Black race
  • Family history of myeloma / plasma cell dyscrasia
  • Radiation + chemical exposure (e.g., pesticides)
  • Obesity
  • Certain genetic syndromes (e.g., Down syndrome)

Multiple Myeloma Signs and Symptoms

  • Bone Pain: Most common symptom, often located in the back, ribs, pelvis, or skull.
  • Fatigue & Weakness: Due to anemia, a common complication of myeloma.
  • Frequent Infections: Weakened immune system makes patients susceptible to infections.
  • Kidney Problems: Myeloma proteins can damage the kidneys, leading to impaired kidney function.
  • Hypercalcemia: High blood calcium levels can cause confusion, constipation, and kidney stones.
  • Enlarged Spleen & Liver: May occur due to myeloma cells infiltrating these organs.
  • Neurological Problems: May occur if the myeloma cells infiltrate the spinal cord or nerves.

Diagnosis

  • Blood Tests:
    • Complete Blood Count (CBC): Shows anemia, thrombocytopenia, and white blood cell abnormalities.
    • Protein Electrophoresis: Detects the presence of abnormal proteins in the blood, known as M-protein.
    • Immunofixation Electrophoresis: Identifies the specific type of M-protein.
  • Urine Tests:
    • Bence-Jones Protein: Detects the presence of light chains (small proteins) in the urine.
  • Bone Marrow Aspiration and Biopsy: Confirms the diagnosis, showing the presence of cancerous plasma cells in the bone marrow.
  • Imaging Studies:
    • X-rays: Reveal lytic lesions (holes) in the bones.
    • MRI: Provides detailed images of the bones and surrounding tissues.
    • PET Scan: Helps detect the spread of myeloma to other areas of the body.

Treatment Approaches:

  • Chemotherapy: Used to kill myeloma cells, often in combination with other therapies.
  • Immunotherapy: Uses the body's immune system to target and destroy myeloma cells.
  • Targeted Therapy: Drugs that specifically target proteins involved in myeloma cell growth.
  • Stem Cell Transplant: Used to replace the bone marrow after high-dose chemotherapy.
  • Radiation Therapy: Used to treat localized myeloma tumors or bone pain.
  • Supportive Care: Includes pain management, treatment of infections, and management of kidney problems.

Prognosis

  • Prognosis for multiple myeloma varies greatly depending on various factors:
    • Stage of disease: Early stages have a much better prognosis than advanced stages.
    • Cytogenetics: Certain genetic abnormalities in the myeloma cells predict worse outcomes.
    • Patient's overall health: Older patients and patients with other medical conditions tend to have a poorer prognosis.

Monitoring

  • Regular blood tests to monitor:
    • Haemoglobin levels
    • Kidney function
    • Calcium levels
    • Myeloma protein levels
  • Bone marrow biopsies to monitor the response to treatment.
  • Imaging studies to detect relapse or progression of the disease.
  • **

Multiple Myeloma

  • Malignant plasma cell neoplasm that arises in the bone marrow leading to destruction of bones, kidneys, and potentially other organs.
  • A member of the plasma cell dyscrasias, which include MGUS, smoldering multiple myeloma, plasma cell leukemia, POEMS disease, and amyloidosis.
  • Affects individuals aged 60–70 years
  • 13% of blood cancers and 1% of all cancers in Australia with 2,600 new cases annually.
  • 5-year survival rate of ~55%.
  • Risk factors include older age, male gender, Black race, family history of plasma cell disorders, exposure to radiation or chemicals like benzene, HIV, and a history of MGUS.
  • TP53 mutations and cell cycle disruptions are common, impacting disease prognosis and progression
  • Genetic abnormalities, like del13 and del17p, influence prognosis.
  • Translocations such as t(11;14) lead to overexpression of cyclin D1, associated with a more favorable prognosis.

Diagnostic Criteria and Tests

  • SLiM CRAB criteria used to diagnose multiple myeloma:
    • 60% or more plasma cells in bone marrow.
    • Light chain ratio abnormalities.
    • MRI bone lesions.
    • CRAB: Calcium elevation, Renal failure, Anemia, and Bone lesions.
  • Key Diagnostic Tests:
    • Blood tests: Assess hemoglobin, renal function, and calcium levels.
    • Skeletal survey: CT or X-ray to identify bone lesions.
    • Bone marrow biopsy: Quantifies plasma cells (≥10% required for diagnosis with CRAB features).
    • Serum protein electrophoresis (SPEP): Separates blood proteins to identify abnormal M-spikes indicative of monoclonal paraproteins.
    • Immunofixation: Identifies specific paraproteins (e.g., IgG lambda) after an abnormal M-spike is detected.

Diagnostic Techniques and Their Findings

  • Abnormal monoclonal paraprotein:
    • Blood: Serum protein electrophoresis
    • Urine: Bence Jones protein
    • Elevated serum free light chains
  • Serum Protein Electrophoresis:
    • Measures different fractions of blood proteins (globulins) separated by an electric current
    • Blood serum is applied to a buffered agarose gel matrix (pH ~8.6)
    • Current applied - Globulins are separated based on:
      • Charge (electric force): Determined by sum of charge of amino acids
      • Size of globulin (endo-osmotic force)
    • Albumin is the most negatively charged and moves the furthest to the anode
    • γ-globulins rely on endo-osmotic forces and move in the opposite direction → Cathode (-)
  • Immunofixation:
    • Once an abnormal M-spike is identified, it is important to identify the specific monoclonal paraprotein causing the spike
    • Incubating agarose gel with antibodies against the different types of immunoglobulin by specific staining (chromogen) for antigen-antibody complexes which form:
      • IgG, A, M (generally)
      • Light chains (kappa, lambda)
    • The specific paraprotein is then both identified + quantified
    • Correlated with quantified immunoglobulin levels (serum)
    • Usually undertaken simultaneously with serum protein electrophoresis
  • Blood Film:
    • Shows anemia, rouleaux formation, and the presence of circulating plasma cells in multiple myeloma.
    • “Blue-ish” tinge to background → Monoclonal paraprotein

Bone Marrow Biopsy

  • Aspirate:
    • Liquid sample
    • Romanowsky stain
    • Flow cytometry
  • Trephine:
    • Solid bone component
    • Histology
    • Histological assessment of the marrow: → Preserved architecture of cells and their relationship to each other + bone → Not influenced by peripheral blood contamination
    • Involves 2 x major assessments:
      • Haematoxylin & Eosin (H&E) staining.

Flow Cytometry

  • Quantifies plasma cells and detects prognostic markers (e.g., CD138 for plasma cells, CD38 for diagnosis, CD56 for poor prognosis).
  • Detection of plasma cells allows for:
    • Quantification → Aids diagnosis of myeloma vs.MGUS/SMM
    • Prognostic implications (red = poor prognosis in myeloma)

Cytogenetics

  • Karyotyping + Fluorescence in situ hybridisation (FISH)
  • Most common is t(11;14)(q13;q32) translocation
  • Involves CCND1 leading to overexpression of cyclin D1
  • Associated with a good prognosis
  • Can also identify other changes:
    • Hyperdiploidy
    • Aneuploidy
    • Chromosomal loss, e.g.del13, del17p (TP53)

Immunohistochemistry

  • Uses markers like CD138 (high sensitivity for plasma cells) and MUM1 to stain and identify plasma cells in bone marrow trephine sections.
  • Skeletal Survey (CT / X-Ray)
  • Prognostic and Treatment Considerations

Prognostic Assessment

  • The Revised International Staging System (R-ISS) is used, combining genetic markers with clinical features to assess disease severity and outcomes.
  • Poor prognosis linked to genetic abnormalities like del17p.

Treatment Options

  • Depends on prognosis and general patient fitness.
  • General options include (either alone or in combination):
    • Combination chemotherapy, e.g.VRD (Bortezomib, Lenalidomide, Dexamethasone)
    • Monoclonal antibodies, e.g.Daratumumab
    • Salvage, high dose chemotherapy, e.g.D-PACE
    • Autologous stem cell transplantation
    • Targeted radiotherapy (plasmacytomas)
    • Bisphosphonate therapy
    • Blood transfusion support
    • Palliative / Comfort Care etc

Relapse Monitoring

  • Routine checks include symptom tracking, blood tests, paraprotein levels, skeletal imaging, and potentially repeated bone marrow biopsy if relapse is suspected.
  • Clinical Features:
    • Constitutional Symptoms
    • Bone Pain
    • Blood Tests → Haemoglobin, calcium, renal function
    • Paraprotein Levels + Serum Free Light Chains
    • CT skeletal survey
    • If relapse is suspected based on above:
      • Repeat bone marrow biopsy!
      • Consider alternative treatments (if available)

Conclusion

  • Multiple myeloma is a complex, heterogeneous disease requiring personalized diagnostic and treatment approaches.
  • The diagnostic and treatment paradigms are evolving, with translational research crucial for refining prognostic profiling and improving outcomes.
  • Myeloma is a heterogenous disease
  • Pathobiology involves multiple components of the Cancer Model
  • Therapeutic targets often work in combination to target multiple abnormalities
  • Disease evolution occurs leading to relapsing and treatment refractory disease
  • Diagnostic and treatment paradigm is constantly changing:
    • Becoming more “personalised” to the patient’s disease profile
    • Ongoing translational research is required!
  • Good and accurate diagnosis means adequate prognostic profiling
  • Enables access to the right treatment + improves disease outcomes

Bowel Cancer

  • Malignant neoplasm of the bowel, usually adenocarcinoma of the large bowel (colorectal carcinoma).
  • Other types less common include lymphomas, neuroendocrine tumors, GIST, sarcomas, metastases from other organs, and others.
  • Benign and intermediate-grade tumors include:
    • Benign polyps (neoplastic - hyperplastic polyp; non-neoplastic - hamartomatous polyp, inflammatory polyp, others)
    • Pre-malignant polyps (tubular/tubulovillous/villous adenoma, sessile serrated lesion/adenoma)
  • Adenocarcinoma of the small bowel is less common but similar spectrum of tumours occur there.

Overview of Colon Cancer

  • Definition:
    • Malignant neoplasm, commonly adenocarcinoma, of the large bowel.
    • Other bowel cancers include lymphomas, neuroendocrine tumors, gastrointestinal stromal tumors (GIST), and metastases.
  • Significance:
    • Common and potentially curable if detected early.
    • High morbidity and mortality rates, second most common cancer in Australia.

Epidemiology

  • 17,000 new diagnoses and 4,000 deaths per year in Australia.
  • Higher risk in older adults, men more than women.
  • Lifetime risk: ~1 in 10 for development, ~1 in 46 for mortality.

Risk Factors

  • Family history and genetic predisposition increase risk significantly.
  • Other risks: inflammatory bowel disease, obesity, diet high in processed/red meat.
  • Primarily a disease of older adults
    • Approx 10% are under 50, however approx 5% under 40
    • Family history and genetic factors important
    • Relative risk increases by approx 1.5x with 1 first degree relative affected
    • 3x with two or more first degree relatives.
    • If relative had bowel cancer under 45, RR is 5x.
  • Other risk factors:
    • Inflammatory bowel disease
    • Obesity
    • Diet high in processed meat, red meat
    • 5 year survival has dramatically improved since the 1980s, (66%)
    • Early detection and treatment
    • Identification of high risk individuals
    • New drugs (‘targeted therapy’)

Carcinogenesis and Genetic Pathways

  • Cancers occur as a result of clonal expansion of a single precursor cell line
  • This occurs due to acquisition of multiple non-lethal genetic mutations (variations) or ‘hits’ (Knudson hypothesis)
  • Some people are more genetically susceptible
  • Some cells are more susceptible
  • These primarily occur in one of four classes of regulatory genes
    • Growth promoting proto-oncogenes (gain of function)
    • Growth inhibiting tumour supressor genes (loss of function)
    • Genes that regulate cell death (pro-apoptotic)
    • Genes involved in DNA repair
  • With many genes, both alleles must be affected before phenotype is altered
  • Carcinogenesis is therefore a multistep process at the genetic level, and this is reflected phenotypically as a progression of precursor lesions, as additional ‘hits’ occur, combined with changes in epigenetic signalling, tumour/immune system interactions etc.

Mechanism

  • CRC arises from clonal expansion and non-lethal genetic mutations in four regulatory gene classes:
    • Proto-oncogenes.
    • Tumor suppressor genes.
    • Apoptosis-regulating genes.
    • DNA repair genes.

Genetic Pathways

  • Most CRC arise from sporadic mutation of cancer causing genes, while a subset arise from inherited mutations.
  • Most familial cases are not well understood, but FAP and Lynch syndrome are both important in overall understanding of CRC carcinogenesis.
  • CRC is heterogenous in phenotype, genotype and pathogenesis, and covers the same spectrum of behaviour regardless of pathway, however pathway is relevant to treatment, risk for other family members and understanding of tumour biology
  • Most CRC, regardless of triggers, result in activation of the WNT, MAPK or PI3K pathways leading to growth promotion and anti-apoptosis, as well as inactivation of the TGF-B and p53 inhibitory pathways.
  • The two most important pathways are the Chromosomal instability pathway (Adenoma-Carcinoma sequence) and the Serrated (Microsatellite instability) pathway.

Mechanism of genetic change in colon cancers:

  • Chromosomal Instability Pathway (Adenoma-Carcinoma Sequence):
    • High somatic alterations, DNA gains/losses.
    • resulting in high levels of somatic copy-number alterations and DNA gains/amplifications or losses/deletions (Chromosomal Instability Pathway / Adenoma-Carcinoma Sequence)
  • Microsatellite Instability (MSI) Pathway due to defective DNA mismatch repair (MMR):
    • DNA mismatch repair defects; high mutation rates.
    • leading to high mutation rate (MSI / serrated pathway, although note that MMR gene abnormalities are common as later events in both other pathways as well).
    • Most of these tumours show CpG island hypermethylation
  • Defective DNA polymerase proofreading, POLE Pathway:
    • DNA polymerase proofreading defect, very high mutation rate but mostly silent mutations.
    • with a very high mutation rate, affecting large numbers of genes.
    • Most of these are silent ‘passenger’ mutations, with some mutations occurring in driver genes (POLE pathway) *we won’t discuss this pathway in detail today

How Does Colon Cancer Develop (precursors)

  • ‘Adenoma-carcinoma’ Sequence – usually occurs in chromosomal instability pathway
    • Adenoma:
      • Macroscopic: large, exophytic, obstructing, irregularly shaped, ulcerated and haemorrhagic surface, complexity caused by tortuous folds and fusion of glandular structures.
      • Microscopic: infiltrative, irregular glands, variable architecture (can be solid, papillary, mucinous, tubular or a mix), often with desmoplastic stromal reaction and usually with intraluminal necrosis and inflammatory cells (‘dirty’ necrosis).
  • Serrated / Microsatellite Instability Pathway
    • Defects in mismatch repair genes (MLH1, MSH2 and others) leads to microsatellite instability, which creates an environment allowing accelerated accumulation of mutations in numerous genes.
    • Depending on the genes affected, this can lead to cancer.
    • In the colon, this often includes BRAF, which can trigger the serrated pathway.

Key Mutations

  • Activation of WNT, MAPK, PI3K pathways; inhibition of TGF-B, p53.
  • APC, TP53, KRAS mutations common in sporadic CRC cases.

Development of Colon Cancer: Stages

  • Normal Mucosa: No abnormalities.
  • Mucosa at Risk: Mild histological changes; early mutations.
  • Adenoma: Low-grade dysplasia; additional mutations.
  • Advanced Adenoma: High-grade dysplasia; mutations accumulate.
  • Carcinoma: Invades bowel wall, less differentiated.

Familial Colon Cancer Syndromes

  • Most colon cancers are sporadic.
  • Undefined/unknown mutations explain the majority of CRC in familial settings, but the known mutations are very important to understand.

Familial Colon Cancer 1- Familial Adenomatous Polyposis (FAP)

  • Autosomal dominant (1 in 10 - 30 000)
  • 20% of FAP cases are new germline mutations acquired during embryogenesis
  • 100% risk of colon cancer by age 40
  • Mutation in APC gene at 5q21 (or rarely MYH gene)
  • ‘Carpet’ of >100 adenomas increases probability of second, third hits
  • Prophylactic total colectomy by age 25, screening of relatives

Familial Colon Cancer 2- Familial Adenomatous Polyposis (FAP):

  • Autosomal dominant, APC gene mutation, 100% cancer risk by age 40.
  • Managed by prophylactic colectomy and family screening.
  • Hundreds of polyps carpeting the large bowel

Familial Colon Cancer 3- Hereditary Nonpolyposis Colorectal Cancer (HNPCC/Lynch Syndrome):

  • Fewer polyps, mismatch repair gene mutation.
  • Associated with multiple cancer types; requires regular screening.
  • Autosomal dominant (1 in 600 - 2000)
  • Fewer adenomatous polyps than FAP, more than sporadic cancers
  • Mutations in mismatch repair gene(s) MLH1 or MSH2 (most) as well as MSH6, PMS2, and EPCAM
  • Results in inherited microsatellite instability (MSI)
  • Increased risk of bowel, endometrial, bladder, gastric and skin cancers
  • “Amsterdam criteria” for genetic testing: 3 or more family members with CRC (at least one first degree), two successive generations, at least one before age 50, FAP excluded.
  • “Bethesda criteria” for genetic testing: CRC

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Description

This quiz covers the fundamental aspects of neoplasms, including the differences between benign and malignant tumors, the importance of reactive stroma, and key tumor classification systems. It also explores various grading systems and the factors influencing cancer prognosis. Test your knowledge on tumor morphology and metastasis.

More Like This

Ovarian Tumors and Neoplasms Quiz
5 questions
Bone Tumor Classification Quiz
17 questions
Classification of Salivary Neoplasms
24 questions
Neoplasia Overview
33 questions

Neoplasia Overview

TrustedJuxtaposition6728 avatar
TrustedJuxtaposition6728
Use Quizgecko on...
Browser
Browser